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Introduction and thesis outline:
Mimicking cellular structures
Part of this chapter has been published as a review: 
R. J. R. W. Peters, I. Louzao, J. C. M. van Hest, Chem. Sci. 2012, 3, 335–342.
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1.1 Introduction
Compartmentalisation is crucial to life, as is clearly manifested by the occurrence of 
the living cell and the different compartments it contains. In fact, according to some of the 
leading theories, compartmentalisation has even been instrumental to the origin of life,[1] since 
in order to start an evolutionary process molecules should be kept closely together, to allow 
advantageous mutations to lead to preferential replication. The cell membrane is only one 
of many organisational structural elements found in nature. Inside the cell, most metabolic 
processes are also highly organised. For example, in prokaryotes local assemblies of enzymes 
can be observed as a result of concurrent and diffusion-limited protein expression, which are 
involved in cascade processes.[2] Compartmentalisation in cells is most obvious in eukaryotes, 
where different organelles can be identified, each surrounded by their own membrane[3]. The 
presence of organelles allows a better control over the biological processes that occur inside 
these compartments. Compartmentalisation in this case has some additional advantages: 
fragile processes are protected from undesired influences, and highly reactive conditions, as 
found in the peroxisome and lysosome, cannot harm the rest of the cell. Furthermore, also in 
organelles positional assembly of enzymes takes place; for example in the mitochondrion,[4] 
where both in the mitochondrial membrane (oxidative phosphorylation) and in the matrix (for 
example, the tricarboxylic acid (TCA) cycle), spatially arranged enzyme complexes can be 
observed. This enhances the efficiency of these multistep processes, allows the introduction 
of feedback mechanisms and enables the use of labile intermediates. 
Due to compartmentalisation and positional assembly a cell can perform many different 
chemical processes simultaneously, which do not affect each other in an uncontrolled way. 
For molecular scientists, this phenomenon is highly inspirational and in recent years increased 
attention has been given to mimic the compartmentalisation and positional assembly 
strategies found in nature.[5] In fact, this interest serves a twofold purpose: it leads to a better 
understanding of the organisation of multistep biological processes, and secondly it enables 
the development of methodologies that allow a better control over complex synthetic reactions. 
In order to mimic the natural compartmentalisation process, synthetic nano- or 
microcapsules have to be developed. Lipids, being Nature’s own building block, have 
been the most widely used components to construct synthetic vesicles, which are called 
liposomes. In recent years, however, we have seen the design of a variety of different types of 
nanocontainers, based for example on other natural systems, such as plant viruses,[6] or even 
on inorganic structures such as mesoporous silica.[7,8] Another important class are polymer-
based capsules, which have been used to encapsulate many different cargos, especially 
therapeutics for drug delivery applications[9–11], but also enzymes[12,13] to generate single-
enzyme nanoreactors, able to mimic metabolic reactions. These polymeric compartments 
include, for example, Layer-by-Layer (LbL)  capsules[14] and polymer vesicles that are also 
known as polymersomes (Figure 1.1).[15,16]
This chapter reviews the advances in the development of synthetic vesicles from simple
11
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micro- or nanoreactors into compartments that combine both biological functionality and 
structural organisation in a (multi)compartmentalised system to try to mimic the complexity of 
organelles and cells.
Figure 1.1. Various polymers used to form polymersomes. A) The bilayered structure of a polymersome 
can be formed by self-assembly of amphiphilic block copolymers, like PS-b-PIAT (1), PS-b-PEG (2), 
PB-b-PEG (3), or PMOXA-b-PDMS-b-PMOXA (4). B) The multi-layered structure of Layer-by-Layer 
capsules is formed by alternating adsorption of polycationic and polyanionic polymers on a solid template, 
followed by template removal to yield hollow capsules. Common polymers used are poly(L-lysine) (5), 
poly(L-arginine) (6), poly(allylamine) (7), poly(L-glutamic acid) (8), dextran sulphate (9), or poly(styrene 
sulfonate) (10). Adapted from reference 104 with permission.
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1.1 Single compartment nanoreactors
Polymersomes are the polymeric analogues of liposomes, with the main difference being 
that the bilayer is built from amphiphilic block copolymers instead of lipids (Figure 1.1.1A). As a 
result the polymer capsules are more stable, less permeable and chemically easier to modify. 
Until recently, polymersomes were mainly regarded, based on these properties, as smart 
drug delivery vehicles, which could be tailor made with respect to surface functionality, shape 
and size. Furthermore, the large hydrophobic domain of the bilayer allows a better loading of 
hydrophobic drugs.[17,18] However, these capsules are in principle also perfectly suited for the 
encapsulation of catalytic species. Within a polymersome, one can even identify three different 
domains that can be used for catalyst positioning, namely the lumen (water pool inside), the 
bilayer and the polymersome surface. Several methods can be employed to achieve specific 
positioning of the catalysts into the polymersome structure, like encapsulation of enzymes 
in the lumen via rehydration,[19,20] nanoprecipitation,[21] or after assembly by electroporation.
[22] Furthermore, also covalent attachment of the catalyst to the block copolymer before self-
assembly can be used to confine a catalyst to the membrane;[23] post-assembly surface 
modification via reactive handles[24] can be used to attach a catalytic species to the surface. 
The benefits of the use of polymersomes for drug delivery purposes also account for the use 
of the capsules as catalytic containers, with one exception, which is the bilayer permeability. In 
order for this field of science to develop, methods had to be introduced first, which allowed the 
transport of substrate and product molecules across the polymer membrane, while retaining 
the catalysts inside the nanoreactor structure.
The large hydrophobic domain of polymersomes makes transport of small molecules 
across the membrane very difficult and in fact should actually disqualify them as suitable 
nanoreactors. In some limited cases transport is still efficient enough to enable a 
catalytic process to take place inside the lumen.[25] Polymersomes constructed of poly(2-
methyloxazoline)-b-poly(dimethylsiloxane)-b-poly(2-methyloxazoline) (PMOXA-b-PDMS-b-
PMOXA) proved to be permeable for oxygen and superoxide radicals, which were neutralised 
by the encapsulated superoxide dismutase enzyme.[26] However, normally porosity has to be 
introduced in the polymer membrane. A bio-inspired approach is the use of channel proteins, 
for example aquaporin B.[27] The polymer bilayer can accommodate the smaller protein in 
such a way that the channel function remains intact and transport of small molecules across 
the membrane is achieved. An interesting application of this system features the enzyme 
Penicillin acylase, which can locally convert a pro-drug into an active anti-biotic capable of 
inhibiting bacterial growth (Figure 1.2A).[28]
In other cases porosity is an intrinsic property of the polymers that constitute the membrane. 
This is the case for polyelectrolytes. Layer-by-layer capsules (Figure 1.1B) constructed of 
alternating layers of polyanions and polycations have proven to be permeable for substrates. 
This property has been extensively used for the construction of a series of nanoreactors, of 
which some of them are multi-compartmentalised.[14,29–31] Several approaches can be used 
13
Introduction and thesis outline
to build the LbL structure around the solid template,[32,33] allowing for the encapsulation of 
biologically relevant molecules, like enzymes, which were shown to retain their activity under 
mild template removal conditions.[34] Polyelectrolytes of opposite charge can also be used for 
the formation of polyion complex vesicles, or PICsomes.[35,36] 
Charge can also be applied to introduce permeability in polymersomes, by using charged, 
pH-sensitive species in the side chains of the hydrophobic block. When the pH is changed to 
introduce charge, by (de)protonation of the side chains, the entire block copolymer becomes 
soluble, while upon removing the charge again, the ionic block becomes hydrophobic and 
causes vesicle assembly. To use this system to introduce permeability without losing vesicle 
stability, the groups of Voit and Battaglia used protonatable tertiary amine groups as the pH-
responsive moiety, while also introducing cross-linking groups to allow the system to retain 
its stability upon protonation of the side chains.[37] In this fashion, vesicle permeability, but 
also activity of encapsulated myoglobin, could be reversibly induced by changing the pH of 
the solution. Similarly, block copolymers with photocaged amine groups in the side chain can 
be used to construct permeable polymersomes, where upon UV-irradiation the amines will 
be deprotected in situ. The amines also partially undergo a cross-linking reaction with other 
polymer chains, giving the vesicle stability while the remaining fraction of amines can provide 
permeability to the system. In this example, the activity of alkaline phosphatase could be 
modulated by using the UV stimulus to switch on the nanoreactor.[38] Using a double emulsion 
approach, also capsules can be made from poly(acrylic acid)-b-poly(distearin acrylate), which 
uses the acrylic acid segments in the membrane to induce permeability upon pH change.[39] 
Finally, Yan and co-workers devised an approach that uses the addition or removal of CO2 
from the vesicle solution to protonate or deprotonate the dodecylacrylamide side chains in 
the hydrophobic segment of the bilayer. Upon protonation the vesicles swell and become 
permeable, allowing the presence of CO2 to be used as a reversible trigger to swell and shrink 
the vesicles and modulate the porosity (Figure 1.2B).[40,41]
However, charge is not a prerequisite per se. We have demonstrated that polymersomes 
composed of the neutral block copolymer polystyrene-b-poly(3-(isocyano-L-alanyl-amino-
ethyl)-thiophene) (PS-b-PIAT) are inherently porous, due to the frustrated packing of the 
molecules in the polymer bilayer. The porosity is such that large molecules like proteins cannot 
diffuse across the membrane, but smaller molecules can; examples of specific systems will be 
discussed in more detail later in this chapter (Figure 1.3).[42,43]
Another interesting option is to use a sacrificial block copolymer, which is mixed in with 
a traditional amphiphilic block copolymer during polymersome formation. Upon applying a 
stimulus, the sacrificial block is solubilised and thereby removed from the membrane, leaving 
behind a porous structure. We have demonstrated this principle with a poly(styrenyl-boronic 
acid)-b-poly(ethylene glycol) (PSBA-b-PEG) block copolymer, which was mixed with a 
traditional polystyrene-b-PEG amphiphile (PS-b-PEG) (Figure 1.2C). Upon raising the pH, 
and with the addition of glucose, the boronic acid units turned hydrophilic and the block could 
be removed. By varying the ratio between the two polymers, the degree of porosity could 
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be modified, which was translated into a different reactivity and accessibility of the enclosed 
enzyme.[44]
An approach that does not require changing the solvent composition (i.e. by adding 
base, acid, or sugar), involves using temperature-sensitive enzyme amphiphiles for vesicle 
construction. Here PNIPAM-functionalised BSA was used to form the vesicle membrane, and 
after cross-linking the shell, temperature was used to reversibly change the porosity of the 
system. In this way, the system could discriminate between polar and non-polar substrates 
that were fed to the encapsulated enzymes. At low temperature, the PNIPAM chains were 
soluble and therefore both hydrophilic and hydrophobic substrates permeated the membrane. 
Yet, when the temperature was raised above the lower critical solution temperature (LCST) of 
PNIPAM, the polymer chains became hydrophobic and prevented passage of polar substrates. 
Furthermore, the authors demonstrated that it is possible to perform in vitro transcription and 
translation (IVTT) reactions to produce GFP inside the vesicles.[46]
A post-modification approach to introduce permeability into the vesicle has also been 
demonstrated by the group of Meier, for which regular polymersome-forming block copolymers 
Figure 1.2. Several methods to induce polymersome permeability. A) PMOXA-b-PDMS-b-PMOXA 
polymersomes with an OmpF channel protein encorporated into the bilayer structure. B) PEG-b-
PAD polymersomes with CO2-triggered membrane permeability. C) PS-b-PEG based polymersome 
nanoreactors using a sacrificial PSBA-b-PEG block copolymer that can be washed away by increasing 
the pH and sugar concentration, causing the capsule to become porous. D) A post-modification approach 
using a hydroxyalkylphenone photoreaction to induce permeability, which has been applied in several 
types of polymersomes. Adapted from references 28, 41, 44 and 45 with permission.
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were used without any specific functionality. After vesicle formation, a photoreaction with a 
double radical-forming hydroxyalkylphenone, introduced hydrophilic groups into the vesicle 
bilayer, which caused the membrane to become semi-porous (Figure 1.2D). However, no 
cross-linking between polymer chains was observed, yet still vesicle integrity was retained 
despite the increased hydrophilicity. It is likely that only a small amount of hydrophilic groups 
are introduced, as permeability is mainly improved for hydrophobic substrates for the 
encapsulated horseradish peroxidase (HRP), while hydrophilic substrates show much lower 
permeation through the vesicle membrane.[45]
1.2 Single compartment nanoreactors with multiple catalytic species
Many studies have been performed with different types of nanocontainers that were 
applied in single enzyme reactions,[47] including a large number of polymeric capsules.[12,13] A 
step forward from single enzyme nanoreactors is the development of reactors that facilitate 
cascade reactions using multiple catalytic species in succession. (Bio)catalysts that are 
able to work together in close proximity, yet without influencing each other, contribute to the 
required complexity in order to reach efficient processes. Positional assembly of the different 
components involved, as well as their spatial distance, are also important issues as they 
increase the control over the overall process. This was for example shown in a study by 
Willner et al., who covalently linked Glucose Oxidase  (GOx) and Horseradish Peroxidase 
(HRP) to a DNA strand[48] at pre-determined locations, to optimise the cascade reaction as 
a function of the distance between enzymes. The most effective distance between glucose 
dehydrogenase (GDH) and its immobilised cofactor, nicotinamide adenine dinucleotide 
(NADH), was also investigated, showing that a larger tether improves reaction rate. In this 
section we will discuss enzymatic cascade reactions in polymeric nanoreactors, as well as 
positional assembly approaches that have been developed.
Choi and Montemagno reported one of the first examples of a cascade reaction in a 
polymersome. They used the coupled actions of the channel protein bacteriorhodopsin (BR) 
and F0F1-ATP synthase
[49] to generate ATP in polymersomes made from the amphiphilic triblock 
copolymer poly(2-ethyl-2-oxazoline)-b-poly(dimethylsiloxane)-b-poly(2-ethyl-2-oxazoline) 
(PEtOz-b-PDMS-b-PEtOz). ATP synthase uses the light-driven proton gradient generated 
by BR across the polymersome membrane to produce ATP. This occurs by means of the 
rotational action of the membrane-integrated F0 domain, using ADP and inorganic phosphate 
taken from outside the polymersome. 
Polymersomes made of PS-b-PIAT have been used for the positional assembly of 
the enzyme Candida Antarctica Lipase B (CalB).[50] This enzyme was positioned either in 
the aqueous inner compartment or inside the bilayer membrane. The effect of positioning 
on activity was investigated with the enzymatic ring-opening polymerisation of lactones. It 
was shown that enzymes inside the water pool catalysed the formation of oligolactones of
16
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similar lengths as compared to free enzymes. When CalB was localised in the bilayer, the 
oligolactones formed were significantly shorter as a result of steric hindrance.  
With the same type of vesicles, cascade catalysis was performed using single enzyme-
containing polymersomes. HRP and GOx were encapsulated separately. A cascade reaction 
was initiated by just mixing both types of polymersomes and the protective effect of the 
polymer capsule against enzymatic degradation by proteases was also demonstrated.[42] A 
step further was the development of a three-enzyme cascade. One enzyme was included 
in the lumen (GOx) and another in the shell (HRP) of PS-b-PIAT polymersomes. The third 
enzyme, CalB, was located in the outer solution. The cascade reaction was started upon 
addition of peracetylated glucose. CalB catalyses the formation of glucose, which is able to 
penetrate the polymersome shell to be converted into the corresponding lactone, thereby 
forming H2O2, the substrate for HRP.
[21]
To realise a three–enzyme cascade in which all enzymes were connected to the 
polymersome nanoreactor, a bioconjugation reaction was performed which allowed attachment 
of HRP to the periphery of the capsule.[24]. HRP complemented the enzymes already included 
in the inner part (GOx) and in the shell (CalB) of the polymersomes (Figure 1.3).[51] This is the 
first example involving a three enzyme cascade with positional control in a single vesicle (see 
also section 1.5).
Enzymatic complexes in nature often make use of cofactor regeneration cycles in catalytic 
pathways. Mimicking this system, PS-b-PIAT-based nanoreactors were also applied in cofactor 
regeneration for Baeyer-Villiger reactions catalysed by phenylacetone monooxygenase 
(PAMO).[52] Nicotinamide adenine dinucleotide phosphate (NADPH) is consumed by PAMO 
during the oxidation of the substrate, phenylacetone. Glucose-6-phosphate dehydrogenase 
(G6PDH), located in the polymersome lumen reduced the oxidised NADP+ back to NADPH, 
to be consumed again by PAMO, which was free in solution. This example shows that 
polymersome nanoreactors are capable of performing biologically relevant regeneration 
processes.
Figure 1.3. A three-enzyme cascade reaction in a single polymersome nanoreactor. Glucose 
monoacetate is converted into glucose by CalB; glucose is subsequently oxidised by GOx, producing 
both the gluconolactone and H2O2. The latter is used by HRP to oxidise the assay molecule ABTS. Figure 
reproduced from reference 51 with permission.
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PMOXA-b-PDMS-b-PMOXA-based polymersomes, in which channel proteins were 
introduced in the polymeric layer to increase the permeability, have also been investigated 
as nanoreaction vessels for cascade biocatalysis. Recently, a cascade reaction to scavenge 
reactive oxygen species (ROS)[53] was performed inside polymersomes. Copper-zinc 
superoxide dismutase (Cu,Zn-SOD) and lipoperoxidase (LPO) were both encapsulated in 
polymersomes in order to combat oxidative stress. The application of this system will be 
further described in section 1.4. 
Vesicles made from biohybrid amphiphiles, called giant amphiphiles, are another example 
of nanoreactors performing cascade reactions. One such system features vesicles composed 
of horseradish peroxidase-polystyrene (HRP-b-PS) or horseradish peroxidase-poly(methyl 
methacrylate) (HRP-b-PMMA) in which  GOx was encapsulated.[54] The giant amphiphiles 
were constructed by anchoring a heme group to the polymer chain (PS or PMMA). The addition 
of an aqueous solution containing the apo-enzyme provoked the selective assembly of the 
apo-protein with the heme group to form the polymer hybrid, which subsequently assembled 
in vesicular aggregates, while encapsulating GOx, which was also present in the solution. The 
functional cascade reaction could be triggered by the addition of glucose and observed by the 
oxidation of 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) by HRP.
Microcapsules were also used as containers for performing enzymatic cascade reactions. 
The positional assembly was in this case achieved by vesicle-in-vesicle techniques with 
different hierarchies. Multicompartment systems offer a new degree of complexity and control. 
The cascade reactions performed in this type of containers are described in section 1.5.
Compared to the above listed cascade reactions, cells use a far more complex network 
of enzymes to, for example, replicate and transcribe DNA in order to produce proteins. By 
extracting this machinery from cells an in vitro transcription and translation (IVTT) mixture is 
obtained, which has all the components for protein production. Upon encapsulation in a vesicle, 
a system was constructed that can be regarded as a very simple artificial cell. Previously, 
experiments were already performed in liposomes or in water-in-oil emulsions, where these 
cell-like systems were applied to study the dynamics of transcription and translation in a more 
controlled manner compared to actual cells.[55–59] By encapsulating the IVTT mixture, together 
with a plasmid that encodes for a fluorescently labelled protein inside polymersomes, the group 
of Weitz was able to produce a membrane-binding protein.[60] Another interesting application 
of using the protein production machinery in combination with polymer vesicles, shows how 
transmembrane receptor proteins were produced in a vesicle solution and spontaneously 
incorporated into the membrane of the vesicle and thereby presented on its surface.[61]
1.3 Nanoreactors as artificial organelles in cells
By utilising various methods to induce porosity in a selective manner and to incorporate 
(multiple) enzymes in specific compartments of the vesicle, polymeric capsules have become 
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increasingly more complex model systems of nature. A logical step forward, following these 
developments, is the application of polymer-based nanoreactors as actual artificial organelles 
in vitro and eventually in vivo. Yet the cell, and especially its membrane, poses a challenging 
boundary to be crossed, as most polymeric nanoreactors are not readily internalised by cells. 
Furthermore, trying to specifically target cell types of interest is critical in enabling in vivo 
applications without causing side effects by interactions of the capsules with other cells. 
Hence, developing methods to add both targeting and uptake-inducing moieties to the vesicle 
surface are of vital importance to allow the further development of polymeric nanoreactors as 
artificial organelles for cellular applications.
In recent years, several methods have already been developed for the surface 
functionalisation of polymeric vesicles. To ensure maximum surface coverage, highly reactive, 
but also very selective functional groups are preferred. Several reaction pairs are suitable for 
this and have been successfully implemented, like the widely applied copper-catalysed azide 
alkyne cycloaddition (CuAAC) reaction, which is both fast and selective. In this way, polymeric 
vesicles made from polystyrene-poly(acrylic acid)  (PS-b-PAA) diblock copolymers with 
terminal azides, fully covering the vesicle surface, can be modified with several acetylene-
containing compounds, like fluorescent proteins, gold nanoparticles or biotin for further 
functionalisation.[62] Biotin was also directly attached to vesicle-forming PMOXA-b-PDMS-b-
PMOXA block copolymers to allow a two-step functionalisation with streptavidin, followed by 
addition of biotinylated polyguanine to allow macrophage binding.[63] Similarly, this chemistry 
can also be used to attach and display antibodies onto the polymersome surface for targeting.
[64]
Both previous methods cover the entire surface with reactive groups. Yet in order to gain 
more control over the amount and also density of functional groups on the surface, a system 
with two block copolymers can be used. Here a second block copolymer with a reactive group 
is added besides the inert regular block copolymer, to co-assemble into polymer capsules. 
This allows the amount of functional handle presented on the particle surface to be carefully 
regulated, which is important in drug delivery applications. Using such an approach, PMOXA-
b-PDMS-b-PMOXA polymersomes were functionalised with various amounts of fluorescent 
proteins and antibodies for specific binding to cancer cells via a two-step bis-aryl hydrazone 
conjugation strategy.[65] A similar approach employed for PS-b-PIAT polymersomes involved 
the use of a structurally different PS-b-PEG based second polymer, to add a functional handle 
to the vesicle. This block copolymer not only gave the vesicle a reactive handle, but also 
PEGylated the vesicle, to provide it with “stealth” characteristics towards the immune system. 
The solvent-exposed PEG block contained terminal acetylene moieties that allowed reaction 
with various azide-containing proteins.[24,51] A very broadly applicable method for protein 
immobilisation on polymersomes uses the presence of a nitrilotriacetic acid group, which can 
conjugate Ni2+ ions, on the vesicle surface. This metal complex is capable of binding the 
commonly used hexahistidine protein purification tag, and can therefore be used to bind a wide 
range of different recombinant proteins.[66,67] Finally, Leung and coworkers developed a bio-
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inspired approach to functionalise vesicle surfaces. They attached a short peptide recognition 
sequence to LbL capsules that can be recognised by Sortase A, a bacterial enzyme that can 
couple another protein to this small recognition peptide.[68]
Addition of a structurally different second block copolymer can also be used to induce 
phase separation of the two polymers in the polymersome membrane. For example, using a 
block copolymer capable of copper or calcium binding and one incapable of this, reversible 
lateral segregation of the block copolymers in the vesicle membrane was induced by the 
addition of metal ions. This led to the formation of separate patches of one block copolymer 
type on the surface of the vesicle (Figure 1.4A), instead of having them evenly dispersed 
among the other block copolymer.[69] A different strategy to induce domain formation involves 
using the different characteristics of the hydrophobic or hydrophilic blocks. In the case of the 
hydrophobic block this is either the difference in block length or chemical structure, while with 
regard to the hydrophilic block it can involve repulsive electrostatic interactions (Figure 1.4B).
[70] Domain formation is also observed in nature, where multiple ligands can be positioned in 
close proximity to each other to bolster the effect of the individual interactions. In this way, 
controlling both the amount of functional handles present on the surface and the clustering 
thereof provides an additional level of control over the biological interactions of the capsule. 
In this fashion, packing groups that induce cellular uptake together in surface domains, has 
shown to improve cellular internalisation of polymersomes.[70,71]
Selective targeting of polymer capsules to places of interest can be achieved in multiple 
ways. For example, tumour targeting can be done passively, where the vesicles accumulate 
in tumour tissue due to the enhanced permeation and retention (EPR) effect because of the 
higher permeability of tumour vasculature towards these particles.[72]
Another commonly applied approach to target tumour cells involves the use of antibodies 
that can specifically bind antigens expressed by different cell types. In this light, PEG-coated 
layer-by-layer capsules modified with antibodies for colorectal cancer were successfully 
Figure 1.4. Domain formation in polymersomes at the micro and nano scale. A) Micrometer-sized 
poly(acrylic acid)-b-polybutadiene (PAA-b-PBd)/PEO-b-PBd polymersomes, with different block 
copolymer ratios, showing the Cu2+-induced formation of domains on the vesicle surface, visualised by 
fluorescence microscopy. The insert shows a graphical representation of the lateral segregation of the 
block copolymers in the vesicle membrane. B) Domains in nanometer-sized polymersomes consisting of 
PMPC-b-PDPA and PEO-b-PBO in different block ratios, visualised by 3D reconstructions from confocal 
laser scanning microscopy (top) and FFT-filtered TEM images of selectively stained polymersomes. 
Adapted from reference 69 and 70 with permission.
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applied to specifically target cells positive for the tumour antigen in vitro in the presence of a 
large excess of cells negative for the antigen.[73] A similar result was obtained for polymersomes 
functionalised with a breast cancer antibody.[65] Furthermore, this strategy can also be applied 
to use polymersomes filled with a contrast agent for magnetic resonance imaging to target and 
visualise bone cancer metastasis in vivo.[74] Similarly, smaller targeting groups, like peptides 
have also been used to target polymersomes to prostate cancer cells.[75]
Using the aforementioned tools for functionalisation and targeting that are already more 
widely applied for delivery purposes, polymer nanoreactors can also be introduced into cells 
to catalyse reactions in the interior of the cell. Here the polymer vesicle can act as a protective 
compartment, confining enzymes to the capsule to prevent fast proteolytic degradation. With 
a permeable outer membrane, small substrates are free to enter and leave the capsule, and 
to react with the encapsulated catalyst, effectively making it a mimic of cellular organelles: 
i.e. an artificial organelle. Such a system could be used to complement or recover existing, 
or diminished functions of a cell, but also to give the cell additional capabilities by introducing 
novel functionalities.
    An early example of such a system applied in cells involved trypsin-filled PMOXA-
b-PDMS-b-PMOXA polymersomes, with reconstituted channel proteins for permeability, 
which were used to recover trypsin activity in THP-1 macrophages.[76] Similar to this example, 
PMOXA-b-PDMS-b-PMOXA polymersomes filled with the enzymes superoxide dismutase 
and lactoperoxidase were used to lower artificially increased ROS levels. The system 
converts superoxide radicals, via a cascade reaction between the two enzymes, to water 
and oxygen.[53] An extension to this system shows the use of the same type of nanoreactors 
in HeLa cells, where they function as artificial peroxisomes. Despite of their large size (200 
nm) and in contrast to previous examples, they are apparently capable of spontaneously 
being internalised into HeLa cells and subsequently escaping the endolysosomal pathway 
to function inside the cytoplasm of the cell.[77] Compared to macrophages, regular cells do 
not readily take up polymeric vesicles unless an uptake-inducing signal is presented on the 
vesicle surface. Layer-by-layer particles can be designed in such a manner that the surface of 
the vesicle displays a positively charged polymer and thereby induces cellular uptake.[72] For 
polymersomes also a similar approach has been applied to enable cellular uptake for delivery 
purposes.[70,71] Another method to actively promote uptake of capsules in mammalian cells is to 
apply cell-penetrating peptides (CPPs). These peptides are mostly short virus-derived peptide 
sequences of a cationic nature that interact with the cellular membrane and promote uptake 
of the attached cargo. PS-b-PIAT polymersomes presenting the CPP ‘Tat’[78] via the previously 
mentioned PS-b-PEG functional handle, were shown to be actively taken up by several non-
phagocytic eukaryotic cell lines via macropinocytosis (Figure 1.5). It was demonstrated that 
encapsulation of the model enzyme HRP in these polymersomes allows intracellular activity of 
the enzyme to be measured. Furthermore, activity of the enzyme was maintained for a longer 
period of time compared to that of the free enzyme, effectively demonstrating the protective 
function of the polymer capsule serving as an artificial organelle in cells.[79] 
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Cellular localisation of artificial organelles is still an issue of intense research, since all of
the examples described show polymersomes that are routed to endosomes and lysosomes 
after internalisation. Most cellular chemistry, however, occurs elsewhere in the cell, like in the 
cytosol. Escaping from the endocytotic machinery is therefore a vital step forward to further 
develop artificial organelles for biomedical applications. Some polymersome-based systems 
already exist that can disrupt endosomes and locate to the cytosol. Yet these systems involve 
breaking down the polymeric shell, either by the acidic endosomal pH or via a photoresponsive 
element, to cause an osmotic shock that ruptures the endosomal membrane and allows the 
encapsulated cargo to escape into the cytosol.[80–82] However, for an artificial organelle the 
polymeric shell is an essential part of the system and should be kept intact to protect the 
enclosed enzymes from degradation. Therefore new strategies should be developed to allow 
intact polymeric capsules to reach the cytosol and to hopefully more efficiently serve their 
purpose as artificial organelles.
1.4 Multicompartment systems as structural cell mimics
The cell uses compartmentalisation to carry out complex multi-step reactions in order 
to protect biomolecules from toxic intermediates or from degradation, but also to avoid 
incompatibilities between catalytic steps and the formation of undesired byproducts. Inspired 
by nature, researchers have developed nanocontainers that allow the positional assembly 
of different enzymes involved in cascade reactions (see previous section). In order to get an 
even better level of control, enzymes can be localised inside different compartments within 
one nanoreactor.  The objective of compartmentalisation is thereby not only the controlled 
separation of enzymes, but also for example the control over the temporal availability of 
substrate molecules. In order to reach this level of control, multicompartment systems have 
to been designed. In this section different strategies that have recently emerged to form 
multicompartmentalised systems will be discussed.
Figure 1.5. PS-b-PIAT-based polymer nanoreactor functionalised with the Tat-peptide to mediate cellular 
uptake of the artificial organelle. Encapsulated HRP converts the substrate tetramethylbenzidine, which 
allows the activity of the nanoreactor to be measured by absorption.
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1.4.1 Polymersome-based systems
Recently, vesicle-in-vesicle architectures were obtained by the encapsulation of 
polymersomes during the formation process of a second type of polymer vesicles.  GFP-
loaded polymersomes formed by PMOXA-b-PDMS-b-PMOXA were encapsulated together 
with cyanine-5 conjugated immunoglobulin G proteins (Cy5-IgG) in PS-b-PIAT polymersomes.
[83] Encapsulation is in this case based on a statistical process or a nucleation effect between 
protein and polymer. 
Better control over the composition of the system can be obtained by emulsion-based 
techniques. Using capillary devices, polymersomes composed of poly-(ethylene glycol)-
poly(lactic acid) (PEG-b-PLA) containing multiple compartments were prepared. They were 
constructed out of double emulsions using the water-in-oil-in-water (W/O/W) strategy (Figure 
1.6). The number of inner droplets (2-8) in the double emulsion was controlled by adjusting 
the flow rates of the different phases. After evaporation of the organic phase, non-spherical 
polymersomes with different compartments were obtained (Figure 1.6B).[84] By using this 
approach, also different inner phases could be injected, resulting in two or more different 
compartments loaded with different actives. The same research group used the described 
strategy to prepare PEG-b-PLA polymersomes-in-polymersomes by injecting the polymersome 
dispersion as an inner phase, with programmed release of different coloured dyes, by tuning 
the stability of the bilayer membranes. Membrane rupture was induced sequentially from the 
outermost to the innermost polymersomes by mechanical strain. The stability of the bilayer 
membranes could also be controlled through the use of PLA homopolymers, which were 
incorporated in the hydrophobic region of the bilayer. PLA-homopolymer-loaded bilayers 
Figure 1.6. a) Capillary microfluidic device for preparing double emulsions with two different inner 
phases. b) Two-compartment polymersomes encapsulating two different actives. c,d) Overlays of optical 
microscopy images and fluorescence microscopy images of these polymersomes. Reproduced from 
reference 84 with permission.
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showed enhanced stability in water compared to the PLA homopolymer-free bilayer. Since 
PLA is biodegradable, PEG-b-PLA based polymersomes spontaneously dissociated slowly 
in water (17 days). However, homo-PLA-loaded bilayers showed stability for more than 2 
months. The main advantage of using microfluidic devices resides in the high degree of control 
on size, number of capsules formed (outer and inner), and the loading of the vesicles, which 
is considered to be quantitative. In the abovementioned examples multicompartmentalisation 
was thus achieved, however, still without encapsulation of biological functionality.
An approach developed by the group of Lecommandoux, which is also based on 
emulsion techniques, was used to build a polymersome-in-polymersome system where small 
PTMC-b-PGA polymersomes are encapsulated in larger PBD-b-PEO polymersomes. This 
method relies on the formation of aqueous emulsion droplets in an oil phase that contains 
amphiphilic block copolymers. The polymer stabilises the emulsion droplets with a monolayer. 
This emulsion can then be transferred on top of an oil-water interface, which is also stabilised 
by a monolayer of the same block copolymer. By subsequent centrifugation the emulsion 
droplets are forced to pass through the oil-water interface, thereby picking up the second 
monolayer to form bilayer vesicles (Figure 1.7). Using this technique, they showed that drug 
leakage can be slowed down by confining the drug within two consecutive vesicles, providing 
a double diffusion barrier.[85] Furthermore, they expanded on this technique by demonstrating 
that highly viscous environments, which resemble the cellular cytosol, can be included in 
the interior of the larger vesicle and can limit or inhibit diffusion of the smaller polymersomes 
present in the lumen.[86]
Figure 1.7. Formation of a polymersomes-in-polymersome system using a droplet transfer technique. 
A) The inner aqueous phase containing small polymersomes or other encapsulants is emulsified in an 
oil phase that contains an amphiphilic block copolymer, which stabilises the emulsion droplets with a 
monolayer (1). Subsequently, an oil-water interface is prepared, where the oil also contains the same 
block copolymer, which will form a monolayer at the interface (2). Finally, the stabilised emulsion is 
transferred on top of the interface and the system is centrifuged to transfer the emulsion droplets through 
the oil water interface, where they pick up a second monolayer of polymer to form a bilayer vesicle (3). 
Adapted from 85 with permission.
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1.4.2 Layer-by-Layer capsule-based systems
Compared to polymersome systems, some more progress in making enzyme-containing 
multicompartment systems has already been achieved with LbL systems. Kreft et al. used 
shell-in-shell polyelectrolyte microcapsules to perform a cascade reaction involving two 
enzymes located in two concentric compartments.[31] Capsules were prepared around 
a CaCO3 template in which a peroxidase was entrapped by a coprecipitation method. 
This template was covered by a layer-by-layer (LbL) coating by alternately adsorbing five 
bilayers of polystyrene sulfonate (PSS) and polyallylamine hydrochloride (PAH). Around this 
microparticle a second CaCO3 template was formed, in which the second protein (GOx) was 
entrapped. Also this template was covered with an LbL coating. After removal of the CaCO3 
templates, glucose was added to the capsule-in-capsule nanoreactor to show coupled activity 
of both enzymes via the formation of fluorescent resorufin (Amplex Red assay) exclusively in 
Figure 1.8. Schematic illustration of capsosome assembly. A silica core is coated subsequently with 
a polymer layer and enzyme-loaded liposomes, followed by the alternating adsorption of separation 
layer(s) and liposomes. Finally a polymer capping layer is adsorbed prior to the deposition of poly(N-
vinyl pyrrolidone) (PVP) and thiol-functionalised poly(methacrylic acid) (PMASH) to form the capsule 
membrane upon crosslinking of the thiols. Dissolution of the core results in a capsosome with multiple 
layers of liposomes (CLx). Reproduced from reference 105 with permission.
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the inner compartment. Similarly, Bäumler et al. performed a three-enzyme cascade reaction 
in concentric multicompartment capsules, fully made of cross-linked biomacromolecules by 
the coprecipitation method.[87] After adding a pro-fluorescent glucose precursor, the cascade 
reaction (consisting of β-glucosidase-GOx-HRP) took place sequentially, converging from the 
outer to the inner compartment. 
Two compartment shell-in-shell capsules were also prepared with light-absorbing gold 
nanoparticles on the surface of the inner compartment, serving as a trigger for disassembly. After 
constructing the complete capsule, the content of the inner compartment was released using 
laser light, allowing the mixture of both actives.[88] This is an example of remotely inducing the 
mixing of two components, (i.e. an enzyme and its substrate) as a spark for a biological process. 
An alternative for the use of microcapsules consists of porous CaCO3 microparticles 
covered by nanocontainers. The CaCO3 pores were filled with proteins (i.e. a peroxidase, 
constituting the inner compartment). After covering the particle surface with polyelectrolytes 
following the LbL technique, nanosized liposomes containing the enzyme substrate Amplex 
Red were adsorbed onto the particle core. By utilising ultrasound as a trigger, the liposomal 
membranes were disrupted, releasing their content and generating the corresponding 
resorufin fluorescence after reaching the inorganic core.[89]
A specific LbL-liposome hybrid multicompartment system called a capsosome,[90,91] refers 
to liposomes incorporated inside the shell of a polymeric capsule (Figure 1.8). An efficient way 
to prepare them is by the LbL technique. Liposomes preloaded with different cargos (including 
enzymes) were embedded in between polymer layers of opposite charge (sandwich-like).[90] 
For the stable incorporation of liposomes into the polymer film, cholesterol-modified polymers 
were employed. A maximum of around 1.6·105 liposomes could be embedded in a 3 μm 
capsule.[92] The encapsulation of an enzyme made it possible to trigger a biocatalytic reaction. 
Lysis or destabilisation of the capsule led to an increase of the permeability and therefore 
allowed mixing of substrate, dissolved in the outer solution, and catalyst. Beta-lactamase,[90,92,93] 
luciferase,[92,93] and the protease subtilisin,[94] are among the enzymes used in these studies. 
The group has recently also shown the first step towards an equivalent system using pDNA-
loaded polymersomes made by a pH-responsive block copolymer instead of liposomes.[95] 
Upon decreasing the pH, the polymersomes were ruptured and electrostatic interactions were 
triggered between the phosphate backbone of pDNA and the poly(2-(diisopropylamino)-ethyl 
methacrylate (PDPA) block that formed the polymersomes. After increasing the pH again to 
physiological conditions, pDNA was gradually released from the LbL capsule. 
A final multicompartment system allows the hierarchical assembly of different types of 
compartments around a solid template. Here both polymeric hydrogel capsules and liposomes 
filled with the enzyme beta-lactamase were sequentially assembled into an LbL system. By 
using specific triggers, both capsule types were selectively disrupted, upon which disassembly 
of the liposomes released beta-lactamase to perform a catalytic reaction.[96]
26
Chapter 1
1.4.3. Liposome-based systems
Lipid vesicles have been used extensively for the construction of cell-like compartments, 
especially in order to study cellular processes like transcription, translation[55,57] and vesicle 
division[58] in a confined environment; yet, these are all single compartment systems. Several 
multicompartment structures have also been synthesised, which will be shortly discussed in 
this section.
Liposome-in-liposome assemblies called vesosomes have been developed for 
therapeutic use,[97] as the multicompartment assembly can provide additional protection 
against degradation and also limits leakage of encapsulated bioactive molecules.[98] These 
structures are generally prepared by temporarily disturbing giant unilamellar vesicles (GUVs), 
by either forming cochleate cylinders or interdigitated bilayers, before addition of the small 
unilamellar vesicles (SUVs) and subsequent closure of the large vesicles. Even though 
relatively high encapsulation efficiencies are obtained, their preparation procedure limits the 
applicability of both methods.[99] To form cochleate cylinders, Ca2+ has to be added, which 
can cause negatively charged dioleylphosphatidyl serine (DOPS) liposomes to fuse and form 
cigar-like cylinders.[100,101] Removal of Ca2+ after addition of SUVs closes the liposomes again. 
Due to the need for a negatively charged lipid to form the cochleate cylinders, only a limited 
number of lipids can be used to generate the outer membrane of the vesosome. A similar 
problem presents itself when interdigitated bilayers are used. These structures are generated 
Figure 1.9. Liposomes-in-liposome nanoreactor immobilised on a surface, containing two different 
SUV populations, each made of lipids with a distinct Tm. The SUVs contain either DDAO-phosphate or 
fluorescein diphosphate, both substrates for the enzyme alkaline phosphatase, which resides in the main 
compartment. The microreactor is kept below the Tm of the SUVs, while heating to the Tm of the SUVs can 
selectively release the substrates in a sequential fashion. Reproduced from 103 with permission.
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upon the addition of ethanol to SUVs under the lipid melting temperature (Tm) which will cause 
the liposomes to fuse and form interdigitated bilayer sheets. SUVs can then be added and 
after raising the temperature above the Tm will cause the lipid sheets to fold and form vesicles 
again. However, also here only some types of lipids are capable of forming the interdigitated 
bilayer structures required for this method to be successful. Additionally, the heating step often 
requires a temperature increase to over 40 ºC, which in turn might be harmful for biological 
material.[102] 
Another method to prepare liposomes-in-liposomes uses the commonly applied 
rehydration technique, which relies on statistical encapsulation of small vesicles into the 
larger vesicle. Using this approach, Bolinger and colleagues prepared a multicompartment 
nanoreactor, containing two SUV populations each containing a different substrate for alkaline 
phosphatase. By forming the SUVs from lipids that each have a distinctly different Tm, they 
were able to selectively release the substrate from one SUV population by heating to its 
specific Tm. The other substrate could then be released by further heating the sample to reach 
the lipid Tm of the other SUV population (Figure 1.9).
[103]
1.5 Outline of this thesis
The possibilities polymer capsules have to offer as nanoreactors and nanocontainers have 
increased tremendously in the past couple of years. Control over porosity, positional assembly 
of catalysts and the construction of multicompartmentalised devices have all increased the 
complexity of these particles. Also the ability to integrate these reactors into living cells opens 
up many new avenues.  On the one hand, these artificial organelles can be used to restore 
activity in dysfunctional cells; on the other hand, additional catalytic activity can be introduced 
to possibly even redirect or reengineer metabolic pathways. A current downside, however, 
is that these particles are often still trapped in endosomes after uptake by cells, which limits 
their applicability in modulating cellular processes. Most of the chemistry inside cells takes 
place in the cytosol, or in the different organelle subcompartments, and only a limited amount 
of processes are found in endosomes and lysosomes. Therefore redirecting the nanoreactors 
to the cytoplasm is of vital importance in order to fully explore the possibilities that artificial 
organelles have to offer. In Chapter 2, we describe two strategies to circumvent endosomal 
localisation of nanoreactors. First, the functionalisation of nanoreactors with several different 
endosomolytic peptides is discussed. For this a reactive handle was introduced in the particle, 
to allow for a modular functionalisation with the peptides. To monitor particle routing inside 
the cell, we used both electron microscopy and a pH-sensitive protein-fluorophore conjugate, 
capable of relaying local pH changes around the nanoreactors during cellular internalisation 
by changes in fluorescence intensity. The second approach features the development of 
a cationic liposome-based delivery vehicle, in which the nanoreactors are encapsulated. 
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This multicompartment system should be capable of fusing with the cellular membrane and 
delivering its cargo directly into the cytosol, thereby circumventing endosomal entrapment. 
Efficiency of the delivery vehicle was enhanced by tuning both the lipid composition and also 
by the addition of the above-mentioned endosomolytic peptides.
In Chapter 3, the concept of the multicompartment system containing the nanoreactors 
is further evaluated, not for cellular delivery, but for its ability to mimic the organisational 
structure of a eukaryotic cell. Several types of enzyme-filled nanoreactors, combined with 
reagents and enzymes in solution, were encapsulated inside a giant vesicle and used to 
perform multi-step enzymatic reactions, reminiscent of intracellular enzymatic pathways. 
The concept of compartmentalisation was furthermore also applied to spatially separate 
incompatible enzymes from each other, and allowing them to function simultaneously in a 
cascade reaction. 
In Chapter 4 and Chapter 5, different tools are developed to obtain more control over 
the reactions inside the cell mimics. The system presented in Chapter 3 describes a closed 
system, which upon mixing of the reagents and subsequent encapsulation inside the giant 
vesicles starts immediately with the envisioned enzymatic reactions. To gain more insight in 
the encapsulated processes and to be able to control them, triggering mechanisms need to be 
developed to start the reactions at a specific point in time. In Chapter 4, small molecule triggers 
are introduced that can passively diffuse into the giant vesicles and react with encapsulated 
enzymes. Without the small molecule, the system remains dormant, while upon addition of the 
enzyme substrate a reaction will be started that triggers a response from the giant vesicle. The 
enzymatic reaction causes production or consumption of NADH, a natural cofactor, together 
with production or consumption of a proton, respectively. The trigger therefore offers a method 
to influence the “intracellular” pH by addition of a small molecule. This pH change is then 
applied to reversibly modulate the assembly of a protein-ligand complex in response to an 
external trigger.
In Chapter 5 an additional method for the addition of substrates is introduced. The 
previous method described in Chapte 4 relies on passive diffusion, which is only feasible 
for uncharged, small molecules. Larger or charged molecules, like most enzyme substrates, 
cofactors, or macromolecules are unable to passively traverse the vesicle membrane. For 
this, the concept of membrane fusion, also discussed in Chapter 2, is applied. Smaller 
substrate-containing liposomes are used to transport and introduce their contents into giant 
liposomes, where subsequently enzymatic reactions are performed. To introduce specificity 
in the system, a different lipid composition is applied compared to the both cationic and 
fusogenic composition described in Chapter 2. Omission of the cationic lipid prevents non-
specific binding and fusion of liposomes. Introduction of a peptide-based heterogeneous 
dimerisation domain into the liposomal membranes is then used to bring the small vesicles, 
containing one of the peptides, and the giant vesicle, containing the complementary peptide, 
in close proximity to induce fusion. This approach not only allows for the introduction of a 
larger set of molecules, but also provides specificity, as only liposomes containing one of the 
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peptides are susceptible for fusion.
In Chapter 6, we reflect on the findings presented in this thesis and place them in the 
context of their respective fields. Furthermore, a number of promising avenues for future 
research, as well as several encountered bottlenecks are discussed.
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2.1 Introduction
Enzyme-filled polymeric particles, constructed from amphiphilic block copolymers, have 
extensively been used as nanoreactors.[1] Their structure allows for the encapsulation of 
active enzymes[2] and other metal or organic catalysts during their formation.[3] To function 
as nanoreactors, a semi-porous structure is required, where substrate molecules can freely 
diffuse in and out of the particle, while at the same time keeping the catalysts trapped inside. 
For this, several approaches exist, porosity can either be an intrinsic property of the polymeric 
particles,[4] or they can be equipped with channel proteins in their membranes.[2] Furthermore, 
their structure allows the spatial positioning of catalytic species in either the hydrophobic 
domain, or the aqueous inner compartment.[5,6] More recently, the ability to position polymeric 
nanoreactors in the cellular environment has funded an interest in their use as artificial 
compartments, or artificial organelles, inside living cells to complement existing functionalities 
or to add new capabilities by incorporating the required enzymes inside the nanoreactor 
compartments. Ideally, these organelles should reside inside the cytosol of the cell, like natural 
organelles. Pioneering work in this field already showed the uptake of PMOXA-b-PDMS-b-
PMOXA-based polymersomes in macrophages via a specific trigger,[7] and the introduction of 
trypsin activity into these cells.[8]
Uptake of artificial organelles based on the block copolymer polystyrene40-b-poly[l-
isocyanoalanine(2-thiophen-3-yl- ethyl)amide]50 (PS-b-PIAT) (1, Scheme 2.1A) in non-
phagocytic cells has also been achieved. By admixing a polystyrene-block-polyethylene 
glycol-based (PS-b-PEG) anchoring polymer functionalised with the cell-penetrating peptide 
‘tat’[9] (PS-b-PEG-tat) (2, Scheme 2.1A) these nanoreactors could also be actively taken up 
by HeLa, HEK and Jurkat cells (Figure 2.1 and Figure 2.2A). Here it was further shown that 
encapsulated horseradish peroxidase (HRP) remained active up to 16 times longer compared 
to non-encapsulated HRP inside cells.[10] However, nanoreactor activity still decreased at a 
faster rate inside cells compared to that in solution. To explain this difference, the cellular 
fate of the nanoreactors was investigated, as their localisation, and therefore also the 
surrounding environment in the cell, might influence the longevity of the nanoreactors or of 
the enzymes inside. Initial experiments revealed that the nanoreactors were taken up by 
cells via macropinocytosis, which seemed to result in endosomal routing, rather than the 
desired cytosolic localisation of the particles. Yet, colocalisation studies with a stain for acidic 
organelles only showed partial overlap with the nanoreactors inside cells (Figure 2.2A). Also 
attempts to release the particles from endosomes by adding the compounds chloroquine 
or nordihydroguaiaretic acid (NDGA), which can promote endosomal release of entrapped 
molecules, were unsuccessful in increasing activity or the longevity of the nanoreactors (Figure 
2.2B). Therefore it was speculated that partial routing to non-acidic vesicles, exocytosis of 
nanoreactors or lysosomal degradation of the enzymes could be contributing to the observed 
activity decrease.
If either lysosomal degradation, or routing to non-acidic vesicles occurs, a logical 
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solution would be to influence the intracellular trafficking of the nanoreactors and promote 
cytosolic localisation by means of escaping the endo-lysosomal system. Nature has 
developed several methods to escape from endosomal vesicles, which are most often used 
by viruses. The two most distinct approaches involve either endosomal membrane disruption, 
or fusion of the virus coat with the endosomal membrane to release the capsule content 
into the cytoplasm.[11] In the latter case the virus coat acts as a disposable carrier to deliver 
the viral DNA or RNA enclosed in the particle into the cell; yet in the case of the artificial 
organelle, the protective membrane is a vital and non-disposable feature of the system, and a 
fusion approach would therefore be less desirable, as it removes the protective coating of the 
particle. Membrane disruption or pore formation could therefore be a more useful method to 
release the nanoreactors from endosomes. In viruses, short peptide sequences that are part 
of the coat proteins are responsible for the interaction with the endosomal membrane. These 
fragments are often only exposed, or will only fold into an active form, upon acidification of the 
surrounding environment, as occurs during endosome maturation into a lysosome.[12] Attaching 
such a peptide fragment to the surface of an artificial organelle could therefore help disrupt 
the endosomal membrane to allow endosomal escape of the nanoreactor into the cytosol.
In this chapter we will first attempt to further elucidate the intracellular fate of the PS-b-
PIAT nanoreactors containing 10 w% tat, after which attention will be focussed on influencing 
the intracellular routing of the nanoreactors. For this, two strategies will be presented; the 
first will involve attaching endosomolytic peptides to the system, while the second will apply 
a liposomal delivery vehicle in which the nanoreactors can be encapsulated. For the first 
approach, we devised a modular strategy for functionalisation of the particles with different 
amounts of endosomolytic peptide. The above-mentioned PS-b-PEG-tat (2, Scheme 2.1A) 
can be admixed at 5 or 10 w% with PS-b-PIAT and will also be combined with 5 or 10 w% 
of a PS-b-PEG block copolymer containing a reactive handle. In all cases the total amount 
of PS-b-PEG block copolymer does not exceed 15 w%. The tat-containing polymer should
Figure 2.1. PS-b-PIAT and PS-b-PEG-tat polymers are mixed in a 9:1 ratio in tetrahydrofuran (THF) and 
added to an aqueous enzyme solution to form polymeric nanoreactors capable of entering cells. After 
cellular uptake, the enzyme encapsulated inside the nanoreactors is capable of performing its function 
inside the cellular environment.
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ensure cellular uptake, while the reactive handle can then be used to attach the desired 
endosomolytic peptide. For the second approach, the nanoreactors require no surface 
functionalisation and we envisioned the usage of a cationic carrier liposome containing the 
nanoreactors. This system should be capable of fusing with cellular membranes, which upon 
successful fusion should deliver the nanoreactors directly into the cell cytosol.
2.2 Results and discussion
2.2.1 Intracellular routing of tat-functionalized nanoreactors
To learn more about the intracellular fate of the PS-b-PIAT nanoreactors, first it was 
assessed if exocytosis might take place, by analysing the polymersome content inside cells 
over time. Cells were incubated for 4 hours with nanoreactors filled with bovine serum albumin 
(BSA) labelled with a pH-stable Atto488 fluorophore. After washing away non-internalised 
vesicles, the cells were either directly imaged, or incubated for another 22 hours in order to 
determine whether exocytosis of the particles took place. For both concentrations tested, 
no decrease in intracellular fluorescence was observed after 22 hours, indicating that no 
exocytosis took place (Figure 2.3).
Figure 2.2. Nanoreactor uptake in cells and its enzymatic activity over time. A) GFP-loaded nanoreactors 
(green) show partial colocalisation (orange in overlay) with the acidic compartment marker Lysotracker 
(red). B) Graph showing the decrease in activity of the HRP-filled nanoreactors over time as a result of 
cellular uptake and C) the influence of endosome disruptive agents on the rate of enzymatic activity loss. 
Reproduced from reference 10.
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Scheme 2.1. A) Compounds 1-3 used in this chapter. B) Synthesis scheme for PS-b-PEG-BCN. a) i) 
Styrene, CuBr, PMDETA, 90 ºC, ii) 1-phenyl-1-trimethylsilyloxyethylene, b) DCM/TFA (1:1), c) H2N-PEG67-
NH-Boc, HATU, DIPEA, DMF, d) DCM/TFA (1:1), e) BCN-OSu, DIPEA, DCM.
Figure 2.3. Nanoreactor exocytosis was assessed by measuring particle-bound Atto488 fluorescence 
inside cells using a platereader setup to determine the amount of nanoreactors residing in cells after 4 
hours incubation, and after a subsequent 22 hours pulse with fresh medium.
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After determining that exocytosis did not occur, we sought to obtain a more detailed 
picture of the intracellular location of the nanoreactors by using transmission electron 
microscopy (TEM) on cells incubated with BSA-filled PS-b-PIAT particles. For this, cells 
incubated with the nanoreactors were first stained, washed and then embedded in an epoxy 
matrix before being sliced using a microtome. These slices were then analysed by TEM 
to visualise the internal structures surrounding the polymer particles. Due to the absence 
of heavy metal staining agents, the polymers provided relatively little contrast, making it 
difficult to distinguish the nanoreactors inside the cells (Figure 2.4A). To improve contrast, 
BSA was first functionalised with several DTPA ligands, which were subsequently used to 
bind gadolinium, a heavy metal that should provide better contrast. Upon analysis of cells 
incubated with nanoreactors containing BSA-gadolinium, the particles could be easily 
distinguished (Figure 2.4B). Furthermore, it became clear that the particles were surrounded 
Figure 2.4. Transmission electron microscopy micrographs. Cells containing A) BSA-filled nanoreactors 
and B) BSA-gadolinium-filled nanoreactors. Insets show magnified segments where nanoreactors can 
be seen. White arrows indicate the presence of a lipid membrane around the particles. Regular TEM 
measurements indicate no distinct difference between BSA-filled nanoreactors (C) and BSA-gadolinium-
filled nanoreactors (D). 
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by a membrane structure, indicating that they still resided inside endosomal vesicles (Figure 
2.4B, white arrows). Interestingly, these experiments also revealed that the particles display 
very high protein loading, where the entire internal volume is packed with labelled proteins. 
Furthermore, the presence of larger domains inside the particle was observed, where no 
proteins are present and which are probably filled with PS-b-PIAT block copolymer, as an 
all-aqueous inner environment would likely show a more homogeneous protein distribution 
(Figure 2.4B). These protein and polymer rich phases, however, were not observed when 
analysing the nanoreactors via regular TEM measurements (Figure 2.4C and D).
As a final method for determining and monitoring nanoreactor trafficking inside the endo-
lysosomal system, the local pH of the surrounding vesicle was used. During endocytosis and 
subsequent maturation of the early endosome into a late endosome and finally a lysosome, 
the pH of the compartment drops significantly, from around neutral pH to values as low as 
pH 4.5.[13] To visualise this transition, a pH-sensing component was added to the inside of the 
PS-b-PIAT nanoreactors, as it was hypothesised that due to the porous nature of the particle, 
it should be possible for an encapsulated pH sensor to detect changes in the surrounding pH. 
Fluorescence is the most convenient read-out system available for cell-based experiments, 
and therefore BSA was equipped with a pH-sensitive fluorophore, Fluorescein, and a pH-stable 
fluorophore, tetramethylrhodamine (TAMRA), both using N-hydroxysuccinimide activated 
esters that can react with lysine side chains. This yielded a ratiometric and therefore also 
concentration independent pH sensor, as TAMRA fluorescence emission remains constant in 
the whole pH range and therefore acts as an internal standard, while Fluorescein emission is 
quenched at acidic pH. The ratio of TAMRA/Fluorescein therefore changes with pH, where an 
acidic pH gives a higher ratio due to Fluorescein quenching and a basic pH will give a lower 
ratio due to an increase in Fluorescein emission. Both the functionalised protein itself and 
the nanoreactors containing the sensor showed a clear increase in Fluorescein fluorescence 
emission upon changing the pH from 4.0 to 8.0 (Figure 2.5A).
After demonstrating that the pH-sensitivity was not lost by encapsulation of the protein in 
the nanoreactors, trafficking of the particles inside the cell was monitored. This showed that 
indeed the Fluorescein emission was quenched during internalisation, which can be seen 
by the changing ratio of TAMRA/Fluorescein for the different spots present inside the cells 
(Figure 2.5B). For each nanoreactor (pixel), a TAMRA/Fluorescein ratio was calculated (see 
experimental section for details) and this ratio was then plotted to obtain a frequency graph 
that displays the distribution of local pH values observed for the nanoreactors inside cells. This 
showed that after 4 hours incubation, a rather broad distribution in the TAMRA/Fluorescein 
emission ratio was observed (Figure 2.5C), while after 24 hours, the population became more 
narrow and shifted towards a more acidic pH (Figure 2.5D). This might indicate that after 4 
hours, the nanoreactors still resided in various parts of the endolysosomal system, while after 
24 hours they arrived at their final destination, which likely are the lysosomes.
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2.2.2 Nanoreactors displaying endosomolytic peptides
As acidification of the local environment of the nanoreactors inside cells could clearly 
be observed, combined with the observations from the TEM analysis, it could be concluded 
that the artificial organelles reside inside endosomal and lysosomal vesicles and do not seem 
to localise to the cytoplasm. Yet, as it would be desirable to achieve cytosolic delivery of the 
particles, a strategy should be designed to allow the particles to escape from endosomes. 
Previous attempts to disrupt endosomes by using either chloroquine or NDGA were 
Figure 2.5. A) Graph showing the pH-dependent change in Fluorescein fluorescence emission intensity 
at 522 nm, normalised for concentration differences by TAMRA emission at 572 nm. Displayed are BSA-
Fluo-TAMRA protein (triangles) and nanoreactors filled with BSA-Fluo-TAMRA (spheres). Protein was 
diluted 100 times in buffer of the desired pH, while nanoreactors were diluted 4 times and set to the 
required pH. B) Ratiometric confocal fluorescence microscopy image of 10% tat nanoreactors filled 
with BSA-Fluo-TAMRA loaded in HeLa cells, showing separate Fluorescein (green) and TAMRA (red) 
fluorescence channels in the insets. C and D) Normalised graphs displaying frequency distributions of 
TAMRA/Fluorescein fluorescence intensity ratios for nanoreactors admixed with 10 w% 2 incubated with 
HeLa cells for either 4 hours (C) or 24 hours (D). Lower ratio indicates higher pH. Separate traces (black 
and grey in C and D) represent individual snapshots of the same experiment.
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unsuccessful, and therefore we sought to devise a modular strategy that uses virus-derived 
endosomolytic peptides, which can be displayed on the nanoreactor surface and facilitate its 
endosomal release by disrupting the endosomal membrane upon acidification of the organelle 
(Figure 2.6). To this end, we synthesised a PS-b-PEG anchoring polymer functionalised with 
a reactive bicyclo[6.1.0]nonyne (BCN) handle[14] (8, Scheme 2.1B) to which azido-peptides 
can be conjugated using a strain-promoted azide-alkyne cycloaddition (SPAAC) via a post-
modification approach.[15] The BCN handle can then be admixed during nanoreactor formation, 
together with the PS-b-PEG-tat polymer (2), which enables cell uptake. Secondly, a library 
of potentially endosomolytic peptides was synthesised, to which either a C-, or N-terminal 
reactive azide handle was added, depending on the importance of an available terminus for 
peptide activity, to allow attachment to the surface of the polymer particle using the SPAAC 
reaction (Table 2.1). Most of the used peptides are derived from virus coat proteins, however, 
His10, GeT and dhvar5 are synthetic derivatives and designed to act as a proton-buffering 
peptide (His10), or as an amphipathic membrane-disruptive peptide (GeT and dhvar5). Of the 
virus-derived peptides, INF7 is a fusiogenic peptide, while gamma1, L2, HGP and pVI are
Figure 2.6. Schematic representation of the endosomal escape strategy using virus-derived peptides 
displayed on the tat-functionalised (red cones) polymeric nanoreactors (green). The modular design 
allows for particle functionalisation with various azido peptides (light brown) using the PS-b-PEG-BCN 
functional handle (A), after which the functionalised particles can be internalised into cells (B) and the 
effect of the peptides upon endosomal routing can be assessed (B, inset).
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all endosomolytic. Finally, Melittin is a membrane-disruptive peptide sequence derived from 
bee-venom. Most peptides only fold into an active form upon acidification, except for Melittin 
and dhvar5, and to a lesser extent also L2, which are already very amphipathic at neutral pH.
Nanoreactors containing 10 w% BCN (8) were made and analysed by TEM and dynamic 
light scattering (DLS) (Figure 2.7), which showed that the presence of the BCN anchor did not 
interfere with nanoreactor formation. Furthermore, the presence of the BCN handle was confirmed 
by reacting it with an azido-coumarin-PEG2000 conjugate (3), which only becomes fluorescent 
upon forming a triazole ring as a result of the SPAAC reaction.[26] This showed that the BCN was 
present and active on the particle surface, as demonstrated by a nearly 6-fold increase in coumarin
fluorescence in the presence of the reactive handle. For cell uptake and localisation studies, 
hybrid nanoreactors, containing both 5 w% 8 and 5 or 10 w% 2 were used, where the tat 
functionality was responsible for cell uptake, while the BCN group allowed for peptide coupling 
with the endosomolytic peptides. However, conjugation to the nanoreactors proved to be 
troublesome. Several peptides were found to cause severe aggregation of the nanoreactor 
particles containing 5 w% 8 and 5 w% 2 in bulk solution, and therefore both derivatives of 
Melittin and L2 were omitted from further studies as these aggregates would not be suitable 
for cell uptake experiments (Figure 2.8). The remaining peptides were used in cell uptake 
studies to determine their effect on the intracellular localisation of the nanoreactors as 
compared to that of regular tat-functionalised particles. However, during initial cell experiments 
several peptides also showed aggregation (Dhvar5-N3, HGP-N3) on the cell surface or hardly
Table 2.1. Overview of the synthesised peptides that can potentially facilitate endosomal escape. 
Peptide Sequence Mass c Found d Ref.
H-dhvar5-N3 LLLFLLKKRKKRKY-N3 1971.31 [M+2H]
2+ 987.20 [16,17]
H-GeT-N3 KIAKLKAKIQKLKQKIAKLK-N3 2443.67 [M+2H]
2+ 1223.08 [18]
H-HGP-N3 RGWEVIKYWWNIIQY-(CH2CH2O)3-N3 
a 2253.18 [M+2H]2+ 1128.1 [19]
H-pVI-N3 AFSWGSLWSGIKNFGSYVKN-N3 2315.16 [M+2H]
2+ 1158.84 [20]
N3-pVI-OH N3-AFSWGSLWSGIKNFGSYVKN 2330.12 [M+2H]
2+ 1166.36 [20]
H-Melittin-N3 IGAVLKVLYYGLPALISWIKRKRQQ-N3 2980.80 [M+2H]
2+ 1491.64 [21]
N3-Melittin-OH N3-IGAVLKVLYYGLPALISWIKRKRQQ 2995.76 [M+2H]
2+ 1499.08 [21]
H-L2-N3 SYFILRRRRKRFPYFFTDVRVAA-N3 3031.70 [M+5H]
5+ 607.68 [22]
N3-L2-OH N3-SYFILRRRRKRFPYFFTDVRVAA 3046.66 [M+3H]
3+ 1017.12 [22]
N3-His10-Lys-OH N3-HHHHHHHHHHK - - [23]
H-INF7-N3 EAIEGFIENGWGMIDGWYGCG-N3 2500.06 [M+2H]
2+ 1251.16 [24,25]
H-gamma1-N3 ASNleWERVKSIIKSSLAAASNIG-N3 
b 2368.33 [M+2H]2+ 1185.40 [22]
Azides are attached either at the N-terminus using azido acetic acid, or at the C-terminus using an 
amino-ethyl-azido spacer that was already attached to the resin (see experimental section for details). 
a (CH2CH2O)3 represents a triethylene glycol spacer,
 b Nle is norleucine, c calculated mass, d masses found 
using LC-MS analysis.
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displayed any uptake (INF7-N3, gamma1-N3). Of the remaining peptides (GeT-N3, pVI-N3, 
N3-His10), some seemed to show localisation to less acidic compartments compared to 
tat-only particles, yet the results were inconsistent (Figure 2.9). For example, the GeT-N3 
peptide showed higher local pH values as the tat-only control (Figure 2.9D) after 24 hours, 
while upon repeating this experiment, similar pH values compared to tat-only particles were
Figure 2.8. Aggregation studies performed using DLS on nanoreactors containing 5 w% 8 and 5 w% 2 
functionalised with azide-containing endosomolytic peptides. Histogram displaying z-average diameters 
of nanoreactors after dialysis (black bars) and their polydispersities (PDI, grey bars). Error bars indicate 
standard deviations.
Figure 2.7. DLS graph (A) and TEM micrographs (B) of PS-b-PIAT nanoreactors admixed with 10 w% 
PS-b-PEG-BCN.
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observed (Figure 2.9B). Similar results were obtained for the N3-His10 peptide. 
Furthermore, after 4 hours generally a lower pH was observed compared to the situation 
at 24 hours for the peptide-functionalised particles, while for the tat-only particles the pH 
decreased after 24 hours (Figure 2.9A vs. B, and 2.9C vs D). Also there was a distinct 
difference in the observed pH between tat-only and peptide-functionalised particles at 
the 4 hour time-point, showing a much less acidic environment for the tat-only particles 
(Figure 2.9A and C). These observations again indicate that a difference in intracellular 
handling of the particles takes place, yet the results vary between experiments.
This seemed to indicate that the particle formulation was not reproducible. To investigate 
this further, we performed sequential conjugation reactions of azido-coumarin-PEG2000 (3) 
and GeT-azide to the nanoreactor surface. PS-b-PIAT nanoreactors containing 10 w% 8 and 5 
w% 2 were used for this experiment instead of 5 w% 8 for the cell experiments to increase the 
observed signal from the reaction of BCN with 3. The particles were first reacted with either 3 or 
Figure 2.9. Normalised frequency graphs displaying distributions of TAMRA/Fluorescein fluorescence 
intensity ratios for nanoreactors admixed with 10 w% 2 and 5 w% 8 incubated with HeLa cells on two 
different occasions for either 4 hours (A and C) or 24 hours (B and D). Red lines represent snapshots 
of the same experiment for GeT-N3, black and grey lines represent snapshots of N3-tat and blue lines 
represent snapshots of N3-His10 functionalised nanoreactors. A lower ratio represents a higher local pH 
value for the nanoreactor.
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GeT-N3 for 8 hours, before adding the other of the two reagents and allowing overnight reaction. 
If the peptide successfully reacted with the BCN group, this moiety should not be available 
anymore for a SPAAC reaction with 3. Therefore also no increase in coumarin fluorescence 
should be observed. However, in all cases we observed similar coumarin fluorescence 
emerging, irrespective of the prior addition of GeT-N3, indicating that no SPAAC reaction took 
place with this peptide (Table 2.2). However, as we did observe an effect on the local acidity 
of the PS-b-PIAT nanoreactors upon introduction of the peptides, even after removing any 
unbound peptides by dialysis, we further investigated the possibility of strong physisorption of 
the peptides to the nanoreactors. For this we performed the same experiment as described 
above, but now with FITC-labelled azido-His10 peptide instead of GeT-N3, in combination with 
3. Azido-His10 was chosen because also for this peptide an effect on nanoreactor localisation 
was observed (Figure 2.9C and D) and due to the presence of a single lysine that could be 
conveniently used for FITC attachment. After sequential functionalisation of the nanoreactors 
with 3 and N3-His10-FITC, and subsequent dialysis of the samples, it was observed that in both 
cases coumarin and FITC fluorescence could be observed on the particles, again indicating 
that the peptide does not react with the BCN groups, but instead is capable of non-covalently 
adhering to the particle surface (Table 2.3). Non-covalent binding to the surface, instead of 
covalent binding could explain the inconsistent results for the cell localisation experiments, 
Table 2.2. Fluorescence emission intensities measured at 418 nm, indicative of triazole ring formation 
upon reaction of surface-exposed BCN (10 w%) with 3 on polymeric nanoreactors. 
Sample 1st reagent a 2nd reagent b Em. 418 nm (a.u.)
Nanoreactors - - 50
Nanoreactors 3 - 300
Nanoreactors GeT-N3 3 290
Nanoreactors 3 GeT-N3 280
Nanoreactors GeT-N3 - 60
a The first reagent was allowed to react for 8 hours, b after which incubation with the second reagent was 
performed overnight.
Table 2.3. Fluorescence emission intensities measured at 418 nm and 522 nm, indicating formation of 
the triazole ring upon reaction of surface exposed BCN (10 w%) with 3 (418 nm emission, coumarin) and 
binding of azido-His10-FITC (522 nm emission, FITC) on the surface of polymeric nanoreactors. 
Sample 1st reagent 2nd reagent Em. 418 nm (a.u.) Em. 522 nm (a.u.)
Nanoreactors - - 110 33
Nanoreactors 3 - 199 19
Nanoreactors N3-His10-FITC 3 165 >1000
Nanoreactors 3 N3-His10-FITC 170 >1000
a The first reagent was allowed to react for 8 hours, b after which incubation with the second reagent was 
performed overnight.
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as this would cause the production of peptide-functionalised nanoreactors to be much less 
reproducible.
2.2.3 Liposomal carrier for cytoplasmic nanoreactor delivery.
To circumvent the need for surface functionalisation of the nanoreactors, a different 
approach was attempted. Cationic liposomes have shown to be able to bind and fuse 
with cells and release their contents into the cytosol.[27,28] Using fusogenic liposomes as a 
delivery vehicle in which the nanoreactors are encapsulated,  should allow the delivery of 
the nanoreactors into the cell cytosol, thereby avoiding direct entrapment in endosomes after 
uptake. To successfully apply this method, encapsulation of PS-b-PIAT particles in liposomes 
has to be achieved, but also a liposome formulation should be designed that can fuse with 
the cell membrane.
First, in order to find a suitable fusogenic lipid mixture, several liposome formulations 
were tested for their ability to deliver a small molecule into cells. The membrane impermeable 
molecule propidium iodide (PI) was chosen, as upon cytosolic delivery it binds DNA and 
displays a strong characteristic fluorescence increase in the nucleoli of cells. A mixture of 
DOTAP/DOPE/PC/DSPE-PEG2000 (15/30/54/1 w/w, Scheme 2.2) was selected; where PC 
lipids and PEGylated lipids provide stability, DOPE introduces the fusogenic nature, while the 
cationic DOTAP enables cell binding (Figure 2.10A). As negative control, PC/DSPE-PEG2000 
(99/1 w/w) was used, as this mixture was not fusogenic due to a lack of DOPE and DOTAP 
(Figure 2.10B).  
Scheme 2.2. Chemical structures of the lipids used in this study.
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As the observed membrane fusion was still not very high, we attempted tofurther improve 
this by incorporating a BCN-containing derivative of DOPE in the lipid mixture (Scheme 2.2), 
to allow functionalisation with the above-mentioned endosomolytic peptides (Table 2.1). The 
applied mixture consisted of DOTAP/DOPE/PC/DSPE-PEG2000/DOPE-BCN (15/25/54/1/5 
w/w), to which the peptides could then be coupled after liposome formation. For several of 
the tested peptides, an increased fluorescence was observed inside the nucleoli of cells 
compared to non-functionalised liposomes. In general a mixture between punctate endosomal 
fluorescence and nuclear fluorescence was observed, where the amount of fluorescence in 
the nucleus and in endosomes seemed to depend on the attached peptide (Figure 2.10C-H 
and Table 2.4 for an overview). Interestingly, HGP-N3 only showed endosomal localisation 
Figure 2.10. Overview of the observed PI localisations in cells after incubation with peptide-functionalised 
liposomes. Displayed are non-fusogenic control (A), fusogenic liposomes without peptide (B), fusogenic 
liposomes with pVI-N3 (C), HGP-N3 (D), Melittin-N3 (E), N3–L2 (F), gamma1-N3 (G) and His10-Lys-N3 (H). 
Images are overlays between PI fluorescence and transmission channels, cell nuclei marked with white 
dashed circles contain PI-stained nucleoli. Scale bar is 20 μm.
Figure 2.11. Confocal microscopy images of GUVs containing the lipid mixture DOTAP/DOPE/PC/DSPE-
PEG2000 (15/30/54/1 w/w). The left side shows fluorescence of membranes stained with 1 w% DOPE-
NBD lipid, while the right side shows transmission images. The scale bar is 10 μm.
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(punctate signals, Figure 2.10D) and no nuclear PI fluorescence. Furthermore, dhvar5-N3 
and the Melittin and L2 derivatives predominantly showed membrane binding (Figure 2.10E, 
representative image from Mellittin-N3), which might indicate aggregation, as this was also 
observed for the PS-b-PIAT nanoreactors functionalised with these peptides (Figure 2.8). 
Only N3-L2 also displayed strong nuclear fluorescence next to the high membrane binding, 
indicating that the peptide is active in triggering cytosolic delivery in spite of its tendency for 
aggregation (Figure 2.8F).
After having established a system capable of fusion with the cell membrane, we continued 
to try and also form giant vesicles using this lipid composition. Eventually these giant vesicles 
should be capable of also encapsulating the nanoreactors. For this, giant unilamellar vesicles 
(GUVs) were rehydrated from a glass surface that was first functionalised with a cross-linked 
PEG-dextran hydrogel, on which the fusogenic lipids were deposited.[29] After rehydration, the 
GUVs were transferred to a microscopy slide for imaging, where successful formation of giant 
vesicles was observed (Figure 2.11).
Table 2.4. Overview of PI fluorescence localisation in cells after incubation with peptide-functionalised 
liposomes.
Liposome and peptide Cytosolic delivery a PI localisation b
H-pVI-N3 + Nucleus and endosomes
N3-pVI-OH + Nucleus and endosomes
N3-His10-Lys-OH + Nucleus and endosomes
H-gamma1-N3 + Nucleus and endosomes
N3-L2-OH + Nucleus, endosomes and on membrane
H-INF7-N3 +/- Nucleus and endosomes
H-GeT-N3 +/- Nucleus and endosomes
H-L2-N3 +/- Nucleus, endosomes and on membrane
Unconjugated c +/- Nucleus and endosomes 
H-Melittin-N3 +/- Endosomes and on membrane
N3-Melittin-OH - Endosomes and on membrane
H-HGP-N3 - Endosomes
H-dhvar5-N3 - On membrane
Non-fusiogenic d - -
a Assessment of cytosolic delivery based on the amount of PI fluorescence in the nucleus, where + indicates 
strong fluorescence, +/- indicates moderate to weak fluorescence, and – indicates no fluorescence in the 
nucleus. b Localisation of PI fluorescence in the cell, originating from both liposome-encapsulated and 
free dye. c Unconjugated liposomes contain a fusogenic lipid mixture, yet no BCN functionality. d Non-
fusogenic liposomes are control vesicles not capable of membrane binding or fusion.
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2.3 Conclusion
In order for artificial organelles to function optimally inside cells, the intracellular location 
is of vital importance, not only for the longevity of the enzyme, yet also for being able to 
influence cellular chemistry at specific locations inside the cell, like the cytoplasm or at different 
organelles. Therefore it is important to be able to determine and track the intracellular location 
of nanoreactors and if necessary to manipulate this process. For PS-b-PIAT nanoreactors, we 
have shown via a combination of colocalisation studies, local pH measurements, and TEM 
analysis that these particles undergo endosomal trafficking and remain in these acidic vesicles 
for at least 24 hours. Furthermore, no cytosolic delivery was observed via pH measurements 
or TEM analysis.
Attempts to influence the endosomal trafficking of the nanoreactors by attaching several 
endosomolytic peptides to the surface were inconclusive. The functionalisation with the 
peptides proved to be troublesome, as the SPAAC reaction between the BCN moiety and the 
peptides did not seem to take place. Activity of the BCN moiety was verified by coupling to 
the pro-fluorescent molecule 3, showing that it was still functional, both on the single polymer 
and when incorporated in polymeric nanoreactors. Furthermore, by using fluorescently 
labelled peptides, it was observed that the peptides bound to the nanoreactors via non-
specific adsorption. The combination of strong non-specific adsorption and unpredictable 
covalent attachment yielded a rather inconsistent system for cellular applications. In some 
cases average increases of the local pH around the nanoreactor compared to the tat-only 
control could be observed, yet these proved to be only partially reproducible, likely as a result 
of the inconsistent surface modification. Lack of coupling between the BCN and the azido-
peptides might be explained by backfolding of the BCN to more hydrophobic domains in the 
nanoreactor, thereby becoming less accessible[26], and by the highly charged and amphiphilic 
nature of the peptides, which might cause strong surface binding, or prevent access to the 
more lipophilic BCN.
Furthermore, since we neither observe endosomal escape through the addition of 
chloroquine or NTGA, nor as an effect of the adsorbed endosomolytic peptides, it might be 
possible that the nanoreactor size of approximately 150 nm is too large to escape through the 
pores that are created in the membrane by the endosomolytic agents, and they thereby also 
fail to achieve cytosolic delivery. 
As an alternative, a different delivery approach was devised, which uses a liposomal 
delivery vehicle that can fuse with the cellular membrane in order to release its cargo. For 
this, a fusogenic lipid mixture was developed, which allows the formed liposomes to fuse with 
the cell membrane. We showed that not only small liposomes, but also giant liposomes can 
be made using this lipid mixture. The fusogenic nature of the lipid mixture was verified by 
successful delivery of propidium iodide to cell nuclei. Furthermore, attaching endosomolytic 
or fusogenic peptides to the liposome surface further enhanced fusion efficiency for some 
of the peptides tested. However, until now fusion was only demonstrated for relatively small 
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liposomes with propidium iodide and was not yet attempted for larger liposomes that contain 
PS-b-PIAT nanoreactors. These initial results show that this could be a viable alternative to 
achieving cytosolic delivery of polymeric nanoreactors. But for this approach to succeed, the 
giant liposomes will most likely need to be resized to sizes around 1 μm, while still retaining a 
high loading of nanoreactors.
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2.5 Materials and methods
2.5.1 Chemicals
PS40-b-PIAT50 was purchased from Encapson B.V. Nijmegen. Biotech cellulose ester dialysis 
tubing (1 MDa MWCO) and regenerated cellulose (MWCO 3.5 kDa and 12-14 kDa) were 
obtained from Spectrapor, Breda, The Netherlands. THF was distilled under Argon from 
sodium/benzophenone prior to use. “MilliQ” water was doubly deionised (18.2 MΩ). His10-
Lys-N3 was kindly donated by Morten Borre Hansen. Compound 3 was kindly provided by Ton 
Dirks. PS-b-PEG-tat was synthesised as previously described.[10] 2-(4-isothiocyanatobenzyl)-
diethylene triamine  pentaacetic acid (p-SCN-Bn-DTPA) was obtained from Macrocyclics, 
Texas, USA, while TAMRA-NHS  and Lysotracker Red were from Invitrogen, Fluorescein-
NHS from Berry & Associates Inc., Dexter, Michigan, and Atto488-NHS was from ATTO-TEC 
GmbH, Siegen, Germany. Lipids were obtained from Avanti Polar Lipids. All other reagents 
and solvents were of the highest quality grade and purchased from commercial suppliers and 
used without further purification unless stated otherwise. HEPES-buffered saline (HBS buffer) 
was prepared by making an aqueous solution containing 4-(2-hydroxyethyl)-1-piperazine 
ethanesulfonic acid (HEPES, 10 mM), NaCl (135 mM), KCl (5 mM), CaCl2 (1.8 mM) and MgCl2 
(1 mM) and setting the pH to 7.4.
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2.5.2 Instrumentation
Nuclear magnetic resonance (NMR) spectra were recorded on a Varian Inova 400 (400 
MHz for 1H). Transmission electron microscopy (TEM) images were obtained using a JEOL 
JEM 1010 microscope with an acceleration voltage of 60 kV. Dynamic light scattering (DLS) 
measurements were performed on a Malvern Zetasizer Nano-Z (Malvern Instruments, Malvern, 
UK). Plate reader data were obtained using 384-well flat black polystyrene plates (Greiner 
Bio-one) on a TECAN Infinite 200 PRO machine. High-resolution mass spectrometry (MS) 
measurements were performed with a JEOL AccuToF (electrospray ionisation). Deconvoluted 
mass spectra were obtained using MagTran 1.03b2. Fluorescence spectroscopy was 
performed on a Perkin-Elmer LS55 fluorescence spectrometer. Fourier transformed infrared 
spectra were obtained using an ATI Matson Genesis Series FT-IR spectrometer fitted with an 
ATR cell. Gel permeation chromatography (GPC) was performed on a Shimadzu (CTO-20A) 
system with a guard column and a PL gel 5 μm mixed D column (Polymer laboratories) with 
differential refractive index and UV (254 nm) detectors, using tetrahydrofuran as a solvent 
with a flow rate of 1 mL/min. Preparative-HPLC was performed using a Shimadzu LC-20A 
Prominence system with a C18 ReproSil column, 250x10 mm, particle size 5 μm (Screening 
Devices), applying a acetonitrile/water gradient (5-100%, 5-50 min, 4 mL/min flowrate) 
supplemented with 0.1% trifluoracetic acid. HeLa cells were maintained in RPMI 1640 (PAN 
Biotech, Aidenbach, Germany), each supplemented with 10% fetal calf serum (FCS; PAN 
Biotech). Cells were incubated at 37°C in a 5% CO2-containing, humidified incubator. Confocal 
laser scanning microscopy was performed on a TCS SP5 confocal microscope (Leica 
Microsystems, Mannheim, Germany) equipped with an HCX PL APO 63 x N.A. 1.2 water 
immersion lens. Live cells were maintained at 37°C on a temperature-controlled microscope 
stage. GFP and fluorescein were excited with a 488 nm argon ion laser, while lysotracker and 
TAMRA were excited a HeNe 561 nm laser. Emission was detected between 500 and 550 nm 
for GFP and fluorescein, and between 575 and 670 nm for lysotracker and 580 to 635 nm for 
TAMRA. 
2.5.3 Experimental procedures
OtBu-PS44=O
A Schlenck-tube was charged with Cu(I)Br (106.27 mg, 0,75 mmol) and subsequently put 
under vacuum and backfilled with argon, which was repeated a total of three times. After this, 
a mixture of tert-butyl 2-bromo-2-methylpropionate (139.91 μL, 0.75 mmol), styrene (6.75 mL, 
80 eq, 60 mmol), N,N,N′,N′,N′′-pentamethyl diethylene triamine (155.3 μL, 1.07 eq, 0.8 mmol) 
and anisole (3 mL) was added using a syringe. The mixture was then bubbled through with 
argon, after which it was heated to 90 ºC and allowed to react until 50% of the monomer was 
consumed. The reaction was then quenched by adding 1-phenyl-1-trimethylsilyloxyethylene 
54
Chapter 2
(4.6 mL, 30 eq, 22.5 mmol), diluted with DCM (20 mL),washed twice with an aqueous EDTA 
solution and subsequently precipitated in methanol. The precipitate was lyophilised from 
dioxane to afford the polymer as a white powder (4.43 g yield).
1H NMR (400 MHz, CDCl3) δ 7.3-6.2 (bs, aromatics, 220H), 2.2-1.2 (bs, aliphatic backbone, 
120H), 1.53 (s, C(CH3)3), 9H), 1.1-0.9 (s, C(CH3)2, 6H). GPC (polystyrene calibration) Mn: 
4122 g/mol, Mw: 4462 g/mol, Mw/Mn: 1.08
O=PS44-CO2H
OtBu-PS44=O (2.09 g) was stirred overnight in a mixture of DCM / trifluoroacetic acid / water 
(3 / 3 / 1), after which the solvent was evaporated under reduced pressure. Coevaporation 
with EtOAc/HCl (2.3 M), tert-butanol in toluene (1:1) and finally twice with toluene yielded the 
desired product. The polymer was lyophilised from dioxane to yield a white powder (1.71 g, 
81.8%)
1H NMR (400 MHz, CDCl3) δ 7.3-6.2 (bs, aromatics, 220H), 2.2-1.2 (bs, aliphatic backbone, 
120H), 1.1-0.9 (s, C(CH3)2, 6H).GPC (polystyrene calibration) Mn: 3922 g/mol, Mw: 4263 g/
mol, Mw/Mn: 1.09
PS44-b-PEG67-Boc
H2N-PEG67-Boc (100 mg, 31.3 μmol) and O=PS44-CO2H (201.8 mg, 1.5 eq, 45.45 μmol) 
were dissolved in DMF (3 mL, dry), to which diisopropylethylamine (25.8 μL, 5 eq, 151.5 
μmol) and 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid 
hexafluorophosphate (19.6 mg, 1.7 eq, 51.5 μmol) were added. The mixture was allowed to 
react overnight at room temperature. The DMF was evaporated and the crude was dissolved 
in DCM (5 mL) and poured over a silica plug. Unreacted PS39-N3 was eluted by flushing 
with 1% methanol in DCM, while block copolymer product was subsequently obtained by 
eluting with 10% methanol in DCM. The product fractions were then pooled, concentrated and 
finally lyophilised from dioxane to yield the polymer as a white powder (152 mg, 64.9%). 1H 
NMR (400 MHz, CDCl3) δ 6.2-7.3 (bs, aromatics, 220H), 3.7-3.5 (bs, (CH2-CH2-O)n, 288H), 
2.2-1.2 (bs, aliphatic backbone, 120H), 1.44 (s, C(CH3)3, 9H), 1.1-0.9 (s, C(CH3)2, 6H). GPC 
(polystyrene calibration) Mn: 8507 g/mol, Mw: 9379 g/mol, Mw/Mn: 1.10.
PS44-b-PEG67-NH2
PS44-b-PEG67-Boc (51.5 mg, 6.14μmol) was dissolved in 2 mL DCM, to which 2 mL of a 
mixture of trifluoroacetic acid, triisopropylsilane, ethanedithiol and MilliQ (92.5 / 2.5 / 2.5 / 2.5) 
was added. The reaction was allowed to stir overnight, after which the solvent was evaporated 
under reduced pressure. Coevaporation with EtOAc/HCl (2.3 M), tert-butanol in toluene (1:1) 
and finally toluene yielded the desired product, which could be obtained as a white powder 
after lyophilisation from dioxane (43 mg, 85%).
1H NMR (400 MHz, CDCl3) δ 6.2-7.3 (bs, aromatics, 195H), 4.9-5.1 (bs, CH-Br, 1H), 3.5-3.7 
(bs, (CH2-CH2-O)n, 288H), 1.2-2.2 (bs, aliphatic backbone, 117H), 1.44 (s, C(CH3)3, 9H), 0.9-
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1.1 (s, C(CH3)2, 6H)
GPC (polystyrene calibration) Mn: 8045 g/mol, Mw: 8982 g/mol, Mw/Mn: 1.11
PS44-b-PEG67-BCN
To a solution of PS44-b-PEG67-NH2 (27.4 mg, 3.26 μmol) in DCM was added BCN-OSu (19.95 
mg, 68.5 μmol, 20 eq) and N,N-diisopropylethylamine (5.8 μL, 34.25 μmol, 10 eq), and the 
reaction was left to stir overnight. Disappearance of free amines was verified by a Kaiser test. 
The solvent was subsequently evaporated under reduced pressure and the crude polymer 
was purified using preparative GPC. Lyophilisation of the pure fractions from dioxane yielded 
the desired product as a white powder (22.8 mg, 83.2%).
1H NMR (400 MHz, CDCl3) δ 6.2-7.3 (bs, aromatics, 195H), 5.2 (bs, 1H), 5.0-4.8 (bs, CH-
triazole, 1H), 4.14 (d, 2H), 3.7-3.4 (bs, (CH2-CH2-O)n, 288H), 2.84 (m, BCN), 2.40 (m, BCN), 
2.2-1.2 (bs, aliphatic backbone, 114H), 1.44 (s, C(CH3)3, 9H), 1.1-0.9 (s, C(CH3)2, 6H). GPC 
(polystyrene calibration) Mn: 8713 g/mol, Mw: 9958 g/mol, Mw/Mn: 1.14. Presence of the BCN 
was further verified by azido-coumarin-PEG-2000 coupling as described in the main text.
BSA-atto488
BSA (2.5 mg, 36.2 nmol) was dissolved in 1 mL of HBS buffer pH 8.3 and to this, Atto488-NHS 
(0.063 mg, 1.75 eq, 63 nmol) in 50 μL anhydrous DMSO was added and allowed to react for 
1.5 hours at room temperature. The mixture was subsequently dialysed against HBS buffer 
pH 7.5 for 48 hours using a 3.5 kDa MWCO membrane, with regular changes of the dialysis 
medium. Degree of labelling was determined to be 1-2 by mass spectrometry. 66432 Da found 
for unlabelled BSA, 67002 Da (+1 dye), 67575 Da (+2 dyes) found for labelled BSA.
BSA-DTPA-Gd
Solutions of 20 mM NaH2PO4 at pH 8.5 and 5.0 were stirred overnight with Chelex to remove 
divalent metal ions from solution. After this, BSA (3.75 mg, 54.1 nmol) was dissolved in 500 
μL of metal-free buffer. To this, p-SCN-Bn-DTPA (0.18 mg, 5 eq, 270.5 nmol) was added 
and allowed to react for 1.5 hours at room temperature. Next, 1 mL of a solution of GdCl3 
(0.5 mg, 1.35 μmol, 25 eq to protein) in pH 5.0 buffer was added to the protein mixture and 
shaken for 4 hours at room temperature. To remove unbound ligand and gadolinium, the 
protein solution was dialysed against fresh 20 mM NaH2PO4 buffer at pH 7.5 using a 3.5 kDa 
MWCO membrane, with regular changes of the dialysis medium. 
Degree of labelling was determined to be 1-3 by mass spectrometry. 66429 Da found for 
unlabelled BSA, 67126 Da (+1 Gd), 67820 Da (+2 Gd) and 68515 Da (+3 Gd) found for 
labelled BSA.
BSA-Fluo/TAMRA
BSA (25 mg, 3.38 μmol) was dissolved in 4.8 mL of HBS buffer pH 8.3 and to this, Fluorescein-
NHS (0.54 mg, 3 eq) in 100 μL anhydrous DMSO and TAMRA-NHS (0.6 mg, 3 eq) in 100 μL 
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anhydrous DMSO were added and allowed to react for 4 hours at room temperature. The 
mixture was subsequently dialysed using a 12-14 kDa MWCO membrane against HBS buffer 
pH 7.5 for 36 hours with regular changes of the dialysis medium. Degree of labelling was 
determined by mass spectrometry to range from 1 up to 4 dyes, with an estimated average of 
2.5 dyes/protein.
2-azidoethan-1-amine
To a solution of 2-bromoethan-1-aminium bromide (20.49 g, 100 mmol) in MilliQ was added 
NaN3 (19.50 g, 3 eq, 300 mmol). The reaction was stirred overnight at 70 ºC, after which it 
was cooled to 0 ºC and diluted with diethyl ether, before adding potassium hydroxide (32.18 
g). The organic phase was collected and the aqueous phase was extracted twice with diethyl 
ether. The organic phases were combined, dried over MgSO4 and concentrated under reduced 
pressure, 750 mbar at 35 ºC, to yield a colourless liquid (10.79 g, 87.8%).
1H NMR (400 MHz, CDCl3) δ 3.30 (t, CH2-NH2, 2H), 2.80 (t, CH2-N3, 2H)
Resin functionalisation with 2-azidoethan-1-amine and Fmoc-Gly-OH
To FMPB AM resin (aldehyde terminated) (3 g, 1.0 mmol/g) was added 2-azidoethan-1-amine 
(3.67 g, 10 eq, 30 mmol) in 50 mL DMF/MeOH (1:1), after which NaCNBH3 (1.89 g, 10 eq, 30 
mmol) and acetic acid (1.71 mL, 10 eq, 30 mmol) were added and the reaction was heated to 
80 ºC for 2 hours. The resin was subsequently filtered off and washed with DMF, DCM, MeOH, 
DCM and DMF. Fmoc-Gly-OH (2.68 g, 3 eq, 9 mmol) was then coupled overnight using 1M 
diisopropylcarbodiimide in DMF (9.9 mL, 3.3 eq, 9.9 mmol) and 1M hydroxybenzotriazole 
in DMF (10.8 mL, 3.6 eq, 10.8 mmol). The resin was then washed with DMF and remaining 
free amines were acetylated using an excess of acetic anhydride and pyridine in DMF, after 
which the resin was washed with DMF, DCM, iPrOH, DCM and twice with diethylether. Resin 
loading was determined to be 0.503 mmol/g by determining the Fmoc content using UV-Vis 
spectroscopy.
Peptide synthesis
All peptides were synthesised via standard Fmoc solid phase peptide synthesis using the 
pre-functionalised FMPB AM resin (see above, for dhvar5-N3 and GeT-N3), or a Barlos resin 
(for pVI, Melittin, L2, INF7, gamma1 and HGP). Couplings were performed with 3 eq of Fmoc-
amino acid, 3.3 eq diisopropylcarbodiimide and 3.6 eq hydroxybenzotriazole for 45 minutes. 
Fmoc groups were removed with 20% piperidine in DMF for 20 minutes. 
For dhvar and GeT on the modified FMPB AM resin, the Fmoc group was removed after the 
final amino acid was coupled and the peptides were subsequently cleaved off the resin using 
a mixture of trifluoroacetic acid, triisopropylsilane, thioanisole and MilliQ (92.5 / 2.5 / 2.5 / 2.5) 
and precipitated twice in cold diethylether, before being lyophilised and finally purified using 
HPLC.
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For INF7, HGP and gamma1, the final amino acid of the sequence contained a Boc-group 
instead of an Fmoc group. The peptide was then cleaved off the resin using trifluoroethanol, 
acetic acid and dichloromethane (1 / 1 / 3), yielding a fully protected peptide with a free 
carboxyl group at the C-terminus for further functionalisation.
For Melittin, L2 and pVI, either N or C-terminal functionalisation was required. For N-terminal 
azidation the peptides were functionalised with azidoacetic acid and cleaved from the resin 
using a mixture of trifluoroacetic acid, triisopropylsilane, thioanisole and MilliQ (92.5 / 2.5 / 2.5 
/ 2.5) and precipitated twice in cold diethylether, before being lyophilised.
For C-terminal functionalisation the final amino acid was coupled with an N-terminal Boc 
group and peptides were cleaved using trifluoroethanol, acetic acid and dichloromethane (1 / 
1 / 3), yielding a fully protected peptide with a free carboxyl group at the C-terminus for further 
functionalisation.
Peptides (200 mg, ~60 μmol) still containing all protective groups and requiring C-terminal 
azidation were dissolved in 10 mL DMF, to which N,N-diisopropylethylamine (51.2 μL, 5 
eq, 300 μmol), 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid 
hexafluorophosphate (68.4 mg, 3 eq, 180 μmol) and 2-azidoethan-1-amine (36.9 mg, 5 eq, 
300 μmol) were added and stirred overnight at room temperature. DMF was evaporated and 
the peptide was precipitated twice in cold water before being lyophilised from acetic acid. After 
this, peptides were deprotected using trifluoroacetic acid, triisopropylsilane, thioanisole and 
MilliQ (92.5 / 2.5 / 2.5 / 2.5) and purified using HPLC.
His10-Lys(FITC)
To a solution of His10-Lys (5 mg, 3 μmol) in 0.5 mL DMF was added fluorescein isothiocyanate 
(2.1 mg, 2 eq, 6 μmol) and triethylamine (12.53 μL, 30 eq, 90 μmol). The reaction was stirred 
overnight at room temperature, after which the solvent was removed in vacuo. The crude was 
then dissolved in MilliQ and further purified using HPLC. Collected fractions were analysed 
using LC-MS and pure fractions were pooled and lyophilised. Regular peptide [M+H] 1573.72, 
modified peptide, calcd 1932, found [M+2H] 967.2, [M+3H] 645.3. [M+4H] 484.2.
Formation of enzyme-loaded PS-b-PIAT nanoreactors
PS-b-PIAT nanoreactors were formed by dissolving 0.5 mg of the desired enzyme or protein 
in HBS solution (2.5 mL, pH 7.4). This mixture was then gently agitated, while a solution of 
PS-b-PIAT (0.5 mL, 1 mg/mL) in THF was added dropwise until an opaque suspension was 
obtained. To construct functionalised nanoreactors, desired quantities of PS-PEG-tat and/or 
PS-PEG-BCN were admixed in the PS-PIAT polymer solution, while keeping the total polymer 
amount at 0.5 mg. The mixture was then left to self-assemble for 30 minutes before being 
transferred into a 1000 kDa MWCO dialysis bag. The nanoreactors were dialysed for 48 hours 
against HBS (pH 7.4), with regular changes of the external dialysis buffer, to remove non-
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encapsulated enzymes from the solution.[10] After dialysis, volumes were corrected to 2 mL 
and the nanoreactor solutions were directly used. Structural integrity was confirmed by TEM 
and DLS measurements.
Peptide conjugation to nanoreactors
Nanoreactors displaying BCN groups in HBS buffer were mixed with desired peptides in 
DMSO (10 eq, 2.5 mg/mL stock) and allowed to react overnight. After this, the reaction mixture 
was transferred to a 12-14 kDa MWCO dialysis membrane and dialysed for 24 hours with 
regular changes of the dialysis medium. Analysis was performed using DLS and after this, 
functionalised nanoreactors were stored at 4 ºC until further use.
Cellular uptake and colocalisation studies with nanoreactors
HeLa cells were seeded at a density of 30,000 cells per well one day before the experiment in 
8-well microscopy chambers (Nunc, Wiesbaden, Germany). For uptake studies, GFP and tat-
GFP nanoreactors were added to a final concentration of 50 μg/mL (polymer / medium). For 
pH-sensing studies, concentrations of the different samples were corrected by measuring the 
emission at 579 nm. Cells were incubated with nanoreactors in RPMI, containing 10% FCS 
and 1% penicillin/streptomycin, at 37°C for four hours. Cells were washed twice with fresh 
medium and imaged immediately using confocal microscopy. 
Image analysis
To calculate the TAMRA/FITC ratio of nanoreactors inside cells, the images were analysed 
using ImageJ, (NIH, available as public domain software at http://rsbweb.nih.gov/ij/). Images 
were first smoothed, (Filter Mean, radius 2), after which saturated pixels were removed from 
one channel (threshold 254-255) and the image was converted to a binary mask. Subsequently 
a difference operation was performed between the two channels. Next, background was 
substracted from both channels. The green channel was then converted to a mask and 
applied to the red channel. The red channel was then divided by the green channel to obtain 
the TAMRA/FITC ratio’s. Data was subsequently plotted as histograms (256 bins, 0-5).
DOPE-BCN
DOPE (100 mg, 0.134 mmol) was dissolved in dry DCM (2 mL), and triethylamine (93.4 μl, 
0.670 mmol, 5.0 eq) was added. BCN-OSu (117 mg, 0.402 mmol, 3.0 eq) was dissolved in 
dry DCM (1 mL) and subsequently added to the reaction mixture. The reaction mixture was 
stirred under argon atmosphere for 24 h and was then evaporated. The crude was redissolved 
in chloroform and extracted with MilliQ twice, dried over anhydrous Na2SO4, after which 
the solvent was evaporated. The final product was obtained by column chromatography in 
DCM:MeOH (9:1), yield n.d.
LC-MS (ESI+) m/z calculated for C52H90NO10P [M+H]+ 919.6, found 918.7. 
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Liposome formation
Lipids were dissolved in chloroform and mixed in the appropriate ratio’s in glass vials, after 
which the solvent was evaporated by argon flow. Then 100 μl of HBS, containing 10 mM PI, 
was added, and the lipids were rehydrated at 65 ºC under gentle agitation for 20 minutes. The 
final lipid concentration was 20 mM in the samples. The samples were then diluted to 500 
μL and extruded 9 times at 65 ºC using a mini-extruder apparatus with 1 μm polycarbonate 
membranes (Whatmann). Size-exclusion chromatography (Sepharose CL-4B column in HBS) 
was performed to remove all unencapsulated material. The most concentrated liposome 
fraction (≈1 ml) was used for further experiments.
Peptide conjugation to liposomes
The liposomes were assembled and extruded as described above using the lipid composition 
15/25/54/1/5 (DOTAP/DOPE/PC/DSPE-PEG2000/DOPE-BCN w/w). Peptide stock solutions 
of 2.5 mg/ml in DMSO were prepared and diluted 4 times with HBS (final volume 480 μL, 10 eq 
per BCN), after which 500 μl of DOPE-BCN-containing liposomes were added. The reaction 
mixtures were left at 25 ºC and incubated overnight, before purification by size-exclusion 
chromatography as described above.
Cellular uptake studies with liposomes
For fusion experiments, cells were grown in boro-silicate chamber slides (8 wells, LabTek). 
Slides were coated using a 0.1% gelatin solution for 30 minutes at 37 ºC. Cells were then 
seeded on the slide at a density of 40,000 cells/well one day before imaging. The following 
day, the cells were washed with 10% FBS DMEM without antibiotics (incubation medium) and 
incubated for 4 hours with 300 μl of a pre-mixed solution of liposomes in incubation medium. 
Afterwards, cells were washed 3 times with fresh incubation medium, and directly imaged. 
GUV formation by rehydration
Lipids (5 μL, 10 mM in MeOH/CHCl3 7:3, composition DOTAP/DOPE/PC/DSPE-PEG2000/
DOPE-NBD 15/25/58/1/1) were deposited on glass slides functionalised with a dextran-PEG 
cross-linked hydrogel[29] (provided by N. Lopez-Mora, Leiden University). The solvent was 
allowed to evaporate and slides were put under vacuum for 1 hour to completely remove the 
solvent. Subsequently, o-rings were mounted on the glass slides, encompassing the lipid 
depositions, and filled with 200 μL of 200 mM sucrose solution in HBS to rehydrate the lipids 
and form GUVs. After overnight rehydration, the GUV solution was transferred to BSA-coated 
(1 mg/mL in MiliQ; 2 hours) microscopy slides for imaging.
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3.1 Introduction
Compartmentalisation is one of the key features developed by nature during the evolution 
of eukaryotic cells.[1,2] In fact, according to some of the leading theories, compartmentalisation 
has even been instrumental in the origin of life,[1] as in order to start an evolutionary process 
molecules should be kept closely together to allow advantageous mutations to lead to 
preferential replication.[1] In recent years, a growing effort is being made to study cellular 
function by artificially mimicking or reconstructing (parts of) cells.[3,4] Single-compartment 
“minimal cells”, which are lipid-based systems containing the minimal components necessary 
to be living,[5] have been created that are capable of DNA replication and protein production[6,7] 
or self-replication.[8] 
Eukaryotic cells are however multicompartmentalised structures, where also smaller 
organelle compartments reside inside the cell. Multicompartmentalisation in eukaryotic 
cells allows the positional assembly and spatial separation of biomolecules and processes 
in different compartments inside the cell, providing the cell with spatiotemporal control over 
metabolic reactions.[9] Confinement also leads to the possibility of spatially separating reaction 
pathways or incompatible components, or locally creating high amounts of reagents, or 
concentration gradients, to guide metabolic flux.[10,11] Examples of natural reaction pathways 
which involve multiple enzymes and substrate molecules and which can take place in multiple 
successive cellular compartments, are the Calvin cycle for carbon fixation,[12] or the citric acid 
cycle, which takes place in mitochondria, but interacts with many cytosolic pathways.[13]
Previously, a number of multicompartmentalised structures have been reported with 
the advent of developing new microreactor architectures,[3] which were either based on a 
liposomes-in-liposome system,[14] or liposomes in LbL capsules,[15–17] and in which single 
enzyme reactions were described. Also a concentric, two compartment, LbL capsule-in-
capsule architecture with a known two-enzyme cascade, based on glucose oxidase and 
horseradish peroxidase was reported.[18] Polymersomes are a third class of membrane-
mimetic materials used for the construction of multicompartmentalised systems. These 
polymer-based vesicles offer several beneficial properties: good colloidal and mechanical 
stability, tailored permeability,[19] as well as stimuli-responsiveness[20] or biodegradation.[21] On 
one hand, active enzymes can be trapped in semi-permeable polymersomes that only allow 
diffusion of small substrate molecules into their structure, yielding nanoreactors;[22–24] when 
these nanoreactors are incorporated into living cells, they function as “artificial organelles”.
[25–27] On the other hand, by loading smaller polymersomes into the lumen of a larger one, a 
polymersomes-in-polymersome system can be created.[28–31] 
While already demonstrating some of the possibilities of multicompartmentalisation, the 
aforementioned microencapsulated reactors, however, still do not possess the complexity 
required to mimic cellular reaction pathways that take place in multiple successive 
compartments. 
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Here we combine both the structural cell mimicry of polymersomes-in-polymersomes 
and the functional aspects of enzymatic polymersome nanoreactors as organelle mimics, into 
one single system in order to study the effects of multicompartmentalisation and confinement 
on cellular multistep reaction pathways (Figure 3.1a). By placing the enzymes needed for 
each separate cascade step in different (sub)compartments we aim to force the reaction 
intermediates to cross over compartmental boundaries. We thereby hope to observe truly 
confined reactions and local or gradient-like generation of reaction products as also occurs 
in nature. 
3.2 Results and discussion
To demonstrate structural and functional control in a multicompartmentalised system, an 
original and complex multi-step model reaction that resembles a natural enzymatic pathway, 
as depicted in Figure 3.1b, was investigated. Here, the pro-fluorescent substrate (1) first 
undergoes oxidation by the solvent- and temperature-stable Baeyer-Villiger monooxygenase, 
Figure 3.1. A) Concept of the cell mimic, showing first encapsulation of different enzymes in PS-PIAT 
nanoreactors (1), followed by mixing of organelle mimics, cytosolic enzymes and reagents (2) before 
encapsulation of the reaction mixture in PB-b-PEO vesicles (3) to create the functional cell mimic (4), in 
which enzymatic multicompartment catalysis takes place inside, showcasing the system as a functional 
cell mimic. B) Detailed cascade reaction scheme. Pro-fluorescent substrate (1) undergoes a Baeyer-
Villiger reaction catalysed by PAMO, while consuming one unit of NADPH, to yield an ester (2) that is 
subsequently hydrolysed by CalB or Alcalase to provide a primary alcohol (3). ADH oxidises the alcohol, 
using the cofactor NAD+, to give an aldehyde (4), which then undergoes spontaneous beta-elimination to 
yield resorufin as the final fluorescent product (5).
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phenylacetone monooxygenase (PAMO),[32] which uses NADPH as a cofactor. The resulting 
ester moiety is then hydrolysed by Candida antarctica lipase B (CalB), and subsequent 
oxidation of the resulting alcohol to an aldehyde is achieved by an NAD+-dependent alcohol 
dehydrogenase (ADH). Finally, the last reaction yields fluorescent resorufin via a non-
enzymatic, but spontaneous, beta-elimination step. In particular, the use of cofactors like 
NADPH and NAD+ as electron donors or acceptors in enzymatic reactions is very common in 
nature.[33]
For the development of the synthetic organelles, enzymes involved in the cascade 
reaction were encapsulated in the intrinsically porous, sub-micrometric polystyrene40-b-
poly(3-(isocyano-L-alanyl-amino-ethyl)-thiophene)50 (PS40-b-PIAT50) nanoreactors.
[22] The PS-
b-PIAT nanoreactors, cytosolic enzymes and reaction components were then quantitatively[34] 
encapsulated in micrometer-sized polybutadiene-b-poly(ethylene oxide) (PB-b-PEO) 
polymersomes via a previously reported emulsion-centrifugation approach, to create the 
functional multicompartmentalised structure.[28] PAMO was kept in the lumen of the large PB-
b-PEO vesicle, as encapsulation in nanoreactors lowered its affinity for the substrate (data not 
shown). CalB was encapsulated in nanoreactors, as it has been shown previously to remain
Figure 3.2. TEM micrographs of CalB PS-b-PIAT nanoreactors (left, scale bar 500 nm), ADH nanoreactors 
(middle, scale bar 200 nm) and Alcalase PS-b-PIAT nanoreactors (right scale bar 500 nm for top 
micrograph and 1000 nm for bottom micrograph).
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highly active in this state,[22] and ADH was used either as a cytosolic enzyme, or incorporated 
in PS-b-PIAT nanoreactors, providing a second organelle-bound enzyme. 
The PS-b-PIAT nanoreactors encapsulating CalB and ADH were prepared and purified 
according to a previously described procedure[35] and loading efficiencies of 21.4 % (± 0.2) 
Figure 3.3. A) Ensemble fluorescence measurements of the cascade reaction at 25 ºC, showing the 
complete reaction mixture with 10 μΜ cytosolic free ADH (squares), and control reactions having no 
CalB (triangles), no ADH (diamonds), no CalB and ADH (stars), or no PAMO (spheres). B) Ensemble 
fluorescence measurements of the cascade reaction with either all enzymes in solution (black triangles), 
CalB in nanoreactors (black squares) or CalB and ADH in nanoreactors (grey spheres). In all cases 
the CalB and ADH concentrations were kept equal, at 0.41 μM and 0.26 μM, respectively. C) Graphical 
visualisation of cascade reactions described in (B).
Table 3.1. Encapsulation efficiencies and incorporated quantities of enzymes in PS-b-PIAT nanoreactors 
determined via ICP-MS measurements and calculated final enzyme concentrations in PS-b-PIAT 
nanoreactor solutions.
Enzyme Amount (mg) Mol. Weight (kDa) Encapsulated (nmol) Concentration (μM)
CalB 0.5 33 3.24 (21.4 %) 1.62
ADH 0.5 150 1.71 (51.2 %) 0.85
Alcalase 0.5 27 0.62 (3.4%) 0.31
Table 3.2. Numerical data for Figure 3.2b, showing relative reaction rates and relative conversions for 
each of the displayed cascade reactions after 15 hours.
Encapsulated enzymes Enzymes in solution Rel. reaction rate (%) Rel. conversion (%)
- PAMO, CalB, ADH 100 100
CalB PAMO, ADH 83 81
CalB, ADH PAMO 87 83
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(CalB) and 51.2 % (± 3.2) (ADH) were determined via inductively coupled plasma mass 
spectrometry measurements (Table 3.1).[35] Structural integrity of the nanoreactors was verified 
by transmission electron microscopy (Figure 3.2) and size was determined by dynamic light 
scattering measurements, yielding average sizes of 187 ± 2 nm, polydispersity 0.15 (CalB) 
and 318 ± 26 nm, polydispersity 0.28 (ADH), respectively. 
Different cascade reaction mixtures of increasing complexity were first screened in 
bulk ensemble measurements via fluorescence spectroscopy to obtain reaction conditions 
that would allow monitoring of the cascade reaction in single functional polymersomes-in-
polymersomes systems (Figure 3.3). First, all enzymes were used free in solution. These 
experiments showed that elimination of PAMO from the cascade mixture completely inhibited 
the reaction, while omission of CalB, ADH, or both enzymes, severely lowered the speed of 
the cascade reaction, demonstrating that all enzymes are indeed required for the production 
of fluorescent resorufin (Figure 3.3A). Next, cascade systems were investigated in which first 
only CalB was encapsulated in nanoreactors, and finally both CalB and ADH were confined 
to nanoreactor subcompartments. In this approach, the amounts of enzyme loaded in the 
nanoreactors were kept the same compared to the concentrations of the free enzymes.
After 24 hours at room temperature, the reactions typically reached conversions ranging 
from 10 – 25 %, depending on the applied conditions. The low reaction rate likely results 
from the usage of substrate 1 and its subsequent intermediates, whose structures deviate 
considerably from the standard substrates of the used enzymes. However, we still opted for 
this pro-fluorescent substrate, even if it would be less well accepted by one or more of the 
enzymes, as fluorescence is the most efficient readout method for our multicompartment 
system.
Both cascade systems in which one or two enzymes were encapsulated gave a small 
decrease in the overall speed of the reaction, of 17% and 14%, respectively, compared to 
the same reaction with the enzymes free in solution (Figure 3.3B and Table 3.2). The slight 
decrease in reaction rate due to encapsulation could be a result of the encapsulation procedure. 
In the case of ADH it can also be attributed to decreased diffusion of the polar cofactor into 
the nanoreactor.[36] Yet, these results clearly demonstrate that reaction intermediates still can 
easily travel across multiple compartments, to react with the different enzymes, which are 
confined in their cavities.
To prove that compartmentalisation is a generic strategy for the successful execution 
of biocatalytic cascade reactions, where also compatibility issues can occur, we replaced 
CalB, the enzyme of the second step of the cascade reaction, with Alcalase, a protease that 
shows comparable esterase activity to CalB for certain substrates at room temperature. Its 
proteolytic activity, including self-degradation, however, becomes much more predominant 
at elevated temperatures such as 37 ºC, compared to that at room temperature (Figure 3.4). 
Proteases are of course not compatible with other enzymes, as they will degrade any other 
enzymes present in solution. Yet, if Alcalase is encapsulated in a PS-b-PIAT nanoreactor 
(Table 3.1 and Figure 3.2), it is physically separated from the other enzymes and should
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not be able to degrade them, thus allowing the cascade reaction to take place normally. 
Alcalase and PS-b-PIAT-bound Alcalase showed similar rates compared to CalB for the ester 
hydrolysis reaction at 25 ºC (Figure 3.5A). Next, the cascade reaction was performed with 
Alcalase at 37 ºC (Figure 3.6), where protease activity is more predominant. Clearly, the 
cascade reaction containing free Alcalase was severely inhibited and leveled off much faster 
compared to the reaction with CalB (Figure 3.6A and Table 3.3), indicating that degradation 
of the enzymes is taking place during the cascade reaction. When using the PS-b-PIAT 
nanoreactors to encapsulate Alcalase, a much smaller effect on reaction speed was observed, 
indicating that compartmentalisation of Alcalase reduces proteolytic degradation of the other 
cascade components and therefore increases the compatibility of this cascade reaction (Figure 
3.6A and Table 3.3). To gain more insight into the effect of compartmentalisation of Alcalase 
on the cascade reaction rate, an additional experiment was performed. Here the cascade 
reaction mixture with either free Alcalase or encapsulated Alcalase was pre-incubated without 
substrate for a certain period of time at 37 ºC to allow Alcalase degradation to occur. After 
the pre-incubation step, the substrate was added and the reaction mixture was kept at 25 ºC 
to observe the reaction rate of the cascade without further interference from the proteolytic 
activity of Alcalase (Figure 3.5B-E). This also further demonstrated that spatial confinement of 
Alcalase allowed the overall reaction to proceed with a higher rate compared to where Alcalase 
was used in solution. The observed decrease in cascade activity for the encapsulated system 
can be explained by self-degradation of the protease inside the nanoreactors.
To further demonstrate and analyse the multicompartmentalised nature of this system, 
the reaction mixture containing free PAMO, CalB and ADH-loaded polymersomes, substrate 
and cofactors was loaded into micrometric PB-b-PEO polymersomes following a previously 
reported procedure.[28,37] First, an inverted emulsion was created with aqueous droplets of 
reaction mixture suspended in a solution of toluene; the amphiphilic PB-b-PEO was dissolved 
Figure 3.4. A) UV measurements of loss in proteolytic activity of Alcalase due to self-degradation over 
time, using N-succinyl-AAPF-nitroanilide as substrate to measure remaining activity, after pre-incubation 
for 0, 2.5, or 8 hours at 25 ºC (red bars) or 37 ºC (black bars). Enzyme activity was based on the initial 
slope (0-30 sec) of the substrate conversion plot.
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Figure 3.5. Ensemble fluorescence intensity measurements using Alcalase as a substitute for CalB in 
the cascade reaction. In all cases, non-encapsulated ADH and PAMO are used. A) Absolute fluorescence 
intensity graphs for the comparison of cascade reactions performed with free CalB (squares), free 
Alcalase (spheres) and Alcalase nanoreactors (triangles) at equal enzyme concentrations. Reaction 
is performed at 25 ºC, where only esterase activity is observed for Alcalase. B-D) Assessment of 
proteolytic degradation in time by introducing a pre-incubation step at 37 ºC to allow degradation, before 
performing the Alcalase-containing cascade reactions at 25 ºC. B) Absolute fluorescence intensity 
graphs with different pre-incubation times: 0 h (grey upward triangles, nanoreactors; black squares, 
free enzyme), 2.5 h (grey diamonds, nanoreactors; black spheres, free enzyme) and 8 h (grey right 
arrow, nanoreactors; black diamonds free enzyme). C) Normalised fluorescence intensity measurements 
for cascade reactions using Alcalase in PS-b-PIAT nanoreactors after 0 (squares), 2.5 (spheres) and 
8 (triangles) hours pre-incubation at 37 ºC. D). Normalised fluorescence intensity measurements for 
cascade reactions using Alcalase in solution after 0 (squares), 2.5 (spheres) and 8 (triangles) hours >>
71
Cascade reactions in multicompartmentalised polymersomes
in the toluene, stabilizing the droplet interface. It is to note that the emulsion droplets were still 
stable regardless of the higher level of complexity of the aqueous content compared to previous 
reports.[28,37] A fraction of the emulsion was subsequently poured over a biphasic toluene/water 
interface, stabilised by PB-b-PEO. Finally, centrifugation of the emulsion droplets through the 
polymer-stabilised solvent/water interface, yielded the “organelle”-containing cell mimics (see 
also Figure 1.7 in Chapter 1).[28]
Confocal fluorescence microscopy was used to prove that the generation of the final 
fluorescent reaction product exclusively takes place in the cell mimics over time. Numerous 
vesicles were imaged over time and the state of the confined reaction at different time 
points is depicted in Figure 3.7 and Table 3.4. Qualitatively, an increase in fluorescence 
intensity can clearly be observed with time. This was quantitatively demonstrated by the 
fluorescence intensity plot profile of individual vesicle cross-sections for each acquisition 
shown in Figure 3.7. At initial time (t=0h), which also corresponds to the negative control
Figure 3.6. A) Comparison of ensemble fluorescence measurements of the cascade reaction at 37 
ºC, using CalB (squares), Alcalase (black circles) or PS-b-PIAT-bound Alcalase (grey triangles) for the 
ester hydrolysis step. Conversions were normalised based on the maximum conversion of the sample 
containing CalB. B) Graphical representation of the utilised cascade systems in (A).
Table 3.3. Numerical data for Figure 3.6, showing relative reaction rates and relative conversions for each 
of the displayed cascade reactions after 14 hours.
Encapsulated enzymes Enzymes in solution Rel. reaction rate (%) Rel. conversion (%)
- PAMO, CalB, ADH 100 100
- PAMO, Alcalase, ADH 31 33
Alcalase PAMO, ADH 71 71
<< pre-incubation at 37 ºC. Graphs were normalised based on the maximum conversion of the sample 
without pre-incubation. E) Overview of decreases in reaction rate of the cascade reaction after pre-
incubation at 37 ºC for different periods of time, using either Alcalase (black bars) or Alcalase nanoreactors 
(red bars) in the cascade. Data was normalised based on the activity observed for Alcalase at t=0 hours.
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Figure 3.7. Spinning disk confocal fluorescence micrographs of multicompartmentalised polymersomes. 
Image A shows a graphical representation of the applied system. Images B-J show the fluorescence 
intensity of generated resorufin displayed at initial time (t=0h) (top), an intermediate time point (t=7h55) 
(middle), and after full conversion (t=32h) (bottom). Images B, E and H correspond to the raw acquisitions, 
those that are analysed in terms of intensity. Image C is observed under bright field. Images F and I 
are enhanced and colored images for the reader’s better visualisation. Scale bar is C) 20µm, E) 40µm, 
H) 60µm. A plot profile of the cross-section for each time point demonstrates the drastic increase of 
fluorescence, from initial background signal to a clear vesicle-based fluorescent signal (D, G and J).
73
Cascade reactions in multicompartmentalised polymersomes
without PAMO for longer reaction times, the signal is similar to background intensity, with an 
average around 1100 a.u. at any coordinate. At intermediate times (t=7h55), there is a “bump” 
rising from the background signal up to 1250 a.u. intensity. And finally, at full conversion 
(t=32h) the fluorescence inside this cell mimic significantly increases up to 1900 a.u. (Figure 
3.7). Table 3.4 displays the average mean intensities and standard errors obtained from 5 
to 10 independent multicompartmentalised reactors at these various time points, showing a 
significant increase of the fluorescent intensity over time. 
Finally, one of the cell mimics at full conversion (t=32h) was reconstructed in 3D to better 
investigate the location of the final fluorescent product. In Figure 3.8, both on the 2D confocal 
acquisition as well as on this 3D reconstructed vesicle, the fluorescence clearly appears to 
be compartmentalised, confined to the most inner compartments. This confinement of the 
final product is due to the fact that resorufin interacts electrostatically with ADH, the enzyme 
that enables the last enzymatic reaction step, preventing fast diffusion of the final fluorescent 
product from the synthetic organelle. This also indicates that the reactions take place 
exclusively in the organelle subcompartments, as for enzymes in solution a homogenously
Table 3.4. Averaged numerical data for all multicompartmentalised polymersomes, showing mean 
intensities, standard deviation and error, and number of vesicles used to determine these averages.
Time Mean intensity (a.u.) Standard errora
Initial (t=0h) 1109.8 0.90 (n = 5)
Intermediate (t=7h55m) 1161.8 2.54 (n = 10)
Full conversion (t=32h) 1483.4 46.2 (n = 5)
a  Standard error was determined as the standard deviation divided by the square root of the number of 
samples (n).
Figure 3.8. A) Enhanced spinning disk confocal fluorescence micrograph at full conversion of a 
multicompartmentalised polymersome, obtained with higher laser power (50% instead of 30%) to 
better highlight the compartmentalised confined fluorescence, as the resorufin is generated in the ADH 
polymersomes. Scale bar is 60 μm. B) The 3D representation of this full conversion system showing 
the presence of a large number of such nanosized ADH polymersomes. C) multicompartmentalised 
polymersome containing only CalB nanoreactors and free ADH enzyme in the lumen of the large 
compartment (scale bar 20 μm).
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distributed fluorescence was indeed observed (Figure 3.8).  Such confinement of fluorophores 
via electrostatic interactions has been observed previously in PS-b-PIAT nanoreactors 
when a highly charged polymer was included in the particles together with an enzyme.[38] 
The interaction between ADH and resorufin was further demonstrated by size exclusion 
chromatography, which only showed co-elution of fluorescent product together with ADH 
enzymes or ADH nanoreactors (Figure 3.9).
Figure 3.9. Fluorescence spectroscopy measurements of size-exclusion chromatography fractions of 
cascade reaction mixtures, showing colocalisation of fluorescent resorufin with ADH enzyme or ADH 
nanoreactors. The enzymes and nanoreactors elute simultaneously (fractions 4-7) as both have higher 
molecular weights than the column exclusion limit (~30 kDa), resorufin elutes in fractions 20-35. A) Control 
samples of ADH in solution (diamonds), ADH nanoreactors (open spheres), CalB nanoreactors (open 
triangles), all without profluorescent substrate, and CalB in solution with resorufin (black arrowheads), 
showing no colocalisation. Also displayed are reaction mixtures containing both ADH and CalB in 
solution with substrate (black spheres), or without substrate (black squares), in which only the substrate-
containing sample shows strong emission at 592 nm. B) Zoom of fractions 3-8 of graph A, in which protein 
and nanoreactors elute, showing resorufin colocalisation with ADH. C) Normalised graphs for reaction 
mixtures containing both ADH and CalB nanoreactors (spheres), ADH in solution with CalB nanoreactors 
(black squares), and both ADH and CalB in solution (triangles), all showing product conversion and 
interaction of fluorescent product with ADH nanoreactors or ADH in solution (panel D for zoom).
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3.3 Conclusion
In conclusion, we have shown that we can construct a structural and functional eukaryotic 
cell mimic through multicompartmentalisation, by loading functional organelle mimics inside 
larger polymersomes. The concept of enzyme  compartmentalisation was used to spatially 
separate incompatible enzymes to retain the functionality of the applied cascade reaction. 
Furthermore, we applied an original three-enzyme cascade reaction that takes place inside 
such a scaffold. The cofactor-dependent cascade reaction involved two different enzyme-
containing “organelles”, as well as a “cytosolic” enzyme. Interestingly, as is particularly visible 
in 3D-reconstructed cell mimics and by colocalisation experiments, the fluorescent end-
product seems confined mainly in the ADH-containing “organelles”, where the production of 
the final dye takes place.
We anticipate that our multicompartmentalised system can act as a mimic of cellular 
reaction pathways that take place in multiple successive compartments, and that this system 
can provide a way to study such cellular processes in more detail. Such research is of 
fundamental biological and chemical relevance, as investigating how cellular reactions or 
interactions, in biomimetic, confined, and multicompartmentalised architectures take place, 
should improve the understanding of how complexity of the eukaryotic cell is established step 
by step. Also in materials chemistry, this level of control over chemical reactions, can provide 
access to powerful new materials; reactions can be truly confined to provide increased 
efficacy,[39] incompatible reactions can be separated and therefore conducted simultaneously. 
As such, miniaturised microreactors should allow control over attolitric or femtolitric volumes, 
increasing safety and efficacy, for biocatalysis/bioengineering purposes.
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3.5 Materials and methods
3.5.1 Chemicals
Recombinant histidine-tagged PAMO is a fusion protein of Phenylacetone monooxygenase 
and the NADPH-regenerating enzyme phosphite dehydrogenase (PTDH), for which the 
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plasmid was kindly provided by Marco Fraaije (Rijksuniversiteit Groningen, The Netherlands). 
The fusion enzyme is more solvent and temperature stable. The NADPH-cofactor regenerating 
function, however, is not used in this study. The protein was overexpressed as described 
elsewhere.[32] Alcohol dehydrogenase from Saccharomyces Cerivisae, Candida Antarctica 
Lipase B, Alcalase and N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide were obtained from Sigma-
Aldrich. PS40-b-PIAT50 was purchased from Encapson B.V. Nijmegen. Poly(butadiene)46-b-
poly(ethylene oxide)30 (PB46-b-PEO30) (P9095-BdEO, Mn PB=2,500 g/mol and Mn PEO=1,300 
g/mol, PDI=1.04) were purchased from Polymer Source. Biotech cellulose ester dialysis tubing 
(1 MDa MWCO) was obtained from Spectrapor, Breda, The Netherlands. THF was distilled 
under Argon from sodium/benzophenone prior to use. “MilliQ” water was doubly deionised 
(18.2 MΩ).  All other reagents and solvents were of the highest quality grade and purchased 
from commercial suppliers and used without further purification unless stated otherwise.
3.5.2 Instrumentation
Nuclear magnetic resonance (NMR) spectra were recorded on a Varian Inova 400 (400 
MHz for 1H) and on a Bruker DMC300 (75 MHz for 13C). Inductively coupled plasma – mass 
spectrometry (ICP-MS) measurements were conducted on a Thermo Fisher Scientific 
Xseries I quadrupole machine using 5 mL sample solutions with a 0.49 mg/mL InCl3 internal 
standard. Transmission electron microscopy (TEM) images were obtained using a JEOL 
JEM 1010 microscope with an acceleration voltage of 60 kV. Dynamic light scattering (DLS) 
measurements were performed on a Malvern Zetasizer Nano-Z (Malvern Instruments, 
Malvern, UK) and sizes were obtained via the Cumulant algorithm (error indicated is standard 
deviation). Plate-reader data were obtained using 384-well flat black polystyrene plates 
(Greiner Bio-one) on a TECAN Infinite 200 PRO machine. High-resolution mass spectrometry 
(MS) measurements were performed with a JEOL AccuToF (electrospray ionisation). Size-
exclusion measurements were performed on an Amersham Ettan LC system (GE Healthcare, 
Diegem, Belgium) equipped with a fraction collector, using a self-packed Sephadex G-50 (GE 
Healthcare) column (50 mm length, 8 mm diameter) in 50 mM Tris/HCl buffer (pH 7.6) using 
a flow rate of 0.5 mL/min.
3.5.3 Experimental procedures
7-(3-(2-methyl-1,3-dioxolan-2-yl)propoxy)-3H-phenoxazin-3-one (I)
To a solution of 7-hydroxy-3H-phenoxazin-3-one (100 mg, 0.47 mmol) in DMF (5 mL), was 
added 2-(3-chloropropyl)-2-methyl-1,3-dioxolane (176.4 μL, 1.173 mmol) and K2CO3 (162 mg, 
1.173 mmol). The reaction mixture was stirred for 48 hours at 65 ºC. The mixture was diluted 
with ethyl acetate (30 mL) and extracted with 1 M NaOH (3 x 10 mL), after which the organic 
phase was dried over Na2SO4 and concentrated. Column chromatography (EtOAc : heptane, 
3:1, Rf 0,48) yielded the product as an orange solid (64 mg, 40%). 
1H NMR (400 MHz, CDCl3) 
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δ 7.68 (d, J = 8.9 Hz, 1H), 7.41 (d, J = 9.8 Hz, 1H), 6.92 (dt, J = 8.9, 2.4 Hz, 1H), 6.82 (dt, J 
= 3.9, 2.0 Hz, 1H), 6.79 (d, J = 2.6 Hz, 1H), 6.31 (t, J = 2.0 Hz, 1H), 4.09 (t, J = 6.4 Hz, 2H), 
4.03 – 3.92 (m, 4H), 2.01 – 1.91 (m, 2H), 1.88 – 1.82 (m, 2H), 1.37 (s, 3H). 13C NMR (75 MHz, 
CDCl3) δ 186.36, 163.27, 149.95, 145.78, 145.47, 134.77, 134.21, 131.64, 128.38, 114.18, 
109.74, 106.76, 100.57, 69.13, 64.85, 35.45, 24.05, 23.73. HRMS (ESI) m/z calculated for 
C19H19NO5 : 342.13415 [M+H]
+, found: 342.13339
7-((4-oxopentyl)oxy)-3H-phenoxazin-3-one (1)
Compound (I) (77 mg, 0.225 mmol) was dissolved in acetone (8 ml), to which HCl (2 mL, 2 
M) was added. The mixture was stirred overnight, after which the pH was adjusted to 8 via 
addition of a saturated NaHCO3 solution. EtOAc (50 mL) was added to the mixture, after 
which the layers were separated. The organic phase was washed with 1 M NaOH (3 x 10 
mL). The combined aqueous layers were washed with EtOAc (2 x 10 mL). After combining 
the organic phases, they were dried over Na2SO4 and evaporated. Column chromatography 
(DCM : MeOH, 99:1, Rf 0,52) yielded the product as an orange solid (62 mg, 93%). 
1H NMR 
(300 MHz, CDCl3) δ 7.71 (d, J = 8.9 Hz, 1H), 7.44 (d, J = 9.8 Hz, 1H), 6.94 (dd, J = 8.9, 2.6 
Hz, 1H), 6.89 – 6.77 (m, 2H), 6.34 (d, J = 2.1 Hz, 1H), 4.11 (t, J = 6.2 Hz, 2H), 2.70 (t, J = 6.9 
Hz, 2H), 2.22 (s, 3H), 2.14 (t, J = 6.6 Hz, 2H). 13C NMR (75 MHz, CDCl3) δ 207.77, 186.37, 
162.97, 149.92, 145.75, 145.64, 134.79, 134.28, 131.69, 128.47, 113.99, 106.83, 100.69, 
68.04, 39.64, 30.17, 23.08. HRMS (ESI) m/z calculated for C17H15NO4 : 298.10793 [M+H]
+, 
found: 298.10847
Formation of enzyme-loaded PS-b-PIAT nanoreactors
PS-b-PIAT nanoreactors were formed by dissolving 0.5 mg of the desired enzyme in 50 
mM Tris/HCl buffer (2.5 mL, pH 8.0). This mixture was then gently agitated, while a solution 
of PS-b-PIAT (0.5 mL, 1 mg/mL) in THF for CalB and Alcalase, or dioxane for ADH, was 
added dropwise until an opaque suspension was obtained. The mixture was then left to self-
assemble for 30 minutes before being transferred into a 1,000 kDa MWCO dialysis bag. 
The nanoreactors were dialysed for 48 hours against 50 mM Tris/HCl buffer (pH 8.0), with 
regular changes of the external dialysis buffer, to remove non-encapsulated enzymes from 
the solution.[25] After dialysis, volumes were corrected to 2 mL and the nanoreactor solutions 
were stored at 4 ºC and used within 3 days. Structural integrity was confirmed by TEM and 
DLS measurements.
Ruthenium-labeling of enzymes
To determine encapsulation efficiencies of ADH, CalB and Alcalase in PS-b-PIAT nanoreactors, 
2 mg of protein was dissolved in 0.5 mL phosphate buffer (20 mM, pH 7.4). The proteins 
were first washed by centrifugation (3 x 5 min, 13000 rpm), using Amicon Ultra centrifugal 
filters with 10 kDa membranes. In between centrifugations, the supernatant was replenished 
with 400 μL phosphate buffer. After the final washing, the proteins were resuspended in 500 
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μL phosphate buffer, to which was added K2CO3 (60 μL, 1 mg/mL) and bis(2,2’-bipyridine)-
(5-isothiocyanato-phenanthroline) ruthenium bis(hexafluorophosphate) (2.5 equivalents per 
protein, 1 mg/mL in phosphate buffer). The yellow/orange mixture was shaken overnight at 
25 ºC. Labeled proteins were then purified by spin filtration using Amicon Ultra centrifugal 
filters 10 kDa membranes (5 x 5 min, 13000 rpm). In between washings, the supernatant was 
replenished with 400 μL of 50 mM Tris/HCl pH 8.0 buffer. After the last centrifugation step, the 
proteins were redissolved in a total volume of 500 μL and stored at 4 ºC.
Encapsulation efficiencies via ICP-MS analysis
Nanoreactors containing Ru-labeled enzymes were prepared as described above. After 
dialysis, the suspensions were lyophilised and then destructed in nitric acid (65%, 0.5 mL) for 
3 hours at 80 ºC. Next, the samples were cooled down to room temperature and, after adding 
an internal standard of InCl3 (1.5 mL, 0.49 mg/mL), the volume was adjusted to 5.0 mL with 
MilliQ. The Ru-counts of each sample were standardised using the internal standard counts 
and subsequently compared to samples with a known amount of Ru-labelled enzyme.
Enzymatic activity assays
Reaction mixtures for fluorimetry plate-reader experiments were prepared in volumes of 200 
μL of 50 mM Tris/HCl pH 8.0 buffer; 3 wells of a 384-wells plate were each filled with 60 μL of 
the mixture. Reaction mixtures contained CalB nanoreactors (50 μL), NADPH (24 μL of 5 mM; 
600 μM), NAD+ (24 μL of 5 mM; 600 μΜ), substrate (1) (6 μL of 10 mM in DMSO; 300 μΜ), 
PAMO (40 μL of 100 μM; 20 μM) and either ADH enzyme (20 μL of 100 μM; 10 μM) or ADH 
nanoreactors (62 μL). Assays were performed at 25 ºC, while fluorescence emission intensity 
was measured at 590 nm, with an excitation wavelength of 561 nm.
For determination of relative reaction speeds between compartmentalised and non-
compartmentalised cascade systems, the slopes of the reactions were compared between 
t=10200 sec and t=20100 sec and expressed as a percentage of the free enzyme cascade 
reaction. The conditions used were based upon nanoreactor loading efficiencies: CalB: 50 μL 
nanoreactors which contained 0.40 μM enzyme; ADH: 62 μL nanoreactors which contained 
0.26 μM enzyme; Alcalase: 122.2 μL nanoreactors which contained 0.19 μM enzyme, for 
comparison the concentration of free CalB in solution was adjusted to that of the respective 
Alcalase or CalB concentrations in the nanoreactors.
Alcalase degradation assay
A solution of Alcalase (6.24 μL, 0.1 mg/mL, 0.19 μM final) was added to 113.76 μL of 50 mM 
Tris/HCl pH 8.0 buffer and shaken at 750 rpm at either 25 ºC or 37 ºC for 0, 2.5 or 8 hours. 
At the designated time points, 10 μL of this solution was mixed with 28 μL buffer and 2 μL 
N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide (20 mM in DMSO; 1.25 mM final). The reaction was 
followed via the production of para-nitroaniline by a UV spectrophotometer measuring at 410 
nm. The slope observed for the initial 30 seconds of the reaction was used to determine the 
79
Cascade reactions in multicompartmentalised polymersomes
residual enzymatic activity.
Encapsulation of PS-b-PIAT nanoreactors in giant PB-b-PEO polymersomes
All the components for the nanoreactor cascade mixture were mixed together in similar ratios 
as described for the plate-reader experiments, yet to a final volume of 40 µL instead of 200 
µL; CalB nanoreactors (10 μL), NADPH (4.8 μL of 5 mM; 600 μM), NAD+ (4.8 μL of 5 mM; 
600 μΜ), substrate (1) (1.2 μL of 10 mM in DMSO; 300 μΜ), CRE3-PAMO (8 μL of 100 μM; 
20 μM) and ADH nanoreactors (10 μL).  As soon as the substrate, the final component added, 
was mixed in, the Eppendorf tube containing the mixture was placed in a Thermomixer® 
(Eppendorf) at 25°C and agitated with 800 rotations per minute (pm). The nanoreactor cascade 
solution was submitted to 30 minutes of agitation to thoroughly mix all the components of 
the cascade together and dissolve the sucrose responsible for the 380 mOsm inside the 
final PB-b-PEO vesicles. Then, following a procedure published elsewhere,[28] 5 µL of the 
nanoreactor cascade solution was first poured in another Eppendorf tube containing 3 mg/
mL PB-b-PEO in 500 µL toluene (step 1). The PB-b-PEO solution in toluene was previously 
stirred overnight to ensure a complete dissolution of the copolymer, as verified by DLS (no 
scattering intensity). In another tube (step 2), 30 µL of the same organic solution was poured 
over 30 µL of a 430 mOsm aqueous glucose solution and allowed to stabilise for 30 min. 
Finally, the first tube was emulsified with vigorous agitation by hand yielding inverted emulsion 
droplets. Then 50 µL of this emulsion was poured slowly over the interface tube. The sample 
was then immediately centrifuged at 25 °C at 500 g for 4 min and the aqueous polymersomes-
in-polymersomes suspension was recovered in the lower phase. The samples were always 
kept in thermomixers at 25°C until the moment they were put in microscopy chambers and 
analysed by spinning disk confocal microscopy.
Spinning disk confocal microscopy
Microscopy chambers were µSlides VI 0.4 (hydrophobic, uncoated, Ibidi, Germany). The 
spinning disk microscope was a Leica DMI6000 (Leica Microsystems, Wetzlar, Germany) 
equipped with a confocal Scanner Unit CSU-X1 (Yokogawa Electric Corporation, Tokyo, 
Japan) using for this experiment the objective HCX PL Apo 63X oil NA 1.4 and an EMCCD 
camera Photometrics Quantem (Roper Scientific, Evry, France). Z-stack analysis was 
performed with a piezo (Physik Instrumente (PI), Karlsruhe, Germany). The diode laser used 
was a Cobolt Calypso of 100mV (Cobolt AB, Solno, Stockholm), which emitted at 491 nm. 
A Semrock emission filter with a bandpass window in the red (593 to 668 nm) was used. 
Exposure time was set at 250 ms and the laser power was always set at 30% except when 
stated otherwise. The experiments were performed in the Bordeaux Imaging Center of the 
University of Bordeaux Segalen. (CNRS / University of Bordeaux Segalen / Inserm).
Image processing and analysis for spinning disk confocal microscopy
Processing and analysis of spinning disk fluorescence confocal acquisitions were performed 
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with ImageJ software developed by the NIH and available as public domain software at http://
rsbweb.nih.gov/ij/. The mean intensity of the complete 2D area of the multicompartmentalised 
structures was analysed. For Figure 3.4, a plot profile of the cross-section of the frames was 
also extracted, giving intensity vs distance on this cross-section. The analysed data were raw 
and unenhanced. Z-stacks were reconstructed to a three-dimensional structure with Imaris 
software (Bitplane, Zurick, Switzerland).
Colocalisation studies via size-exclusion chromatography
For analysis, 100 μL sample was applied onto the Sephadex G-50 column with a flow rate of 
0.5 mL/min at room temperature. After separation, fractions of 300 μL each were collected and 
analysed via fluorescence measurements using a plate-reader (excitation 561 nm, emission 
592 nm).
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4.1 Introduction
Compartmentalisation is a key organisational feature in nature. It allows cells to spatially 
arrange enzymatic complexes in order for their processes to proceed unaffected, but also to 
function more efficiently.[1,2] In eukaryotic cells, organelles are the most predominant subcellular 
compartments designed to spatially separate biosynthetic pathways and to protect them from 
undesired interactions with other cellular components, or to ensure that toxic intermediates 
are efficiently metabolised in a confined area.[3,4] Next to these permanent spatial assemblies 
of biomolecules, the cell also applies a host of dynamic interactions that temporarily interface 
proteins and ligands, thereby triggering a specific spatiotemporally controlled cellular process. 
In contrast to organelle-segregated processes, these dynamic assemblies often form and 
dissociate in response to changes in their interaction domains.[5] These cues can originate 
either from elsewhere inside the cell, or from the outer environment. External signals are 
mainly molecule-based and can among others allow communication between cells, indicate 
the presence of an energy source or the occurrence of a cell-threatening situation, and will 
often force the cell to respond to their presence. Only a small fraction of relatively hydrophobic 
molecules can passively pass through the membrane and influence intracellular chemistry. 
Other compounds require active transport via channel proteins[6] or endocytosis[7] to enter the 
cell, or the use of cell surface receptors[5] to influence cellular processes. Useful molecules 
are metabolised and applied, however, harmful compounds have to be dealt with and their 
presence often triggers a response to neutralise them.
Cellular responses often involve signalling pathways facilitated via a biomolecular 
assembly process, for example triggered by the binding of the signalling compound to a 
membrane-bound receptor or other protein and subsequently activating it. Many of these 
events involve protein-protein, or protein-ligand binding, which can cause a change in protein 
or ligand localisation and allows the cell to direct these molecules to the site of action. 
Controlling and understanding these complex processes is of vital importance for 
unravelling the functioning of the cell. Research into protocells and artificial cell-mimics has, 
among others, already focussed on transcription and translation processes,[8–11] cytoskeletal 
structures,[12–16] the use of organelle subcompartments for spatial organisation,[17–19] the 
induction of selective permeability[11,20] and molecular crowding.[21–23] Reversibly triggering 
protein interactions and assemblies inside cell mimics, however, has to our knowledge hardly 
been explored yet.
To see how cells can react to changes in their environment, i.e. the addition of food 
sources, or signalling molecules, we apply lipid giant unilamellar vesicles (GUVs) as a cell-
mimicking platform. We use the semipermeable nature of the lipid membrane to allow small 
molecules to passively diffuse into the vesicle lumen and trigger a response inside. Through 
enzymatic conversion of the small molecule, a pH change can be created[24] that allows for the 
selectively triggered assembly and disassembly of a protein-ligand complex. The pH change 
inside the GUVs can be controlled by using enzymes that require natural cofactors, like NADH
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and NAD+, where protons can either be consumed or produced during conversion of the 
cofactor (Figure 4.1). The maximum pH change is therefore limited by the amount of cofactor 
present inside the system, and the pH effect can be reversed upon addition of the opposite 
trigger. The system responds to the enzymatically triggered pH variation by inducing or 
inhibiting protein-ligand interactions (Figure 4.1).
Two routes to achieve such a system were devised: a one-enzyme and a two-enzyme 
system. The first option features an alcohol dehydrogenase (ADH), which can catalyse both 
oxidation and reduction of the cofactor NAD(H) and leads to an equilibrium, depending on the 
type and ratio of alcohol and ketone substrates that are used, which in this case will be acetone 
and iso-propanol (iPrOH). The second option features separate enzymes for oxidation and 
reduction of the cofactor: here both an ADH and an NADH peroxidase are used. In this case, 
ADH is only used for substrate reduction. The NADH peroxidase converts hydrogen peroxide 
(H2O2) into water and oxidises NADH in the process. This latter reaction is irreversible and 
employs a different substrate than ADH, increasing the complexity of the system, yet also 
allowing for additional control over the directionality of the action of the system.
The response element in the system is a fluorescent protein, which will undergo 
reversible assembly with a binding ligand on the GUV membrane. A commonly employed 
supramolecular interaction is the interaction between an oligohistidine tag (His-tag) and a 
Nickel(II) nitrilotriacetic acid ligand (Ni-NTA),[25,26] which is furthermore also pH-dependent.[27] 
Upon acidification of the environment, the interaction between the His-tag and Ni-NTA can be 
broken. The pH of the environment in the GUV can be reversibly changed upon addition of a 
small molecule, which causes the enzyme(s) inside the GUV to either produce or consume 
protons as they convert the substrate and NAD(H) cofactor. In this chapter we aim to use 
this reversible pH change to influence the binding of His-tagged proteins to Ni-NTA ligands 
Figure 4.1. The localisation and assembly behaviour of a fluorescent His-tagged protein (red dots) 
inside GUVs can be influenced by addition of an external trigger (yellow or blue small molecule). GUV 
membranes contain a Ni-NTA-presenting lipid to reversibly bind His-tagged proteins, while ADH, or ADH 
and NADH peroxidase (represented by green dots) can be used to reversibly change the local pH inside 
the GUV to influence binding between the Ni-NTA ligand and the His-tagged protein. At acidic pH (A), 
the interaction is prevented, while upon increasing the pH, the interaction is induced (B) and vice versa. 
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positioned on the GUV membrane, causing an external small molecule to effect a reversible 
structural change inside a giant vesicle (Figure 4.1A-B).
4.2 Results and discussion
As lipid membranes are only semi-permeable, first the permeability of the GUVs for the 
substrates was assessed. A mixture of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
(POPC) and cholesterol (1:2 molar ratio) was used, as this lipid composition yields large 
amounts of stable GUVs when formed using the droplet transfer method.[28,29] The GUV 
membrane can be supplemented with a Ni-NTA-presenting lipid, by admixing Ni2+-chelating 
1,2-dioleoyl-sn-glycero-3-[(N-(5-amino-1-carboxypentyl)iminodiacetic acid)succinyl] (DGS-
NTA-Ni) during vesicle formation. Using the droplet transfer method, aqueous emulsion 
droplets are formed in an oil phase containing the desired lipids, which stabilise the emulsion 
with a monolayer of lipids. The emulsion droplets will eventually form the interior phase of 
the GUVs, and therefore contain all the components that should be encapsulated. Upon 
transferring the emulsion on top of a second aqueous solution, the outer phase, the sample is 
centrifuged to force the emulsion droplets to pass through the oil-water interface and pick up a 
second monolayer of lipids to form GUVs (see Figure 1.7, Chapter 1). Confocal fluorescence 
microscopy and cryogenic scanning electron microscopy (cryo-SEM) were used to verify the 
formation of GUVs (Figure 4.2). 
Figure 4.2. Characterisation of POPC/Chol GUVs with 0.5% DGS-NTA-Ni, using confocal fluorescence 
microscopy (A) and cryo-SEM (B). For fluorescence microscopy, the vesicle membrane is stained with 
0.5% DOPE-Lissamine (red) and the lumen with 1 mg/mL FITC-labelled dextran (green). Scale bar is 20 
μm for fluorescence microscopy and 10 μm for electron microscopy.
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Figure 4.3. Small molecule permeability of GUV membranes. A and D) NADH peroxidase (0.5 mg/mL, 
10 μM) and NADH-filled vesicles triggered with 4 mM H2O2, B and E) ADH (0.5 mg/mL) and NADH-filled 
vesicles at pH 5.0, pulsed with 12 mM acetone, and C and F) ADH (0.5 mg/mL) and NAD+-containing 
vesicles triggered with 12 mM iPrOH. All plots show a decrease or an increase in NADH fluorescence 
intensity. The different traces (A-C) represent individual GUVs. Each trace starts at the time point at which 
the GUVs sedimented into focus again after the substrate was added. Confocal fluorescence images 
(D-F) show representative vesicles before (left) and upon completion of the reaction after (right) external 
addition of the substrate.  Scale bar is 10 μm.
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Subsequently, either ADH or NADH peroxidase was loaded into GUVs, together with 
the respective cofactor. NADH is fluorescent, while upon conversion to NAD+ it loses its 
fluorescence. The consumption or formation of NADH was used to verify that the GUVs were 
permeable for the small molecule substrates, but also to show that the cofactor remained 
trapped inside. To image this process in GUVs over time using fluorescence microscopy, the 
GUVs were deposited on BSA-functionalised glass slides to prevent interactions between 
the lipid membranes and the glass surface. Upon addition of the substrate H2O2 for NADH 
peroxidase, fast conversion of NADH to NAD+ in all GUVs could be clearly observed via 
confocal fluorescence microscopy (Figure 4.3A). Similarly, for ADH, either acetone was added 
outside of the GUVs as the substrate, or isopropanol (iPrOH), to produce or consume NADH, 
respectively. In the former case, NADH consumption was observed (Figure 4.3B), while in 
the latter case, fluorescence evolved in GUVs due to NADH formation (Figure 4.3C). The 
Figure 4.4. Fluorescence spectroscopy experiments showing pH changes as a result of the enzymatic 
reactions. Changes in pH are visualised as a change in Fluorescein/TAMRA ratio as a result of the pH-
dependent change of Fluorescein emission. A) NADH peroxidase at 0.1 mg/mL (diamonds) and 0.02 mg/
mL (squares) enzyme concentration, using H2O2 as substrate. B) ADH at 0.5 mg/mL using acetone as a 
substrate and C) ADH with iPrOH. pH calibration of the sensor is included in each graph, showing from 
top to bottom pH 8.5 (solid line, 1.09 ratio), pH 7.0 (dashed line, 0.94 ratio), pH 6.0 (solid line, 0.45 ratio), 
pH 5.0 (dashed line, 0.24 ratio) and pH 4.0 (solid line, 0.10 ratio). Starting pH values are always pH 5.0 
for (A) and (B), and pH 7.0 for (C).
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Figure 4.5. Changes in GUV internal pH caused by addition of an external trigger visualised by confocal 
fluorescence microscopy. A and D) NADH peroxidase-induced pH increase, B and E) ADH-induced pH 
increase, C and F) ADH-induced pH decrease. Starting pH values are always pH 5.0 for (A) and (B), 
and pH 7.0 for (C). Graphs (A-C) display changes in ratio of Fluorescein/TAMRA of a number of traces 
of individual GUVs over time, where a higher ratio represents a higher pH value. Panels D-F display 
representative images of GUVs before addition of substrate and after completion of the reaction. Intensities 
and ratios in graph A and corresponding images in D deviate from the others due to different microscope 
detector settings (see experimental section). Scale bar is 10 μm.
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NADH peroxidase system showed an intensity decrease from 70890 (±5430, 24 GUVs) a.u. to 
13980 (±8690, 20 GUVs) a.u. in 30 min, indicating nearly complete conversion of the cofactor. 
The ADH-catalysed reactions were considerably slower at similar enzyme concentrations (0.5 
mg/mL) and showed a fluorescence decrease from 80520 (±6640, 15 GUVs) a.u. to 48360 
(±9730, 37 GUVs) a.u. in 4 hours, or a fluorescence increase from 200 (±160, 32 GUVs) to 
35630 (±7620, 37 GUVs) a.u. in 4.5 hours. These results indicated that, although there were 
considerable differences in substrate conversion rates, the GUVs are permeable to all tested 
small molecule substrates, and they retain the larger enzymes and cofactors.
After establishing GUV permeability for the small molecule triggers, the ability of the 
enzymes to change and regulate the pH of the solution was explored. Initial studies were 
performed in bulk, using fluorescence spectroscopy and applying a ratiometric pH-sensor to 
follow pH changes as a result of enzymatic activity. The pH sensor consists of a labelled dextran, 
containing carboxyfluorescein (Fluorescein) and tetramethylrhodamine (TAMRA), where 
TAMRA has a pH insensitive emission, while Fluorescein displays a pH-dependent increase 
in fluorescence intensity between pH 4.0 and 9.0 (Figure 4.4A-C, depicted as horizontal 
calibration lines). By calculating the ratio of Fluorescein emission over TAMRA emission, 
the solution pH can be determined independently of pH sensor concentration. To allow pH 
changes in the reaction mixture to take place, a weak sodium phosphate buffer (0.5 mM) was 
applied to provide a relatively stable pH environment, while still allowing the enzymes to adjust 
Figure 4.6. Analysis of His6-tdTomato expression. A) SDS-PAGE gel showing bacterial cell lysate 
supernatant (lane 1) and flow through (lane 2), wash (lane 3) and elution (lane 4) of Ni-NTA affinity 
chromatography, and SEC elution fraction (lane 5). B) ESI-ToF mass spectrometry analysis of purified 
protein showing multiply charged ion species. C) Deconvoluted total mass spectrum.
Figure 4.7. Binding of His6-tdTomato (2.5 μM) to GUV membranes containing different percentages of 
DGS-NTA-Ni, both at disassembly conditions, pH 5 (A) and at assembly conditions, pH 7 (B). Scale bar 
is 10 μm.
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the pH as the reaction progresses. Upon using 5-10 mM cofactor, changes from pH 5.0 to over 
pH 7.0 and back were achieved (Figure 4.4). For NADH peroxidase, stoichiometric amounts 
of H2O2 were sufficient for full conversion, as the reaction is irreversible, while for ADH slightly 
higher amounts of substrate were necessary to achieve the desired pH changes, as this 
reaction reaches an equilibrium that is dependent on both cofactor and substrate ratio. These 
experiments also showed that NADH peroxidase is very efficient in consuming its substrate 
and changing the pH of the solution (Figure 4.4A), even at very low enzyme concentrations. 
ADH on the other hand is slower, which is especially notable in the region between pH 6.0 and 
5.0 upon decreasing the pH, where increasingly more protons are required to lower the pH 
further (Figure 4.4C). Eventually, after approximately 70 min, also this reaction went below pH 
5.0, which is the expected point for disruption of the Ni-NTA and His-tag complex.
We then investigated the ability of the enzymes to generate and maintain the same pH 
change in GUVs. Here, the presence of the vesicle membrane should cause a pH gradient to 
arise between the inside and outside of the vesicle; the pH of the outside solution should not 
significantly vary, whereas the inside pH should change as a result of the reaction. It thereby 
should be taken into account that if the GUV membrane is too permeable for protons and the 
reaction is not fast enough, a stable pH gradient will not be formed and no assembly can be 
triggered. Therefore the same pH sensor as described above, was also loaded into GUVs, 
together with the enzyme and corresponding cofactor to study the pH change inside the 
vesicles using confocal fluorescence microscopy. For NADH peroxidase a notable increase 
in pH was observed for all vesicles (Figure 4.5A), however, the starting pH, as obtained from 
the Fluorescein/TAMRA ratio, for each reaction seemed to slightly deviate, which indicated 
that the pH of the vesicles at the start of the reaction was not always identical. This was also 
observed from the average initial Fluorescein/TAMRA ratio of all vesicles compared to the final 
ratio, which varied between 0.55 (±0.15), and 0.61 (±0.18) after the reaction. When looking at 
the individual traces, however, the desired pH increase was achieved for each vesicle.
Similarly, also a pH increase was observed when using ADH instead of NADH 
peroxidase, but in this case, the reaction took longer to level off (Figure 4.5B). ADH was then 
used to attempt to lower the vesicle pH from 7.0 to 5.0; here again the expected pH change 
was observed, however, not all vesicles participated and some GUVs maintained a constant 
pH during the experiment (Figure 4.5C, purple line). In the experiments for small molecule 
permeability, where all GUVs showed cofactor production, no difference between the vesicles 
was observed, indicating that the problem should not lie with substrate permeability, but rather 
with an inability of some of the liposomes to maintain the pH gradient. These vesicles might 
therefore be considered leaky. The GUVs that were capable of showing a decrease in pH, did 
so as expected and reached a pH of around 5.0, however they required significantly longer 
reaction times due to the slower reaction of ADH (Figure 4.5C). 
After having established the possibility to accomplish enzyme-mediated small-molecule 
induced pH changes in GUVs we wanted to demonstrate that triggering a pH change in the vesicles 
could also lead to a change in protein assembly. To visualise this, a His6-tagged version of the
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fluorescent protein tdTomato[30] was expressed and purified (Figure 4.6). This protein was 
chosen for both its high brightness and stability at acidic pH, which was necessary to monitor 
protein localisation at lower pH inside the GUVs. As a binding partner a Ni-NTA labelled lipid 
was used, DGS-NTA-Ni. This lipid was mixed in during GUV formation at different molar 
percentages, in order to achieve different ligand densities on the vesicle membrane. To 
compensate for increasing DGS-NTA-Ni concentrations, less cholesterol was used. To assess 
which conditions were required to achieve successful assembly and disassembly of tdTomato 
on the GUV membrane, several different DGS-NTA-Ni concentrations were screened. Amounts 
ranging from 0.1% up to 5% were used in vesicles containing only the fluorescent protein, 
dissolved in either 10 mM NaH2PO4 buffer set to pH 7.0, to mimic assembly conditions, or 
pH 5.0 for disassembly. For 30 μm GUVs containing 0.5% DGS-NTA-Ni, a 1.1-fold excess of 
tdTomato (2.5 μM) was present inside the vesicle lumen, while for a 50 μm GUV the tdTomato 
excess increased to 1.8-fold. In all cases membrane binding was observed at pH 7.0, except 
for 0.1% DGS-NTA-Ni (Figure 4.7B). At pH 5.0, using higher DGS-NTA-Ni concentrations, 
membrane binding was still evident, while only at 0.5% and 0.1% of ligand there was no 
binding to the membrane (Figure 4.7A). Furthermore, in the case of 1% NTA, decreasing the 
pH to 4.5 also completely inhibited membrane binding (data not shown). However, at this pH 
also the fluorescence emission of the tdTomato protein started to decrease as a result of the 
increasing acidity. Taken together, these results indicated that the ligand density was of vital 
importance to achieve reversible assembly in the pH range between 5.0 and 7.0, and that a 
ligand density which is too high could prevent disassembly. This is likely an effect of the high 
effective molarity created on the membrane as a result of the close proximity of many Ni-NTA 
ligands. A similar effect was observed for monovalent Ni-NTA, compared to multivalent Ni-NTA 
ligands, where also an increase in binding constant was observed due to the close proximity 
of NTA ligands in the multivalent Ni-NTA ligands compared to monovalent Ni-NTA.[26]
Using the system with 0.5% DGS-NTA-Ni lipid in the vesicle membrane and a starting pH 
of 4.8 or 7.0, the respective assembly and disassembly studies were attempted. To monitor 
assembly, the ratio of lumen fluorescence intensity over membrane fluorescence intensity 
was measured. A ratio of 1 would therefore indicate uniform fluorescence and complete 
disassembly, while a ratio close to 0 would indicate a high degree of membrane association 
for the protein. When using NADH peroxidase to trigger assembly by increasing the pH, no 
change in tdTomato localisation was observed over a period of 3 h. The presence of either the
<< Figure 4.8. Assembly kinetics of His6-tdTomato (2.5 μM) in 0.5% DGS-NTA-Ni GUVs upon acetone-
induced pH increase using ADH (1 mg/mL) starting from pH 4.8 (A), with representative images of 
individual GUVs before and after assembly (B). Disassembly kinetics of His6-tdTomato in 0.5% DGS-
NTA-Ni GUVs upon iPrOH-induced pH decrease using ADH, starting from pH 6.1 (C), pH 6.5 (E) or pH 7.0 
(G), showing representative fluorescence images of GUVs before and after disassembly for pH 6.1 (D), 
pH 6.5 (F) and pH 7.0 (H). Assembly kinetics are expressed as the ratio of average lumen fluorescence 
intensity over average membrane fluorescence intensity and displayed from the moment GUVs settle into 
focus (for details see experimental procedures).
94
Chapter 4
large excess of H2O2 or of the enzyme itself might interfere with the interaction between Ni-NTA 
and the His-tag of tdTomato. Yet, neither increasing nor decreasing the concentrations of the 
enzyme or the substrate had an effect on the assembly behaviour of the system. During the 
reaction, conversion of NADH to NAD+ was observed, indicating that the enzymatic reaction 
did take place. This also indicated that a pH increase should have occurred and therefore 
assembly was probably inhibited by the presence of hydrogen peroxide. 
As using NADH peroxidase in combination with the protein-ligand interaction did not 
provide the desired result in GUVs, we attempted assembly using ADH. For this enzyme, both 
assembly and disassembly were observed upon addition of the respective triggers (Figure 
4.8). For membrane assembly, acetone was added, and a clear transition from a ratio of 
1.0 to ~0.3 was observed for nearly all the GUVs that were monitored (Figure 4.8A and B). 
Again a very small fraction of the GUVs either already displayed assembly, likely due to a 
slightly higher starting pH as was already observed in the pH sensor measurements (Figure 
4.5), or showed no assembly, possibly due to a leaky membrane. However, this still clearly 
demonstrated the small molecule triggered assembly of tdTomato on the GUV membrane. For 
GUVs where disassembly was triggered with iPrOH, however, dissociation appeared to be 
highly dependent on the starting pH in the system. Disassembly was observed to take place 
in the range between pH 5.0 and pH 6.0 and from ensemble measurements we observed that 
the enzymatic reaction was capable of achieving the required change in pH from 7.0 to below 
5.0. Yet, when the systems were monitored in GUVs, using the external trigger to start the 
Figure 4.9. Reversible assembly and disassembly kinetics of tdTomato (2.5 μM) in individual surface-
immobilised GUVs containing 0.5% DGS-NTA-Ni as a result of alternating addition of small molecule 
triggers. A) At t=0 s (blue arrow), 20 mM acetone is added to the external solution, triggering assembly. 
At t=2700 s (yellow arrow), acetone is replaced with 20 mM iPrOH to induce disassembly. At t=11700 s 
(blue arrow), iPrOH is again replaced with acetone to induce assembly, while at t=13500 s (yellow arrow), 
disassembly is triggered by addition of iPrOH. B) Fluorescence microscopy images and corresponding 
fluorescence intensity cross-sections displaying protein assembly states in GUVs of black (top) and green 
(bottom row) traces over time. Scale bar is 20 μm.
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reaction, only the system with a starting pH of 6.1 showed complete disassembly in all vesicles 
(Figure 4.8C and D). At pH 6.5 the response was slower and also not complete (Figure 4.8E 
and F), while at pH 7.0 disassembly was even less pronounced (Figure 4.8G and H). As the 
ensemble measurements previously showed that even from pH 7.0, a decrease to pH 5.0 
could be achieved, the GUVs should be capable of reaching the point of disassembly. From 
our observations in GUVs, however, it appeared that the required pH was not reached when 
the reactions were started from a pH between 6.5 and 7.0. Therefore it might be possible that 
the GUVs were unable to build up and subsequently maintain the required pH gradient long 
enough for disassembly to occur. When starting from pH 6.1, disassembly was triggered more 
quickly as the system reached the disassembly point earlier and might be more capable of 
maintaining the pH gradient. Furthermore, if leakage occurs during the reaction, the vesicles 
will adopt the pH of the outer solution, which is in all cases similar to the starting pH value of 
the reaction and this does not allow assembly to occur. 
Finally, to show the reversibility of the assembly under changing external stimuli, GUVs 
needed to be kept in place while the external volume was exchanged in order to add the 
different substrates. For this, we applied biotin-streptavidin labelling to ensure strong 
surface binding of the GUVs. The vesicles were outfitted with 0.5 mol% DSPE-PEG2000-
biotin during formation, while the surface of the microscopy slide was now first incubated 
with biotinylated BSA instead of regular BSA, subsequently washed and incubated with 
streptavidin. In this fashion a streptavidin-functionalised surface was obtained, which was 
capable of binding biotinylated GUVs (for details see experimental section). A setup was 
devised where two syringe pumps were employed to create a flow from an inlet on one side 
of the chamber to an outlet on the other side. To test the stability of the surface binding 
and the resilience of the vesicles under flow, GUVs loaded with tdTomato were imaged over 
time at several flow speeds, ranging from 1 mL/hour up to 10 mL/hour. The highest flow 
should be capable of refreshing the entire volume of the microscope slide in 2 minutes. Most 
GUVs remained surface-bound under all flow rates, only a minority of vesicles was either 
flushed away or seemed to deflate. We therefore applied this method to immobilise GUVs 
containing all the components required for assembly/disassembly experiments, starting with 
GUVs containing NADH, ADH and tdTomato in pH 4.8 buffer, which forced the system to 
assume a disassembled state. Subsequent introduction of acetone (20 mM) rapidly triggered 
tdTomato membrane assembly over the course of 15 minutes (Figure 4.9, blue arrow). After 
allowing the assembly process to level off and the lumen/membrane fluorescence intensity 
ratio to stabilise, disassembly was induced by the substitution of the acetone solution by an 
iPrOH solution (20 mM, Figure 4.9 yellow arrow). The disassembly process was considerably 
slower, compared to assembly, yet this was also expected as a result of the ensemble and 
GUV-based pH measurements  (Figure 4.4B and C and Figure 4.5B and C), where the pH 
decrease also proceeded considerably slower compared to the pH increase. Furthermore, 
the multivalent nature of the NTA-Ni-functionalised membrane might also further slow down 
dissociation. After disassembly had been reached, the cycle was started again to show the full 
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reversibility of the system. Similar time frames were observed for assembly and disassembly 
in all the imaged GUVs and also in the consecutive cycles. 
4.3 Conclusion
Due to the semi-permeable nature of lipid membranes, enzymatic reactions in GUVs can 
be started and controlled using small molecules as external stimuli to trigger these events. 
In this fashion, we showed that both ADH and NADH peroxidase were capable of converting 
their respective cofactors upon addition of the small molecule substrate. Furthermore, 
conversion of the cofactor directly influenced the internal vesicle pH, as conversion of NAD+ 
to NADH produces protons, while NADH consumption removes protons from solution. As a 
result, addition of the enzyme substrates also caused a pH gradient to be established over 
the GUV membranes.
This pH change was then applied to reversibly induce or inhibit binding of a His6-tagged 
fluorescent protein, tdTomato, to Ni-NTA ligands positioned on the GUV membrane. Both Ni-
NTA ligand density on the membrane, and the regime in which the pH changes were carried 
out proved to be critical parameters for the successful reversible assembly of the protein on 
the membrane. High Ni-NTA ligand densities produced a highly multivalent binding area on 
the membrane, which strongly bound the protein in spite of the acidic environment, while a 
low density was incapable of binding sufficient protein, even at neutral pH. Furthermore, if 
the vesicle pH was too high, the disassembly point could not be reached by the enzymes 
as either the required pH difference over the GUV membrane was too large to establish 
and maintain, or the NAD+/NADH ratio reached the equilibrium point too early and prevented 
further production of protons. This last option is less likely, as ensemble measurements 
showed that a pH below 5.0 could be reached under these conditions, although carrying out 
the reaction inside GUVs could further complicate the system. However, when operated within 
the right regime, the system can be cycled between an assembled and disassembled state 
several times, showcasing the reversible and dynamic nature of this system.
Taken together, these results show that GUVs can be produced that mimic the ability of 
cells to react to external stimuli by starting a signalling event to induce a reversible structural 
change inside the vesicle. As NAD+ and NADH are important cofactors in many biological 
processes, these simple external stimuli could therefore be used to modulate a host of more 
complex biological interactions and processes that are linked to these cofactors. Furthermore, 
also other processes, like enzyme activity,[31] can be switched on or off using the pH change 
inside giant vesicles.
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4.4 Materials and methods
4.4.1 Chemicals
Recombinant histidine-tagged tdTomato was provided by the Tsien lab (UC San Diego).
[30] Alcohol dehydrogenase (ADH030) was obtained from EvoCatal (Monheim am Rhein, 
Germany), NADH peroxidase (E. faecalis) from Megazyme (Wicklow, Ireland). All lipids were 
obtained from Avanti Polar lipids, cholesterol from Sigma-Aldrich. The 70 kDa anionic dextran-
fluorescein-tetramethylrhodamine conjugate was purchased from Life Technologies. All other 
reagents and solvents were of the highest quality grade and purchased from commercial 
suppliers and used without further purification unless stated otherwise. Lab-Tek borosilicate 
8-well chambered coverglass slides were obtained from ThermoScientific and coated with 1 
mg/mL of filtered BSA solution before use. “MilliQ” water was doubly deionised (18.2 MΩ). All 
enzymes and proteins used were washed 7 times with the desired buffer using centrifugal spin 
filters at 13 000 rpm and 4 ºC (MWCO 10 kDa, Millipore) and kept at 0 ºC.
4.4.2 Instrumentation
Plate reader data was obtained using 96-well flat black polystyrene plates (Greiner Bio-one) 
on a TECAN Infinite 200 PRO machine. Confocal laser scanning fluorescence microscopy 
was carried out on a Leica TCS SP2 AOBS Confocal Laser Scanning Microscope, using a 405 
nm, a 488 nm and a 561 nm laser as excitation sources. Cryo-SEM was performed on a JEOL 
6330 Cryo Field Emission Scanning Electron Microscope. Mass spectrometry was performed 
by electrospray ionisation time-of-flight (ESI-TOF) on a JEOL AccuTOF. Deconvoluted mass 
spectra were obtained using MagTran 1.03b2. Size-exclusion measurements were performed 
on an Amersham Ettan LC system (GE Healthcare, Diegem, Belgium) equipped with a fraction 
collector, using a Superdex 200 10/300 GL column (GE Healthcare).
4.4.3 Experimental procedures
Protein expression
tdTomato was received in a pRSET vector and transformed into BLEDR3-PLysS cells using 
heat shock.[30] Briefly, a single colony was diluted into 100 mL of 2x HY medium containing 50 
mg/L chloramphenicol and 100 mg/L ampicillin and grown overnight at 37 ºC. After this, the 
suspension was diluted to 1L with 2xHY medium containing 50 mg/L chloramphenicol and 100 
mg/L ampicillin and grown at 30 ºC, upon reaching an OD600 of 0.6, expression was induced 
by adding IPTG (1 mM). After 5 hours the cells were collected by centrifugation (4000 x G, 4 
ºC, 20 min on a Sorvall GS3) and the pellet was stored overnight at -20 ºC.
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The next day, the pellet was thawed and resuspended in 30 mL lysis buffer (50 mM NaH2PO4, 
10 mM imidazole and 300 mM NaCl, pH 8.0) and kept at 0 ºC. The cells were then lysed by 
sonication (6 times 30 sec) after which cellular debris was removed by centrifugation (15 min, 
15000 x G, 4 ºC, Sorvall HB-4). The supernatant was incubated with Ni-NTA beads (washed 
before use) for 30 min at 4 ºC, after which the suspension was poured into a column and the 
flow-through was collected. The column was then washed with two column volumes of wash 
buffer (50 mM NaH2PO4, 20 mM imidazole and 300 mM NaCl, pH 8.0). Finally, the protein was 
eluted with elution buffer (50 mM NaH2PO4, 250 mM imidazole and 300 mM NaCl, pH 8.0) 
in 500 μL fractions. The fractions containing the protein were pooled and concentrated via 
centrifugal spin filtration (MWCO 10 kDa, 13 000 rpm, 4 ºC) and further purified using FPLC 
in 20 mM NaH2PO4 pH 7.5 buffer. The purity of the protein was analysed by Accu-ToF mass 
spectrometry and by SDS-PAGE (Figure 4.6). Expression yield was determined via UV-Vis 
spectroscopy to be ~5 mg/L.
Fluorescence spectroscopy pH measurements
Reaction mixtures for fluorimetry plate reader experiments were prepared in volumes of 100 μL 
in 0.5 mM NaH2PO4 buffer, containing 300 mM NaCl and set to either pH 5.0 or 7.0. Solutions 
contained 10 mM cofactor (20 mM stock), 0.5 mg/mL pH sensor (5 mg/mL stock) and either 
NADH peroxidase or ADH at the designated concentrations. Substrate was added from a 
60 mM stock solution in buffer, to a final concentration of 12 mM. Assays were performed at 
25 ºC, while fluorescence emission intensities were measured at 523 nm and 579 nm, with 
excitation wavelengths of 480 nm and 545 nm. 
GUV formation via droplet transfer
Giant liposomes were formed by following a previously described procedure.[28] Lipids were 
dissolved at 100 mg/mL in chloroform and mixed in the desired ratio; of this mixture 20 μL 
was added to 200 μL paraffin and heated to 80 ºC for 30 min to form the oil phase and to 
evaporate the chloroform. An inner phase, containing 0.5 mM NaH2PO4 buffer, 300 mM NaCl 
and 200 mM sucrose at either pH 4.8 or 7.0, was supplemented with the desired proteins, 
pH sensor and cofactors. After this, 20 μL of inner phase was emulsified in 200 μL of lipid oil 
phase by vortexing for 30 seconds and subsequently incubated at 0 ºC for 10 min to allow 
the emulsion to stabilise. Finally, the emulsion was added onto a layer of 200 μL outer phase, 
containing 0.5 mM phosphate buffer, 300 mM NaCl and 200 mM glucose in an Eppendorf 
tube and centrifuged (30 min, 9000 x g, 4 ºC). GUVs were collected from the tube by carefully 
perforating the bottom with a needle and allowing the vesicle solution to drip out, while leaving 
the oil phase inside.
Confocal microscopy experiments
BSA-coated confocal microscopy slides (see above) were filled with 200 μL of outer phase, 
before adding the desired GUVs. For all experiments, GUVs were first allowed to settle and 
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were then imaged to assess the initial state of the vesicle population. After this, the required 
substrate was added (12 mM, 60 mM stock) and the solution was gently mixed. Several 
minutes later, the majority of the GUVs had settled down again and time-lapse imaging was 
started. Images were taken sequentially as 4 frame averages using a 63x oil immersion 
objective. As excitation sources a 405 nm diode laser, 488 nm and 561 nm lasers were used, 
for NADH (emission 415-490 nm), Fluorescein (emission 500-550 nm) and TAMRA/tdTomato 
(emission 580-650 nm), respectively, using sequential imaging.
Immobilised GUVs for reversible protein assembly
Vesicles were produced as described above, where 1 mol% of POPC was replaced with 1 
mol% of DSPE-PEG2000-biotin. Microscopy slides were functionalised with BSA-biotin (150 
μL, 1 mg/mL in MilliQ) for 2 hours and subsequently washed twice with MilliQ to remove 
unbound protein. The wells were then incubated with streptavidin (150 μL, 0.1 mg/mL in MilliQ) 
for 15 minutes and washed again with MilliQ (2 times) before adding external solution as 
described above for confocal microscopy experiments. The GUVs were allowed to settle and 
bind on the surface for 30 minutes before starting the experiments. Time-lapse imaging was 
started and the external solution was then substituted with acetone solution at a flow rate of 10 
mL/h for 5 minutes using syringe pumps (Screening Devices, Amersfoort, The Netherlands), 
after which the flow was stopped. After protein assembly was achieved, acetone solution 
was substituted with iPrOH solution to trigger assembly, again using a 10 mL/h flow rate for 5 
minutes. This process was reversed again by changing back to acetone as described before.
Image analysis
Obtained images were analysed using ImageJ software, developed by the NIH and 
available as public domain software at http://rsbweb.nih.gov/ij/. Images for the (dis)assembly 
experiments were first smoothed using a 1-pixel radius mean filter. For all experiments 
average fluorescence intensities were calculated for each vesicle by sellecting the lumen 
of the GUVs as region of interest. For membrane assembly and disassembly, rectangular 
regions of interest were setup covering straight sections of the membranes on both sides of 
the GUV in order to obtain plot profiles. These were used to compare membrane fluorescence 
intensity to the average intensity of the GUV lumen.
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Towards enzymatic reactions in giant 
liposomes triggered via membrane 
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5.1 Introduction
Cells can be considered as very complex biochemical reactors, compartmentalized by 
the cell membrane to keep all components close together. They require the constant influx of 
fuels and nutrients in order to function properly; however, the membrane generally does not 
allow passage of all molecules into the cell cytosol. Only a limited amount of molecules can 
passively cross the membrane by diffusion. Therefore various methods have been developed 
by the cell to take up its required nutrients in a controlled fashion, the most common ones 
being endocytosis[1] and selective transport by specific transporter proteins.[2] Analogous 
to cells, liposomal membranes also are only semi-permeable, yet they lack the complex 
machinery of the cell to transport compounds across their membrane. Liposomes are used as 
simple mimics of cells, for example as nanoreactor compartments, by encapsulating enzymes 
inside. To provide these nanoreactors with similar functionality as cells, methods need to be 
developed to introduce the required substrates into the liposomal lumen. Several approaches 
have been described to achieve this goal, like the passive diffusion of small molecules across 
the membrane (Chapter 4), but also membrane permeabilisation by peptide[3] and protein 
channels,[4,5] carbon nanotubes,[6],or the incorporation of selective transmembrane transporters 
have been employed.[7,8] An approach not dependent on membrane permeability, uses the 
fusion of small cationic, substrate-containing carrier liposomes with liposome nanoreactors, 
resulting in content mixing between the liposomes and therefore delivery of the substrate 
into the target vesicle.[9] However, all these approaches have their downsides, for example in 
the case of transmembrane channels there are restrictions with respect to size and charge 
of the molecules to be transported. Furthermore, the application of non-specific channel 
proteins does not provide directionality of transport, which could lead to leakage of essential 
components from the target liposome. Selective membrane channels, on the other hand, do 
offer improved selectivity, but they still remain limited to transporting only small molecules or 
specifically only one type of molecule.
The fusion between a carrier and a target liposome is the most widely applicable 
approach in terms of the type and size of molecules that can be transported. Yet the problem 
of specificity and selectivity of these systems still remains, since the currently applied cationic 
liposomes are prone to interact and fuse with any type of lipid membrane they encounter.[9] 
In this chapter we set out to develop a robust and specific delivery strategy to a cell-
mimetic system based on giant unilameller vesicles (GUVs). To obtain the most generic 
delivery pathway, fusion with substrate-loaded small unilamellar vesicles (SUVs) was 
envisaged. To provide specificity in the fusion process, we applied the selective interaction 
of complementary leucine zipper peptides. These peptides have been extensively applied 
to induce fusion between two populations of SUVs in a specific manner.[10] Leucine zipper 
peptides are characterized by amino acid heptad repeats and have the tendency to adopt 
helical conformations. They can selectively interact with each other and form a coiled-coil 
motif upon dimerization.[11] When one leucine zipper is positioned in the GUV and the other
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in the SUV membrane, coiled-coil formation brings the two membranes in close proximity of each 
other, which facilitates the fusion process (Figure 5.1A). This occurs by means of both charge 
interactions and hydrophobic interactions between the two peptide chains, as is depicted in the 
helical wheel representation (Figure 5.1B-C).[12] In this chapter the heterodimerising leucine 
zipper pair developed by Hodges and co-workers was used.[13] These peptides are based on 
the heptad repeat units EIAALEK (acidic zipper, E) and KIAALKE (basic zipper, K), and they 
form stable heterodimers at neutral pH. Both peptides contain four heptad repeats, as these 
display stronger binding and more efficient fusion behaviour compared to peptides containing 
two or three heptad repeats.[14] One leucine zipper was introduced into the SUV population 
Figure 5.1. A) Introduction of enzyme substrates into GUVs can be performed by forcing SUVs containing 
the substrate (light green) to fuse with GUVs. SUVs can be outfitted with one type of leucine zipper (blue), 
while the GUVs are functionalised with the complementary leucine zipper (red). Heterodimerisation of the 
two leucine zippers will cause the SUV to bind and dock to the GUV, eventually causing membrane fusion. 
Upon fusion, the substrate encapsulated in the SUV will be released into the GUV where it can react with 
enzymes present in the lumen (orange) to form a fluorescent product (bright green). B) Visualisation of 
coiled-coil formation between two complementary leucine zipper peptides. C) Helical wheel representation 
of leucine zipper coiled-coil formation, showing the positioning of hydrophobic amino acids (a, d) and 
charged amino acids (e, g).  D) Chemical structures of the two leucine zippers employed: CP4K4 and 
CP4E4. B and C were reproduced from reference 11 with permission.
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during the formation process by using a hydrophobic anchoring group that will incorporate into 
the lipid membrane, while the complementary zipper was included in the GUV population via 
a post-formation modification (Figure 5.1A). For fusion to be successful, lipid mixtures have 
to be applied that are capable of undergoing fusion under the applied conditions; therefore 
we selected a mixture of 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine (DOPE) and Cholesterol (Chol) in a molar ratio of 50/25/25, 
which has been previously shown to demonstrate fusiogenic behaviour.[10] Furthermore, 
cholesterol was found to be the strongest and most stable hydrophobic anchoring group for 
anchoring the leucine zipper peptides into lipid membranes[15] and therefore this group was 
attached to both peptides using a short tetra ethylene glycol spacer. When mixing SUVs and 
GUVs, the peptide interaction will bring the SUV and GUV membranes in close proximity to 
each other and force the vesicles to dock and eventually fuse (Figure 5.1A).
To gain temporal control over enzymatic reactions and also observe this process, fusion 
between SUVs and GUVs should cause a substrate or enzyme to be delivered into the GUV 
lumen, where the other reaction component already resides. As fluorescence is one of the 
more sensitive detection methodologies, pro-fluorescent substrates were chosen, which could 
be converted into a fluorescent product by the enzymes present inside the GUVs (Figure 5.1A). 
Furthermore, as this system expands on work presented in both Chapter 3 and Chapter 4, 
we would also like to apply this triggering mechanism to control multicompartment reactions, 
where substrates can be converted by enzymes residing in different subcompartments 
of the GUVs. For this, part of the enzymes can be segregated in semi-porous PS-b-PIAT 
nanoreactors, while other enzymes reside in the lumen of the GUV.[16,17] The spatial separation 
of enzymes can be used to allow incompatible enzymes to work together without influencing 
each other. 
Finally, the need for displaying the complementary leucine zipper on the GUV membrane 
could also be used to specifically address and trigger fusion of only a smaller subset of GUVs 
in a larger GUV population mixture. By only incorporating the lipidated leucine zipper in a 
smaller set of GUVs, while leaving the others without or with a different orthogonal zipper 
peptide, the SUVs should only be able to bind and fuse with the GUVs containing the correct 
complementary zipper.
5.2 Results and discussion
To assess if SUV-GUV fusion is a viable option to introduce substrates for enzymatic 
reactions into the larger vesicles, the process was first validated using the model hydrophilic 
fluorescent molecule calcein as SUV cargo via a content mixing assay. The GUVs were made 
using a hydrogel-mediated rehydration approach,[18] which provides a higher degree of control 
over GUV size during rehydration compared to regular vesicle growth methodologies, as the 
cross-linking density of the hydrogel influences the eventually obtained vesicle size. A lipid 
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mixture of DOPC/DOPE/Chol (50/25/25 molar ratio) in CHCl3:MeOH (3:7) was deposited as 
a film on the hydrogel and subsequently dried, before adding a 200 mM sucrose solution 
to grow the vesicles. The formed vesicles were analysed using both confocal fluorescence 
microscopy and cryogenic scanning electron microscopy (cryo-SEM), which revealed 
an average size of about 10 μm, as expected (Figure 5.2A-C and 5.2G-H). Furthermore, 
incorporation of PS-b-PIAT nanoreactors, filled with the enzyme alkaline phosphatase, 
was also demonstrated. For this, the nanoreactors were embedded in the hydrogel before 
lipid deposition. After growing the GUVs, vesicle formation was verified using fluorescence 
microscopy (Figure 5.2D-F) and the presence of the nanoreactors was observed using cryo-
SEM (Figure 5.2I-K). To allow fusion, the cholesterol-anchored basic zipper (CP4K4, Figure 
5.1D) was incorporated into the membrane after GUV formation by adding 1 mol% of CP4K4 
to the GUVs in respect to the total lipid concentration, using a rehydrated CP4K4 solution in 
200 mM glucose solution (Figure 5.2D-F). After incubation, the giant vesicles were diluted 
into 200 mM glucose solution and allowed to sediment for microscopy analysis. For fusion 
assays requiring vesicle immobilisation, 0.1 mol% DSPE-PEG2000-biotin was added to the 
lipid mixture before deposition on the hydrogel. 
To allow for a relatively sensitive detection of fusion in GUVs via content mixing using 
fluorescence microscopy, calcein was encapsulated at a concentration of 100 mM in SUVs 
containing 1 mol% of the cholesterol-anchored acidic zipper (CP4E4, Figure 5.1D) in the 
liposome membrane. The vesicles were grown by rehydration of the lipids in calcein solution, 
and subsequently resized by extrusion and purified by size-exclusion chromatography (SEC),
Figure 5.2. GUV characterisation using confocal microscopy and cryo-SEM. A-C) Confocal fluorescence 
microscopy images of GUVs filled with FITC-dextran (green), membrane-labelled with CellMask Deep 
Red (cyan) and visualised via transmission. D-F) Confocal fluorescence microscopy images of GUVs 
with incorporated FITC-labelled lipidated leucine zipper (green), membrane-labelled  with CellMask Deep 
Red (cyan) and visualised via transmission. Scale bar is 25 μm. G-H) Cryo-SEM micrographs of regular 
GUVs. I) Cryo-SEM micrograph showing the incorporation of PS-b-PIAT nanoreactors inside the GUV. 
J-K) Images displaying magnifications of this vesicle, highlighting the nanoreactors inside (white arrows). 
Scale bar is 1 μm.
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to remove any non-encapsulated calcein. This yielded liposomes with an average size of 243 
± 4 nm and a PDI of 0.107 ± 0.013 (Figure 5.3A and B). The high concentration of calcein was 
used in order to compensate for the high volume dilution that occurs upon introduction of SUV
Figure 5.3. Fusion of calcein-containing CP4E4-functionalised SUVs with CP4K4-functionalised GUVs. 
A) Dynamic light scattering (DLS) analysis of purified calcein SUVs. B) SEC traces of purified lissamine-
labelled SUVs, showing co-elution of calcein (UV absorbance, grey trace) with SUVs (lissamine 
fluorescence, black trace) to demonstrate dye encapsulation. C) Fluorescence increase inside a GUV 
(black trace) plotted over time as a result of fusion of a CP4K4-functionalised GUV with CP4E4-functionalised 
SUVs. Red trace displays background fluorescence due to calcein leakage from SUVs. D) Corresponding 
confocal fluorescence microscopy images for calcein fluorescence for the time points displayed in graph 
(C). E) Images of a GUV before addition of SUVs (green fluorescence left, transmission right) and F) after 
washing away excess SUVs upon completion of fusion, showing calcein (green) and membrane-bound 
lissamine from docked GUVs (red). Scale bar is 10 μm. 
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cargo into the GUV lumen. From a 200 nm SUV to a 30 μm GUV the dilution factor is ± 3.4*106 
fold. This means that to reach a micromolar concentration, which is still visible by confocal 
fluorescence microscopy, over 100-1000 fusion events might be required, and this number 
increases rapidly when either decreasing the SUV size or increasing GUV size. Using small 
GUVs of 10-20 μm should therefore provide a more sensitive detection of content mixing 
between SUVs and GUVs compared to using a 50 μm GUV, as they have a higher surface 
to volume ratio, and which in turn should provide a faster and more sensitive detection of 
successful fusion due to the lower dilution factor.
To assess the possibility of leucine-zipper mediated fusion between SUVs and GUVs, first 
GUVs without nanoreactors were applied. For this, GUVs with both biotin and CP4K4 groups 
presented on the membrane were immobilised on the surface of a streptavidin-functionalised 
microscopy chamber and washed using a 5 mL/h flow with fresh buffer, before adding a 
solution of CP4E4-functionalised SUVs containing calcein. SUV binding and fusion with GUVs 
was followed over time (Figure 5.3C-F). For all monitored vesicles, binding of SUVs to the
Figure 5.4. Lissamine and calcein fluorescence intensities measured in GUVs after fusion and excess 
SUV removal. A) Scatter plot of lissamine fluorescence intensity of GUV-bound SUVs against size. B) 
Scatter plot of calcein fluorescence intensity inside the GUV lumen plotted against size. C) 3D bar graph 
of lissamine fluorescence intensity (y-axis, right) and calcein fluorescence intensity (z-axis) plotted against 
GUV size (x-axis, front). Blue and purple bars depict low calcein fluorescence, green and orange show 
intermediate fluorescence and red and brown bars display high fluorescence.
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membrane was observed, as was visualised by the incorporation of 0.2 mol% lissamine-
labelled lipid in the SUV membrane, which after removal of SUVs from the outer solution was 
still present on the GUV membrane (Figure 5.3F), indicating successful binding. Furthermore, 
the average lissamine intensity from SUVs found on GUV membranes was similar for all 
vesicles, irrespective of the average diameter (Figure 5.4A and Figure 5.3F). This indicated 
that SUV binding to the GUVs was relatively uniform and that the CP4K4 density was similar 
on all GUVs after post-modification with the leucine zipper. We then studied calcein delivery 
into GUVs as a result of fusion. Here a clear increase in lumen fluorescence intensity was 
observed over time as a result of SUV-GUV fusion (Figure 5.3C and D). Furthermore, also 
an increase in background fluorescence from the SUV solution was observed, which likely 
resulted from calcein leakage from the SUVs. However, fluorescence inside the GUV lumen 
was clearly higher, indicating that GUV fluorescence develops as a result of liposome fusion 
instead of passive leakage into the vesicle. 
However, not all vesicles displayed the same amount of internal calcein fluorescence. 
When plotting GUV diameter against calcein fluorescence in the lumen, it appeared that larger 
vesicles generally contained lower concentrations of calcein (Figure 5.4B). This might be 
expected, as GUV volume increases more rapidly compared to the available surface area for 
SUV binding, allowing fewer fusion events per volume unit. When subsequently plotting the 
lissamine intensity observed on GUV membranes versus the calcein fluorescence in the lumen 
and also correlating this to the GUV size, it was found that for similar lissamine intensities and 
GUV sizes very different calcein concentrations were seen in the GUV lumen (Figure 5.4C). 
This indicated that the fusion process did not always proceed with the same efficiency in 
giant vesicles of similar sizes. We therefore decided to study this process in more detail, by 
analysing GUV images taken before SUV addition and after SUV removal upon completion 
of fusion. These showed that the calcein fluorescence remained inside the giant vesicles, but 
now a membrane-bound fraction could also be distinguished, possibly indicating the presence 
of SUVs bound to the membrane that have not fused with the GUVs yet (Figure 5.3E and F). 
As this fluorescence did not yet penetrate to the lumen, the incomplete fusion of SUVs with 
the GUV could be an explanation for the differences in internal calcein concentration. Other 
explanations might be that the GUVs are not all unilamellar, or that leakage from the vesicles 
occurs, and the calcein that is introduced via fusion leaks out again to the outer volume. 
Figure 5.5. A reaction between an enzyme and a substrate, triggered by fusion-induced mixing of the 
reagents inside a GUV. SUVs containing fluorescein dibutyrate were fused with GUVs containing porcine 
liver esterase (1 mg/mL). Pictures display three different GUVs imaged 30 minutes after the addition of 
substrate-containing SUVs, via both transmission (left) and fluorescence, showing lissamine lipids from 
SUVs (red) and the reaction product fluorescein (green). Scale bar is 10 μm.
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After having successfully demonstrated fusion between CP4E4-SUVs and CP4K4-GUVs 
using a content mixing assay, we attempted to load a pro-fluorescent enzyme substrate into 
the SUV lumen and active enzymes in the GUVs in order to trigger an enzymatic reaction upon 
fusion. Using pro-fluorescent substrates removes the background fluorescence observed 
with the calcein-containing SUVs. This should not require a washing step after fusion, as 
fluorescence should only evolve in GUVs where fusion takes place and where the substrate 
and enzyme are combined. As a model system, we selected porcine liver esterase (PLE) as 
an enzyme, which can convert pro-fluorescent fluorescein dibutyrate into fluorescein upon 
cleavage of the butyl ester groups.
Upon mixing SUVs containing 5 mM fluorescein dibutyrate with esterase-containing 
GUVs fluorescein fluorescence was observed inside GUVs after 30 minutes of incubation 
(Figure 5.5). This showed that a substrate and an enzyme could be mixed using this method, 
and that subsequently a reaction could be initiated at a desired time point. Due to the slightly 
hydrophobic nature of the substrate, some more intense areas of fluorescence were observed 
close to the vesicle membrane. 
Using more hydrophilic substrates might alleviate this problem, as they should not 
interact with the membrane. To address this problem, we first attempted to use a combination 
of alkaline phosphatase and the substrate 3-O-methylfluorescein monophosphate, where the 
phosphatase enzyme was positioned in GUVs (1 mg/mL), while the substrate was placed 
in the other compartment. Unfortunately, the solubility of the substrate (10 mM) was found 
to be little better than the dibutyrate described above, and this did not provide a strong 
enough fluorescent response after initiating the fusion experiment. Alternatively, by placing 
the enzyme in the SUVs (1-5 mg/mL), also no fluorescent signal was obtained from the GUVs 
containing 250 μM substrate. This was likely due to the heating and sonication steps required 
to rehydrate and extrude the SUVs, which could affect the activity of the enzyme. 
As a second option, we tried to increase substrate loading in SUVs by using smaller 
hydrophilic molecules like glucose and lactate. Both substrates can be linked via either 
Glucose Oxidase (GOx) or Lactate Oxidase (LOx), to the Amplex Red assay, as hydrogen 
peroxide is produced by conversion of the substrates by GOx or LOx. Horseradish peroxidase 
(HRP, 0.1 mg/mL) can then use hydrogen peroxide to simultaneously convert Amplex Red 
(AR) into fluorescent resorufin. For both glucose and lactate, substrate loadings of 200 mM 
were achieved in SUVs, while GOx or LOx (both 0.1 mg/mL), together with HRP (0.1 mg/mL) 
and AR (200 μM) were loaded into GUVs.
Unexpectedly, both enzyme assays showed high levels of background fluorescence. In 
case of GOx, this was first explained by impurities of glucose present in sucrose necessary for 
GUV preparation. The inner solution for GUVs requires 200 mM sucrose to eventually create 
a density difference between the GUV lumen and the outer solution that contains glucose. 
This density difference causes the GUVs to sediment, aiding in both purification and analysis 
by microscopy. To avoid this problem, a density gradient based on caesium chloride (CsCl) 
as the inner phase, and sodium chloride (NaCl) as the outer phase, was applied instead of 
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sucrose and glucose. The use of these salts did not display any background signal for both 
the GOx and LOx-based AR assay in bulk solution in the absence of glucose or lactate, 
respectively (data not shown). However, when it was attempted to grow GUVs containing the 
AR assay components, the addition of the reaction mixtures onto the lipid-treated, or untreated 
hydrogel substrate, caused red fluorescence to evolve in minutes for both LOx/HRP/AR and 
GOx/HRP/AR mixtures, indicating conversion of AR into its fluorescent form, resorufin. For 
GOx, the presence or formation of free glucose in the dextran hydrogel might be a source 
of background reaction, however, for LOx this should not be the case and therefore a side 
reaction involving HRP or AR is more likely. The hydrogel components could provide HRP with 
a source of peroxides or an alternative substrate, allowing it to convert AR in the process, or 
the hydrogel components might directly interact with AR, as the reaction mixtures themselves 
remain stable and colourless in solution for hours. In all cases, the components were kept in 
the dark to prevent photo oxidation of AR. Further research is still required to determine the 
source of interference with the AR assay. Yet, it is likely that an enzymatic cascade reaction 
that avoids the AR system might be desirable.
5.3 Conclusion
Giant vesicles, outfitted with a cholesterol-functionalised leucine zipper peptide can 
be used to selectively induce fusion and content mixing with small liposomes displaying 
the complementary leucine zipper peptide. Furthermore, we have also demonstrated the 
encapsulation of PS-b-PIAT nanoreactors inside these GUVs, which in future can be used 
to apply not only single-enzyme reactions, but also multi-step enzymatic cascade reactions 
containing incompatible components.
The concept of fusion-guided delivery of cargo molecules to GUVs was first proven by 
introduction of highly charged calcein via SUV-GUV fusion into the GUV lumen. SUV binding 
to GUVs was observed to be homogeneous, with SUVs evenly distributed over the giant 
vesicle membrane, yet despite this, different degrees of fusion were observed in the giant 
vesicle population. A size-dependency was observed for calcein concentrations in the GUV 
lumen after fusion, where larger vesicles generally seemed to contain less calcein. This was 
expected, as vesicle volume increases faster compared to vesicle surface area when the 
diameter becomes larger. The number of fusion events is likely limited by the surface area of 
the GUV and not by the amount of CP4K4 presented on the membrane, as incorporating more 
than 1 mol% CP4K4 was shown not to increase fusion efficiency any further.
[19] As a result, 
there is increasingly less surface area compared to volume, which means that the dilution 
factor of SUV content upon fusion also increases with GUV size, as there is less SUV binding 
area for the same volume in larger GUVs.
However, there was also a part of the population that did not display fusion, which might 
indicate that this part perhaps does not possess a unilamellar membrane, but is multilamellar 
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in nature and that delivery into the lumen would not be possible. Alternatively, the vesicles 
could have become porous during the fusion process, for example due to osmotic pressure 
imbalances that might have been created over the GUV membrane during the fusion process, 
causing them to burst or become porous. In some experiments, indeed GUV shrinkage was 
observed over time, which coincided with content loss.
To show that enzymatic reactions can be started in GUVs by using small liposomes 
to deliver substrates, an esterase, PLE, was encapsulated in the large vesicles, while its 
substrate was positioned in SUVs. After mixing, it was observed that fluorescence had 
evolved inside the GUVs after 30 minutes of reaction, indicating that it was possible to start 
an enzymatic reaction using the SUVs as delivery vehicles. Yet, similarly to calcein delivery 
described above, also not all vesicles displayed the same amount of fusion.
The principle of SUV-GUV fusion was demonstrated to be capable of triggering a reaction 
inside GUVs, however, further experiments need to be performed to study the kinetics of the 
enzymatic reaction in more detail. For this, it might be beneficial to use highly hydrophilic 
substrates, like calcein, as those are often more soluble in aqueous buffers and can be loaded 
into SUVs at higher concentrations. Due to the very large dilution factor from a single SUV 
volume to a GUV, the substrate concentration inside the SUV should preferably be similar 
to, or higher than the above-used calcein concentration of 100 mM. Although, for fluorescein 
butyrate the very hydrophobic nature of the butyrate groups might also have increased the 
encapsulation efficiency in SUVs by promoting membrane interaction or a nucleation event 
with lipids during SUV formation.
Based on the results described in this chapter, the use of AR-based enzymatic assays, 
using either GOx or LOx in combination with HRP, should be avoided. Both assays give a 
high background fluorescence signal in the absence of the actual glucose or lactate substrate, 
respectively, due to a reaction with the hydrogel substrate, which causes the production of 
fluorescent resorufin. 
Therefore another substrate system should be used that can be loaded either at 
high concentrations in SUVs, or for which the enzyme or catalytic co-substrate can be 
encapsulated in SUVs and can withstand the increased temperatures required for rehydration 
and extrusion. Possible options include the use of fluorescein diphosphate, which should 
be more soluble compared to the mono phosphate used in this chapter, or the use of the 
highly soluble glucose-6-phosphate (G6P) in combination with G6P dehydrogenase (G6PDH) 
linked to the diaphorase/resazurin assay. Alternatively, a more sensitive detection method 
can be used that does not rely on the stoichiometric conversion of one substrate molecule 
into one fluorescent molecule. The above-mentioned G6PDH/diaphorase assay requires the 
cofactor NAD+, which is recycled between the two enzymes. Therefore the delivery of NAD+ 
into GUVs could be used as a very sensitive detection method. As the cofactor is continuously 
recycled, only catalytic amounts of cofactor are required to start the enzymatic reaction. Next 
to this, encapsulation of an enzyme like PLE in SUVs for conversion of fluorescein dibutyrate 
located inside GUVs might also provide a more sensitive read out, as one enzyme can convert 
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multiple pro-fluorescent substrate molecules. However, in this case it should be verified that 
the enzyme can retain a sufficient amount of activity during the encapsulation process to be 
able to still convert the substrates after fusion.
Despite the fact that some hurdles remain to be taken, the results presented in this 
chapter demonstrate that the concept of using SUV-GUV fusion to start enzymatic reactions in 
GUVs is very promising and could prove to be an interesting and useful addition to the toolbox 
for controlling processes in cell-like systems.
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5.5 Materials and methods
5.5.1 Chemicals
All lipids were obtained from Avanti Polar lipids, except cholesterol, which came from Sigma-
Aldrich. Alkaline phosphatase, glucose oxidase, lactate oxidase, horseradish peroxidase 
and Alcalase were from Sigma-Aldrich. Sepharose CL-4B in HBS buffer was used for 
size-exclusion chromatography (Sigma-Aldrich). FITC-dextran (3-5 kDa mw), fluorescein 
dibutyrate, Amplex Red (AmpliFlu) and 3-O-Methylfluorescein phosphate were obtained from 
Sigma-Aldrich, fluorescein diphosphate was purchased from Anaspec, calcein from Acros, 
and CellMask Deep Red from Life Technologies. PS-b-PIAT was obtained from Encapson 
(Nijmegen, The Netherlands).
All other reagents and solvents were of the highest quality grade and purchased from 
commercial suppliers and used without further purification unless stated otherwise. Lab-Tek 
borosilicate 8-well chambered cover glass slides were obtained from ThermoScientific and 
coated with 1 mg/mL of filtered BSA solution before use. “MilliQ” water was doubly deionised 
(18.2 MΩ). All enzymes and proteins used were washed 7 times with the desired buffer using 
centrifugal spin filters at 13 000 rpm and 4 ºC (MWCO 10 kDa, Millipore) and kept at 0 ºC. Lab-
Tek borosilicate 8-well chambered cover glass slides were obtained from ThermoScientific. 
HBS solution contained 10 mM (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 135 mM 
NaCl, 5 mM KCl, 1.8 mM CaCl2 and 1 mM MgCl2 in MilliQ water, with a pH set to 7.4. Both 
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glucose and sucrose solutions contained 200 mM of the respective sugar and were prepared 
in 20 mM Na2HPO4 buffer pH 7.4.
5.5.2 Instrumentation
Platereader data were obtained using 96-well flat black polystyrene plates (Greiner Bio-one) 
on a TECAN Infinite 200 PRO machine. Confocal laser scanning fluorescence microscopy 
was carried out on a Leica TCS SP2 AOBS Confocal Laser Scanning Microscope, using 
a 488 nm and a 561 nm laser as excitation sources. Cryo-SEM was performed on a JEOL 
6330 Cryo Field Emission Scanning Electron Microscope. Dynamic light scattering (DLS) 
measurements were performed on a Malvern Zetasizer Nano-Z (Malvern Instruments, 
Malvern, UK). Sonication was performed with a Branson 2510 ultrasonic cleaner or a VWR 
ultrasonic cleaner. Extrusion was performed using a mini-extruder from Avanti Polar Lipids, 
using Whatman 200 nm nuclepore Track-etch membranes. Syringe pumps were obtained 
from Harvard Apparatus.
5.5.3 Experimental procedures
SUV rehydration
Lipids (DOPC, DOPE, Chol, CP4E4, 49/25/25/1 molar ratio) were dissolved in chloroform (1 
mL, 10 mM concentration) and evaporated under nitrogen flow in a glass vial to yield a lipid 
film. If a fluorescent lipid was required, also 0.2 mol% DOPC was substituted with DOPE-
lissamine. After drying the film under vacuum for 2 hours, a solution of cargo molecule in HBS 
buffer was added (0.5 mL, with either 100 mM calcein, 5 mM fluorescein dibutyrate, or 10 mM 
fluorescein monophosphate) and allowed to rehydrate the lipids for 20 min at 50 ºC under 
gentle agitation. The obtained liposome solution was then sonicated for 1 minute at room 
temperature (VWR ultrasonic cleaner) before undergoing extrusion through a 200 nm pore 
size filter (15 times, at 50 ºC). After resizing, the liposomes were purified using a Sepharose 
CL-4B size-exclusion column. Fractions were analysed with fluorescence spectroscopy 
and only the most concentrated liposome fractions were selected based on their lissamine 
fluorescence intensity. Purified vesicles were further analysed by DLS and stored at 4 ºC until 
further use.
Nanoreactor assembly
Alkaline phosphatase nanoreactors were assembled by adding a solution of PS-b-PIAT in 
THF (0.5 mL, 1 mg/mL) to an aqueous solution of the enzyme in HBS (0.2 mg/mL, 2.5 mL) 
in a dropwise fashion under gentle agitation. After allowing the particles to assemble for 30 
minutes, the solution was transferred to a dialysis bag (1000 kDa MWCO, SpectraPor) and 
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dialysed for 36 hours against fresh HBS at 4 ºC. The dialysis medium was refreshed regularly. 
After dialysis, the nanoreactor solution was recovered and the volume was set to 2 mL.
Streptavidin-functionalised microscopy slides
To immobilise GUVs on a streptavidin surface, microscopy slides were first functionalised with 
BSA-biotin (150 μL, 1 mg/mL in MilliQ) for 2 hours and subsequently washed twice with MilliQ 
to remove unbound protein. The wells were then incubated with streptavidin (150 μL, 0.1 mg/
mL in MilliQ) for 15 minutes and washed again with MilliQ (2 times).
GUV rehydration
Glass slides functionalised with a cross-linked dextran-PEG hydrogel,[18] were coated with a 
lipid mixture (5 μL, 10 mM DOPC/DOPE/Chol at a 50/25/25 molar ratio) in CHCl3/MeOH (3:7) 
and subsequently dried under nitrogen flow. After drying the slides under vacuum for 1 hour, 
an O-ring was mounted around the lipid film and fixed using vacuum grease. Next, 300 μL 
of sucrose solution was added, if necessary also supplemented with 1 mg/mL porcine liver 
esterase or alkaline phosphatase. The rehydration chamber was then sealed with a glass 
coverslip to prevent evaporation and the lipid film was allowed to rehydrate overnight. Finally, 
GUVs were collected from the hydrogel slide and used for microscopy experiments by diluting 
them in 400 μL glucose solution in the microscopy chamber and allowing them to sediment.
Alternatively, for the AR assay, sucrose in the inner solution was substituted with 200 mM 
CsCl in 20 mM Na2HPO4 buffer pH 7.4, while 200 mM NaCl was added to the outer solution 
to replace glucose.
In case of incorporation of nanoreactors in GUVs, the particles were embedded in the hydrogel 
during attachment of the gel to the glass slide. After this, lipids were applied on the gel in the 
same fashion as described above.
Leucine zipper incorporation in GUVs
A solution of 50 μM CP4K4 in CHCl3:MeOH (1:1) was evaporated in a glass vial under 
continuous nitrogen flow and subsequently dried under vacuum for 2 hours to remove 
residual solvent. The film was then rehydrated in glucose solution at 40 ºC under sonication 
for 20 minutes, to yield a 50 μM solution. This solution was then diluted 10 times into a GUV 
solution (1 mol% in respect to total lipid concentration) and incubated for 2 hours. GUVs were 
subsequently transferred onto a microscopy slide containing 400 μL glucose solution and 
allowed to sediment and bind, before washing and imaging.
SUV-GUV fusion experiments
For fusion experiments, GUVs containing 1 mol% CP4K4 were immobilised using 0.1 mol% 
DSPE-PEG2000-biotin, as described above. The outer solution was first reduced to about 100 
μL using a syringe pump, before replacing the remaining volume with SUVs containing either 
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calcein or enzyme substrates. A flow rate of 5 mL/hour was applied for 6 minutes to completely 
replace the prior glucose solution. Time-lapse imaging was started just before the addition 
of SUVs and images were taken every 15 minutes. Imaging was performed sequentially, for 
which calcein was excited using a 488 nm laser, while lissamine was exited using a 561 nm 
laser.
Cryo-SEM
GUVs were prepared as described above using the hydrogel-based rehydration approach. 
After overnight rehydration, GUVs in sucrose solution were transferred into an Eppendorf 
tube containing 750 μL glucose solution and gently mixed. The vesicles were then allowed to 
sediment for 2 hours. From the bottom of the tube 5 μL was removed and injected into a hollow 
cylindrical sample holder and flash frozen in liquid nitrogen. The sample was then inserted into 
the cryo-SEM and cleaved to make a horizontal fracture plane. After a 10 minute sublimation 
step, the fracture plane was coated with a thin gold-palladium layer and subsequently imaged.
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6.1 Discussion and outlook
The research presented in this thesis focuses on the application of polymer and 
liposome-based systems in mimicking cellular structure and function. Eukaryotic cells are 
multicompartmentalised structures, and this provides them with spatial control over the 
assembly and organisation of biomolecules. We attempted to use these features to develop 
organelle-like structures that could be introduced in living cells, but also tried to deploy these 
artificial organelles to construct an artificial mimic of a complete cell by introducing these 
smaller compartments in a single larger one. In this section the results and implications of 
this research are discussed, coupled to their respective fields and also several issues will be 
indicated that should be addressed for this research to move forward.
6.2 Artificial organelles
Nanoreactors, filled with enzymes or other catalysts have already been successfully 
applied in living cells to carry out a number of different types of enzymatic reactions.[1–3] Yet 
due to the size of the nanoreactor container, reaching the desired site of action inside the cell 
becomes challenging. As was shown in Chapter 2, nanoreactors can be taken up by cells via 
macropinocytosis, yet localise to endosomes and lysosomes as part of this uptake pathway. 
Avoiding this pathway and achieving cytosolic delivery of nanoreactors will be essential in 
allowing nanoreactors to address processes taking place in the cytosol or other organelles, 
like combatting reactive oxygen species in mitochondria or replacing missing or dysfunctional 
enzymes in cytosolic pathways. In literature there are some claims of nanoreactors 
spontaneously leaving endosomal compartments over time, however, no clear mechanism or 
explanation is provided.[2] We did not observe this for our formulation, therefore it is desirable 
to develop a robust and well-characterised method for achieving cytosolic delivery.
In this thesis we have tried to address the issue of nanoreactor localisation by attaching 
endosomolytic peptides to the nanoreactor surface in the hope of releasing the particles from 
endosomes after uptake, by destroying or disrupting the endosomal membrane surrounding 
the particles. Unfortunately, the conjugation of the peptides proved troublesome due to 
non-specific adsorption, and it yielded particles that showed aggregation behaviour and 
considerable batch-to-batch variation in cell experiments. This made it very difficult to properly 
validate the effects of the peptides on nanoreactor localisation. 
Therefore, a different approach was instigated, by designing a liposome-based delivery 
vehicle containing the nanoreactors, which should be capable of fusing with the cell membrane 
and subsequently releasing the particles into the cell cytosol. Such an approach avoids the 
endolysosomal system and does not require particle surface modifications. We have shown that 
several liposomal formulations, modified with the above mentioned endosomolytic peptides, 
are capable of delivering a small dye into the cytosol. Furthermore, in later Chapters we have 
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also shown that different types of giant vesicles can be made, filled with nanoreactors, which is 
a promising starting point for the further development of this delivery approach. In Chapter 5, 
a leucine zipper-mediated membrane fusion system was developed to fuse small unilamellar 
vesicles (SUVs) with giant unilamellar vesicles (GUVs) and deliver small substrates into the 
giant vesicles. Also this technology might be applied to achieve fusion with live cells; docking 
of SUVs with cells has already been observed using this technology.[4]
However, there are still several important issues that should be addressed. A robust 
preparation method should be developed to make large amounts of GUVs with the desired 
fusiogenic lipid composition and fill them with high concentrations of nanoreactors. The droplet 
transfer methodology allows high encapsulation, yet it is not very compatible with fusiogenic 
lipid mixtures, as the vesicles tend to aggregate upon forming a pellet during the centrifugation 
step. Vesicle yields tend to vary a lot, and are considerably lower compared to those obtained 
for non-fusiogenic lipid mixtures. The hydrogel-based rehydration method is compatible 
with these fusiogenic lipids, however, for achieving efficient nanoreactor encapsulation, the 
particles should be embedded into the hydrogel before applying the lipids and subsequently 
rehydrating them. This process will not be compatible with most types of enzymes that are 
inside the nanoreactor, as it involves exposure to organic solvent and subsequent drying. 
Therefore this process will require some optimisation, or perhaps a different preparation 
method should be set up altogether, for example based on microfluidics.[5] Furthermore, 
finding the correct size of the delivery vehicle for efficient membrane fusion will be crucial, as 
smaller liposomes are more prone to undergo membrane fusion. Downsizing by extrusion will 
provide some degree of control over the size of the vesicles, however, efficient loading will 
be difficult to maintain as soon as the liposome diameter comes close to the diameter of the 
particle. Ideally, a single nanoreactor should be encapsulated in a single liposome, analogous 
to a virus covered with a lipid mantle.[6]
The design of the nanoreactor currently relies heavily on the intrinsic porosity 
introduced by using the PS-b-PIAT block copolymer, yet using this polymer will likely cause 
problems in future biomedical applications, as it is not biodegradable. Therefore finding a 
biodegradable alternative for these nanoreactors will be essential before attempting their 
application in a biomedical setting. For this, some well-established vesicle systems exist, 
based on polypeptide systems,[7,8] or hydrophobic polymers like poly(caprolactone),[9] or 
poly(trimethylene carbonate),[10] combined with a suitable hydrophilic block, like poly(ethylene 
glycol). However, an important consideration remains the introduction of permeability, as for 
this sidechain-modified monomers will need to be included in the hydrophobic block, which 
ensure both the structural stability as well as a sufficient degree of permeability in the vesicle. 
Several interesting methods exist to achieve this,[11,12] but none have been successfully 
applied yet in a fully biodegradable system. Alternatively, a crystalline hydrophobic block 
such as poly(caprolactone) can be used without sidechain modifications, as the crystallisation 
behaviour of the polymer in the vesicle membrane can give rise to leaky, yet stable vesicles. 
Furthermore, permeability will also be directly related to the stability and degradation rates 
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of the polymeric shell and therefore the encapsulated enzyme. If the shell degrades too fast, 
active enzyme will be lost due to premature particle degradation, while slow degradation might 
cause accumulation of nanoreactors filled with inactivated enzyme inside cells, which might 
also result in increased toxicity.
Considering these issues, both the delivery of the particles to the desired intracellular 
location and achieving tuneable degradability will be vital points that need to be addressed for 
artificial organelles to turn from an academically interesting system to a potential therapeutic 
platform that could produce added value over regular protein replacement therapies.
6.3 Cell mimics
Besides the use of nanoreactors in living cells, this thesis also describes their use in 
mimicking cellular structure by making multicompartment systems. In this growing field of 
protocell and minimal cell research, both top-down and bottom-up strategies are applied to 
develop minimal living systems. Researchers either develop new protocell models, which 
aspire to become primitive,[13–15] but often also alternative living systems,[16,17] by means of 
a bottom-up approach, or they develop simple minimal cells using a top-down approach by 
removing all non-essential components form existing cells.[18,19] 
On the one hand, the top-down development of minimal cells will lead to more 
understanding of all the different components of the cell and how they interact with each 
other, and will eventually lead to designer cells with specific functions in biotechnology. On 
the other hand, the more fundamental side of this field, which tries to build living systems 
from the bottom up, might give insight in how life itself developed and which types of primitive 
predecessors might have existed in the past. For this, understanding the organisational and 
multicompartment structure of the cell and how it assembles is an important aspect. 
In Chapter 3, we describe the construction of multicompartment systems that mimic the 
structure of eukaryotic cells, and also use this spatial organisation to separate a protease from 
other enzymes. The application of organelle mimics to separate incompatible components 
might be expanded upon, for example by using the organelle compartments to introduce 
more complex systems to the cell mimic, like energy production, as occurs in mitochondria 
or chloroplasts, to power reactions taking place inside the giant vesicles. Organelles can 
furthermore be used to spatially position enzymes close together to increase metabolic 
channelling of intermediates from one enzyme to another, as positioning consecutive enzymes 
of a cascade close together, improves efficiency of enzymatic pathways.[20,21]
In order to study and mimic cellular functions, also a higher degree of temporal control 
over the activity of the systems should be introduced. In contrast to what is described in 
Chapter 3, where all components are mixed, then encapsulated in a giant polymersome and 
subsequently observed, it would be very interesting to be able to control the start and influence 
the progress of the reactions inside the vesicle. For this we substitute the outer polymer-based 
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membrane for a lipid membrane, which is thinner and more permeable, to create a more 
dynamic system. In Chapters 4 and 5 we describe two methods to gain more control over the 
system, using external addition of the substrate, either via transfer into the giant vesicles via 
passive diffusion, or via active membrane fusion with a carrier liposome. However, this toolbox 
needs to be expanded to accommodate more different types of triggers. Passive diffusion is 
only applicable for small, uncharged molecules, while charged, or larger molecules will remain 
excluded. Introduction via membrane fusion can be a useful alternative to introduce these 
larger and also charged molecules, yet efficiency of this approach is limited due to the large 
dilution of the substrate upon fusion with the larger liposome. However, other methods, like in 
situ photo-activation of a substrate or enzyme could be an interesting addition as it can provide 
faster introduction of substrates, as no transport over the membrane is required. Furthermore, 
these compounds can be loaded directly during formation of the system and their dosage can 
be tuned by changing the illumination time. It might also allow the in situ uncaging of otherwise 
labile compounds that cannot be introduced via the abovementioned methods.
These reaction control tools and external triggers, can then be coupled using this platform 
to cell-mimicking processes like energy production, protein synthesis, signal transduction 
or self-replication. Introducing such functionalities in giant vesicles, and coupling these to 
activating triggers might yield very interesting materials capable of responding to changes 
in their environment. Furthermore, using such a bottom-up method of constructing cell-like 
structures allows precise control over the included components. Combined with suitable 
activation triggers, individual cellular processes or structures can be reconstituted and 
studied in detail and in a controlled environment. This could contribute to our understanding 
of specific cellular processes and the role compartmentalisation plays in the functioning 
of the cell. Subsequently, several of these processes and compartments can of course be 
combined to increase the complexity of the system in order to create structures that display 
an increasing resemblance to actual living cells and might eventually also start to function as 
simple, autonomous, self-sufficient synthetic cells.
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Compartmentalisation is one of the key organisational features used in Nature. Cells 
use this to spatially organise their biomacromolecules and reaction environments in order for 
them to function in close proximity without influencing each other. For example, the degrading 
and acidic environment of the lysosome is kept separated from the protein producing areas 
in the endoplasmic reticulum and Golgi apparatus. Besides allowing for separation, spatial 
organisation and confinement of enzymes can also improve the efficiency of multi-step 
reaction pathways by creating local high concentrations of metabolites. To study the effects 
of compartmentalisation on enzymatic reactions, and to apply the benefits of confinement, we 
attempted to mimic the organisational structure of a eukaryotic cell and its organelles using 
either polymer or lipid building blocks. We used this platform to create both artificial organelles 
for usage in living cells and in simple multicompartmentalised artificial cells.
In order to use compartmentalisation to spatially confine enzymes, capsules are required 
that can both encapsulate the catalytic species and display a sufficient degree of porosity 
to allow substrates and products to pass through the membrane, while at the same time 
retaining the enzymes inside the nanoreactor, or artificial organelle. Furthermore, when 
mimicking a full cell, these smaller organelle subcompartments have to be encapsulated 
inside a larger cell-sized compartment. Chapter 1 describes the advances in the design, 
synthesis, functionalisation, and in some cases already the cellular application, of polymer-
based nanoreactors. Additionally, several methods of creating multicompartment, or vesicles-
in-vesicle systems are highlighted as well. However, the challenge of introducing biological 
functionality into these systems was not yet widely explored.
In Chapter 2, we first explored the use of semi-porous PS-b-PIAT nanoreactors as 
artificial organelles in cells and how their intracellular localisation could be controlled. For this, 
the nanoreactors were first functionalised with the cell-penetrating peptide ‘tat’, which allowed 
the particles to be taken up by cells. Initial studies using Horseradish Peroxidase as an enzyme 
inside the nanoreactors showed that the enzymatic activity was still present upon internalisation 
of the particles into cells. However, it was also observed that this activity decreased over time. 
We speculated that the lysosomal localisation of the nanoreactors after uptake caused the 
enzyme to slowly lose activity and that this could be prevented upon granting the particles 
access to the less hostile environment of the cytosol. The lysosomal routing of the particles 
was first confirmed by colocalisation studies with fluorescent lysosomal stains and by electron 
microscopy, where lipid membranes were observed around the nanoreactors. After this, we 
attempted to functionalise the nanoreactor surface with membrane-disruptive peptides in 
order to escape the endolysosomal system. To monitor this, a fluorescent pH sensor was 
included in the nanoreactors to study the change in pH of the surrounding environment. If 
endosomal escape was successful, the surrounding pH should become neutral instead of 
the acidic pH found in endosomes. Unfortunately, no clear effect of the peptides on particle 
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trafficking could be observed. Due to aggregation and non-specific binding of the peptides to 
the nanoreactors, no well-defined particles could be produced to yield reproducible effects 
on intracellular routing. In an attempt to bypass the endolysosomal system, we devised a 
liposomal carrier system that can directly fuse with the cell membrane to release its cargo into 
the cytosol. Initial studies in delivering a small molecule dye were already successful. Addition 
of the endosome-disruptive peptides further improved the efficiency of cytosolic delivery. This 
methodology can now be further applied to the delivery of nanoreactors. Both Chapter 3 and 
Chapter 5 describe the formation of giant vesicles containing small nanoreactor compartments 
that could serve as carriers for this approach.
To mimic not only organelle subcompartments, but also complete cell structures, the 
formation of multicompartment systems containing nanoreactors was attempted in Chapter 
3. Here we showed that PS-b-PIAT nanoreactors, containing either alcohol dehydrogenase 
(ADH), or Candida Antarctica lipase B (CalB), suspended in a solution containing phenylacetone 
monooxygenase (PAMO), could be encapsulated in large, cell-sized, PB-b-PEG polymersomes 
using an emulsion-based droplet transfer method. Using a pro-fluorescent substrate, which 
required sequential modifications by PAMO, CalB and ADH to become fluorescent, we studied 
the reaction inside the cell mimics. It was observed that fluorescence was produced over 
time, indicating that the multi-step reaction cascade was functioning as expected and that 
the reaction intermediates were capable of moving into the different compartments where 
the enzymes were located. Furthermore, if ADH, the final enzyme of the reaction sequence, 
was confined to an organelle subcompartment, local product formation was observed by 
the evolution of bright fluorescent spots inside the cell mimics, which corresponded with 
the nanoreactors. Finally, the effect of confinement in organelles was applied to separate 
an incompatible enzyme from the other enzymes. To realise this, CalB was replaced by the 
protease Alcalase, which can also perform the CalB step, but simultaneously degrades other 
enzymes in the same solution. Segregation of Alcalase in a nanoreactor clearly showed an 
improvement in reaction rate compared to the system where the protease was in solution and 
capable of degrading both PAMO and ADH.
The system described above is a static system, after encapsulation the reaction inside 
the cell mimic cannot be influenced anymore. To gain control over the start of the reaction, or 
to be able to influence it as it commences, more dynamic systems were devised. Chapter 4 
and Chapter 5 both describe methods for influencing and controlling the chemistry inside the 
giant vesicles using external triggers. To enable this, the PB-b-PEG polymer membrane was 
substituted for a lipid membrane, which is thinner and more dynamic. 
In Chapter 4 we showed that diffusion of a small molecule, either acetone or iso-propanol, 
over the membrane of giant unilamellar liposomes (GUVs) could be used to reversibly change 
the interior pH of the vesicle. In the GUV, the small molecules are converted by an ADH, 
which also uses NAD(H) in the process. During the conversion of NAD(H) either a proton is 
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produced or consumed, therefore allowing the pH of the vesicle lumen to be controlled by the 
addition of an external substrate. We then also used this pH change to reversibly control the 
assembly of a protein-ligand complex on the GUV membrane.
As only small, uncharged molecules can easily traverse the liposomal membrane by 
passive diffusion, an additional strategy was devised in Chapter 5 to also introduce larger 
and more charged molecules into the lumen of GUVs. For this approach membrane fusion 
was selected, as during the fusion of two liposomes, mixing of lumen content is induced. To 
enable efficient membrane fusion, a leucine-zipper-based peptide interaction was employed 
to bind and bring the liposomes in close proximity in order to induce fusion. In this fashion, a 
small unilamellar liposome (SUV), displaying a leucine-zipper peptide, can act as a carrier that 
delivers a substrate to an enzyme already residing in a GUV, displaying the complementary 
leucine-zipper, to start a reaction between them. To prove the concept, first a model fluorescent 
molecule was encapsulated in SUVs and the evolution of fluorescence inside GUVs was 
observed after SUVs were added. Next, SUVs were filled with a pro-fluorescent substrate, 
while the corresponding enzyme was place in GUVs. Also here fluorescence evolved within 
30 minutes after addition of SUVs, yet it was localised for a large part on the GUV membrane. 
As the first enzymatic substrate was relatively hydrophobic, next several less hydrophobic 
pro-fluorescent substrates were explored, yet these could not be delivered into GUVs in 
sufficient quantities. Therefore even more hydrophilic substrates should be investigated to 
achieve sufficiently high substrate loadings in SUVs for future experiments.
Finally, Chapter 6 reflects on the results presented in this thesis and discusses possible 
avenues for future research in the fields of both cell mimics and the use of artificial organelles 
in cells, and additionally includes suggestions for improvement of the systems that were 
developed as part of this work.
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Compartmentalisatie is een van de belangrijkste organisatorische eigenschappen 
die door de natuur wordt toegepast. Cellen gebruiken dit om hun biomacromoleculen en 
reactieve omgevingen ruimtelijk te organiseren en scheiden om deze dicht bij elkaar te laten 
functioneren zonder elkaar te beïnvloeden. Bijvoorbeeld, de zure en afbraak bevorderende 
omgeving in het lysosoom wordt afgeschermd van de eiwit producerende regio’s in het 
endoplasmatisch reticulum en Golgi apparaat. Naast het mogelijk maken van scheiding, kan 
ruimtelijke organisatie en insluiting van enzymen ook de efficiëntie van multistap reactieketens 
bevorderen door lokaal hoge concentraties van metabolieten te creëren. Om het effect van 
compartmentalisatie op enzymatische reacties te bestuderen en om de voordelen hiervan toe 
te passen, hebben wij geprobeerd om de organisatorische structuur van een eukaryotische 
cel en zijn organellen na te bouwen met polymere en lipide bouwstenen. We hebben dit 
platform gebruikt om artificiële organellen te creëren voor gebruik zowel in levende cellen, als 
in eenvoudige kunstmatige cellen met meerdere compartimenten.
Om compartmentalisatie te kunnen gebruiken voor het scheiden en insluiten van 
enzymen zijn capsules nodig die het eiwit efficient kunnen insluiten en vasthouden, maar 
ook voldoende porositeit bieden om substraten en producten door het membrane te laten 
diffunderen. Op deze manier wordt een nanoreactor, ofwel kunstmatig organel, gevormd. 
Daarnaast, wanneer men een volledige cel wil nabootsen, zullen deze kleine organellen 
in een groter compartiment, ter grootte van een echte cel, ingesloten moeten worden. 
Hoofdstuk 1 beschrijft de ontwikkelingen in het ontwerp, de synthese, functionalisatie, en in 
sommige gevallen ook al cellulaire toepassing van op polymeren gebaseerde nanoreactoren. 
Daarnaast worden ook verschillende methoden voor het maken van systemen met meerdere 
compartimenten, of voor compartiment-in-compartiment systemen beschreven. Maar de 
uitdaging om biologische functionaliteiten in deze systemen in te bouwen is nog vrijwel 
onaangeraakt gebleven.
In Hoofdstuk 2 hebben we als eerste het gebruik van semi-poreuze PS-b-PIAT 
nanoreactoren als kunstmatige organellen in cellen onderzocht. Hierbij werd vooral gekeken 
naar hun lokalisatie in de cel na opname en hoe deze kon worden gecontroleerd. Hiervoor 
werd het opname-inducerende peptide ‘tat’ op het oppervlak van de nanoreactoren geplaatst, 
waardoor deze deeltjes actief door cellen opgenomen konden worden. Initiële studies 
waarbij het enzym Horseradish Peroxidase ingesloten was in de nanoreactoren liet zien 
dat de enzymatische activiteit nog steeds zichtbaar was na opname in de cel, maar de 
activiteit hiervan nam wel af met de tijd. We speculeerden dat de intracellulaire verplaatsing 
van de deeltjes richting lysosomen ervoor zorgde dat het enzym langzaam zijn activiteit 
verloor. Waarschijnlijk kon dit voorkomen worden door de nanoreactoren toegang te geven 
tot het cytoplasma van de cel, waar de omgeving minder schadelijk is voor het ingesloten 
enzym. Als eerste werd het transport naar het lysosoom geverifieerd door overlap van de 
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nanoreactoren met lysosoom-specifieke fluorescente kleuringen te bepalen. De lokalisatie 
werd verder bevestigd door elektronen microscopie, waarmee werd aangetoond dat de 
nanoreactoren werden omringd door een lipide membraan. Hierna hebben we geprobeerd om 
de nanoreactoren met peptiden te bekleden die het endosomale membraan kunnen verstoren 
om zo de deeltjes naar het cytosol van de cel te laten gaan. Om dit te kunnen waarnemen werd 
een fluorescente pH sensor in de nanoreactoren ingesloten, welke de verandering in pH van 
de endosomale omgeving (zuur) naar het cytosol (neutraal) kan visualiseren. Helaas konden 
we geen duidelijk effect van de peptiden op de lokalisatie waarnemen. Aangezien de peptiden 
aggregatie en niet-specifieke binding op de deeltjes veroorzaakten konden we geen goed 
gedefinieerde nanoreactoren produceren. Als gevolg hiervan was het effect van de peptiden 
op de intracellulaire lokalisatie niet erg reproduceerbaar. Om dit probleem te omzeilen hebben 
we een alternatief systeem ontworpen dat geen gebruikt maakt van het endosomale systeem. 
Hiervoor werd een liposomale drager ontwikkeld, welke direct met het cellulaire membraan zou 
moeten fuseren en zijn inhoud in het cytosol moeten brengen. Initiële experimenten met een 
klein molecuul waren al succesvol, waarbij de toevoeging van eerdergenoemde membraan 
verstorende peptiden de efficiëntie van dit systeem verhoogden. Deze methodologie is nu 
klaar om getest te worden voor de afgifte van nanoreactoren in cellen. Zowel Hoofdstuk 3 als 
Hoofdstuk 5 beschrijven de vorming van grote compartimenten met kleinere nanoreactoren 
erin die dienst zouden kunnen doen als dragers voor deze aanpak.
Om niet alleen organellen na te bootsen, maar ook complete cel structuren, hebben 
we in Hoofdstuk 3 geprobeerd om de PS-b-PIAT nanoreactoren in te sluiten in een groter 
compartiment. Hier hebben we laten zien dat nanoreactoren, die alcohol dehydrogenase 
(ADH) of Candida Antarctica lipase B (CalB) bevatten, gemengd met een oplossing van 
phenylaceton monooxyganase (PAMO) ingesloten kunnen worden in grote, cel achtige, PB-b-
PEG capsules door gebruik te maken van een emulsiedruppel transfer methode. Door gebruik 
te maken van een pro-fluorescent substraat dat specifiek door PAMO, CalB en als laatste door 
ADH gemodificeerd moet worden, konden we reactiecascades in deze kunstmatige cellen 
bestuderen. Omdat er fluorescentie gedurende de tijd werd geproduceerd toonde dit aan dat 
de drie enzymen samen aan een kettingreactie konden deelnemen en dat de geproduceerde 
metabolieten zich naar de verschillende organellen konden verplaatsen waar de enzymen 
zich bevonden. Buiten dit, bleek ook dat wanneer het laatste enzym van de reactiecascade, 
ADH, zich in een organel bevond er zeer lokale fluorescente punten werden geproduceerd 
in de kunstmatige cel, welke overeenkwamen met de ADH bevattende nanoreactoren. Als 
laatste werd de insluiting van enzymen in organellen gebruikt om incompatibele enzymen van 
elkaar te scheiden. Hiervoor werd CalB vervangen door Alcalase, een protease dat dezelfde 
functie kan uitvoeren, maar daarnaast ook andere enzymen af kan breken. Door Alcalase in 
een organel te plaatsen zorgde dit ervoor dat de kettingreactie veel beter verliep dan in het 
systeem waar de protease zich in dezelfde oplossing bevond als PAMO en ADH en deze 
daardoor kon afbreken.
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Het systeem dat hierboven wordt beschreven betreft een statisch systeem, wat 
betekent dat na het insluiten van alle componenten in de kunstmatige cel, de reactie niet 
meer beïnvloed kan worden. Om meer controle te krijgen over de start van de reactie en 
diens verloop, werden meer dynamische systemen ontworpen. Hoofdstuk 4 en Hoofdstuk 5 
beschrijven beide een methode om systemen te maken die de chemie in een kunstmatige cel 
kunnen beïnvloeden door gebruik te maken van externe signalen. Om dit mogelijk te maken 
werd het PB-b-PEG polymere membraan vervangen door een lipide membraan, omdat dit 
dunner en meer dynamisch is.
In Hoofdstuk 4 werd gedemonstreerd hoe een klein molecuul, aceton of isopropanol, 
het membraan van een groot liposoom kan passeren en binnenin op een reversibele manier 
de pH in het liposoom kan beinvloeden. In het lumen van de capsule wordt het kleine molecuul 
omgezet door ADH, waarbij ook NAD(H) wordt gebruikt. Tijdens deze omzetting wordt ook een 
proton geproduceerd of geconsumeerd, waardoor de pH in het liposoom dus veranderd kan 
worden door de toevoeging van het kleine molecuul aan de liposoom oplossing. Aangezien de 
pH verandering beide kanten op gestuurd kan worden door de keuze van het kleine molecuul, 
kon de pH verandering gebruikt worden om de binding van een pH gevoelig eiwit-ligand 
complex in het liposoom op een omkeerbare manier te controleren en veranderen.
Aangezien alleen kleine en relatief ongeladen moleculen eenvoudig over het liposomale 
membraan kunnen diffunderen door passief transport, werd in Hoofdstuk 5 een tweede 
strategie ontwikkeld om ook grotere en meer geladen moleculen in het lumen van de liposomen 
toe te laten. Voor deze aanpak werd membraan fusie gebruikt, omdat tijdens de fusie van 
twee liposomen hun inhouden gemengd worden. De interactie tussen twee leucine zipper 
peptides werd gebruikt om de liposomen dicht bij elkaar te brengen en membraan fusie te 
induceren. Op deze manier kan een klein liposoom met het ene leucine zipper peptide worden 
gebruikt als drager van een substraat, om deze af te geven na fusie met een groter liposoom 
dat het andere peptide heeft en een enzym bevat dat het substraat kan omzetten. Een model 
fluorescent molecuul, calceine, werd als eerste gebruikt om het concept van membraan fusie 
in dit systeem aan te tonen. Door dit molecuul in kleine liposomen in te sluiten kon het door 
membraan fusie bezorgd worden in het lumen van een groot liposoom. Hierna werd een 
enzym in het grote liposoom geplaatst en hebben we geprobeerd een substraat hiervoor 
te bezorgen. Na 30 minuten wachten zagen we ook nu fluorescentie in het grote liposoom, 
maar deze bevond zich ook voor een deel op het membraan van de grote capsule. Aangezien 
dit substraat redelijk hydrofoob was, werden hierna meerdere substraten geprobeerd die 
minder hydrofoob waren, maar deze konden niet in voldoende hoeveelheden bezorgd worden 
om ze zichtbaar te maken met fluorescentie microscopie. Een belangrijke reden hiervoor 
is waarschijnlijk dat de belading van het substraat in het liposoom niet hoog genoeg was, 
waardoor het voor toekomstige experimenten belangrijk is om een zeer hydrofiel substraat te 
gebruiken dat met hoge concentraties ingesloten kan worden in de drager liposomen.
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Samenvatting
Als laatste blikt Hoofdstuk 6 terug op de resultaten die in dit proefschrift beschreven 
staan en draagt mogelijke opties aan voor verder onderzoek. De resultaten worden geplaatst 
in het perspectief van respectievelijk de ontwikkeling van kunstmatige organellen in levende 
cellen, als in de ontwikkeling en bouw van kunstmatige cellen. Daarnaast worden mogelijke 
verbeteringen en verdere ontwikkelingsmogelijkheden van de in dit proefschrift beschreven 
systemen besproken.
